BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-818. [PMID: 32219356 DOI: 10.1001/jamacardio.2020.1017] [Cited by in Crossref: 1614] [Cited by in F6Publishing: 1512] [Article Influence: 807.0] [Reference Citation Analysis]
Number Citing Articles
1 Nai Fovino L, Cademartiri F, Tarantini G. Subclinical coronary artery disease in COVID-19 patients. Eur Heart J Cardiovasc Imaging 2020;21:1055-6. [PMID: 32671381 DOI: 10.1093/ehjci/jeaa202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
2 Wang N, Cao J, Lal S. COVID-19: getting to the heart of the matter. Eur J Heart Fail 2020;22:2216-8. [PMID: 32945558 DOI: 10.1002/ejhf.2007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Fogante M, Cavagna E, Rinaldi G. Coronary arteries and aortic valve calcifications in COVID-19. Emerg Radiol. [DOI: 10.1007/s10140-021-02011-3] [Reference Citation Analysis]
4 Mihalj M, Carrel T, Gregoric ID, Andereggen L, Zinn PO, Doll D, Stueber F, Gabriel RA, Urman RD, Luedi MM. Telemedicine for preoperative assessment during a COVID-19 pandemic: Recommendations for clinical care. Best Pract Res Clin Anaesthesiol 2020;34:345-51. [PMID: 32711839 DOI: 10.1016/j.bpa.2020.05.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
5 Meyerowitz EA, Vannier AGL, Friesen MGN, Schoenfeld S, Gelfand JA, Callahan MV, Kim AY, Reeves PM, Poznansky MC. Rethinking the role of hydroxychloroquine in the treatment of COVID-19. FASEB J 2020;34:6027-37. [PMID: 32350928 DOI: 10.1096/fj.202000919] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 34.5] [Reference Citation Analysis]
6 Paris S, Inciardi RM, Lombardi CM, Tomasoni D, Ameri P, Carubelli V, Agostoni P, Canale C, Carugo S, Danzi G, Di Pasquale M, Sarullo F, La Rovere MT, Mortara A, Piepoli M, Porto I, Sinagra G, Volterrani M, Gnecchi M, Leonardi S, Merlo M, Iorio A, Giovinazzo S, Bellasi A, Zaccone G, Camporotondo R, Catagnano F, Dalla Vecchia L, Maccagni G, Mapelli M, Margonato D, Monzo L, Nuzzi V, Pozzi A, Provenzale G, Specchia C, Tedino C, Guazzi M, Senni M, Metra M. Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study. Europace 2021:euab146. [PMID: 34297833 DOI: 10.1093/europace/euab146] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, Gal Oz A, Rothschild E, Baruch G, Peri Y, Arbel Y, Topilsky Y. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation 2020;142:342-53. [PMID: 32469253 DOI: 10.1161/CIRCULATIONAHA.120.047971] [Cited by in Crossref: 169] [Cited by in F6Publishing: 99] [Article Influence: 84.5] [Reference Citation Analysis]
8 Tassiopoulos AK, Mofakham S, Rubano JA, Labropoulos N, Bannazadeh M, Drakos P, Volteas P, Cleri NA, Alkadaa LN, Asencio AA, Oganov A, Hou W, Rutigliano DN, Singer AJ, Vosswinkel J, Talamini M, Mikell CB, Kaushansky K. D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis. Front Med (Lausanne) 2021;8:631335. [PMID: 33634153 DOI: 10.3389/fmed.2021.631335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
9 Tamagnini G, Biondi R, Ricciardi G, Rutigliano R, Trias-Llimós S, Meuris B, Lamelas J, Del Giglio M. Cardiac surgery in the time of the novel coronavirus: Why we should think to a new normal. J Card Surg 2020;35:1761-4. [PMID: 32667077 DOI: 10.1111/jocs.14741] [Reference Citation Analysis]
10 Huang B, Xu C, Liu H, Deng W, Yang Z, Wan J, Yan H, Cao G, Chen J, Jiang H. In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic. J Cardiovasc Pharmacol 2020;76:540-8. [PMID: 33170591 DOI: 10.1097/FJC.0000000000000909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
11 Panagides V, Vincent F, Weizman O, Jonveaux M, Trimaille A, Pommier T, Cellier J, Geneste L, Marsou W, Deney A, Attou S, Delmotte T, Fauvel C, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Karsenty C, Duceau B, Sutter W, Mika D, Pezel T, Waldmann V, Ternacle J, Cohen A, Bonnet G; Critical COVID-19 France Investigators. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 2021;114:415-25. [PMID: 34099379 DOI: 10.1016/j.acvd.2021.04.003] [Reference Citation Analysis]
12 Shafi AMA, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID-19 patients-A systematic review. J Card Surg. 2020;35:1988-2008. [PMID: 32652713 DOI: 10.1111/jocs.14808] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
13 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang Y, Coats AJ, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M. Management of heart failure patients with COVID ‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:941-56. [DOI: 10.1002/ejhf.1915] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
15 Giani AM, Chen S. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery. Stem Cell Res 2021;53:102207. [PMID: 33677394 DOI: 10.1016/j.scr.2021.102207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Li Y, Fang L, Zhu S, Xie Y, Wang B, He L, Zhang D, Zhang Y, Yuan H, Wu C, Li H, Sun W, Zhang Y, Li M, Cui L, Cai Y, Wang J, Yang Y, Lv Q, Zhang L, Johri AM, Xie M. Echocardiographic Characteristics and Outcome in Patients With COVID-19 Infection and Underlying Cardiovascular Disease. Front Cardiovasc Med 2021;8:642973. [PMID: 33796573 DOI: 10.3389/fcvm.2021.642973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Chang JJ, Bruxvoort K, Chen LH, Akhavan B, Rodriguez J, Hechter RC. Brief Report: COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System. J Acquir Immune Defic Syndr 2021;88:1-5. [PMID: 34397741 DOI: 10.1097/QAI.0000000000002715] [Reference Citation Analysis]
18 Vitiello A, La Porta R, Ferrara F. Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19. Med Hypotheses 2021;147:110486. [PMID: 33460992 DOI: 10.1016/j.mehy.2021.110486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
19 Camelo S, Latil M, Agus S, Dioh W, Veillet S, Lafont R, Dilda PJ. A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality. Emerg Microbes Infect 2021;10:2256-63. [PMID: 34783636 DOI: 10.1080/22221751.2021.2006579] [Reference Citation Analysis]
20 Rauch A, Labreuche J, Lassalle F, Goutay J, Caplan M, Charbonnier L, Rohn A, Jeanpierre E, Dupont A, Duhamel A, Faure K, Lambert M, Kipnis E, Garrigue D, Lenting PJ, Poissy J, Susen S. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19. J Thromb Haemost 2020;18:2942-53. [PMID: 32881304 DOI: 10.1111/jth.15067] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
21 Wicik Z, Eyileten C, Jakubik D, Simões SN, Martins DC Jr, Pavão R, Siller-Matula JM, Postula M. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. J Clin Med 2020;9:E3743. [PMID: 33233425 DOI: 10.3390/jcm9113743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
22 Brandão SCS, Godoi ETAM, Ramos JOX, Melo LMMP, Dompieri LT, Brindeiro Filho DF, Sarinho ESC. The Role of the Endothelium in Severe COVID-19. Arq Bras Cardiol 2020;115:1184-9. [PMID: 33470322 DOI: 10.36660/abc.20200643] [Reference Citation Analysis]
23 Chamié D, Oliveira F, Braga S, Costa JR, Siqueira DAA, Staico R, Costa R, Maldonado G, Tanajura LFL, Centemero MP, Chaves ÁJ, Abizaid ACSL, Freitas RAP, Coelho NT, Ohe LN, Abboud C, Feres F. Adapted Catheterization Laboratory Practices during the COVID-19 Pandemic: The Instituto Dante Pazzanese de Cardiologia Protocol. Arq Bras Cardiol 2020;115:558-68. [PMID: 33027381 DOI: 10.36660/abc.20200489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 He F, Quan Y, Lei M, Liu R, Qin S, Zeng J, Zhao Z, Yu N, Yang L, Cao J. Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases. Aging Dis 2020;11:763-9. [PMID: 32765943 DOI: 10.14336/AD.2020.0622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Navari Y, Bagheri AB, Akhavan Rezayat A, SeyedAlinaghi S, Najafi S, Barzegary A, Asadollahi-Amin A. Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis. Health Sci Rep 2021;4:e427. [PMID: 34761124 DOI: 10.1002/hsr2.427] [Reference Citation Analysis]
26 Zhao Z, Chen A, Hou W, Graham JM, Li H, Richman PS, Thode HC, Singer AJ, Duong TQ. Prediction model and risk scores of ICU admission and mortality in COVID-19. PLoS One 2020;15:e0236618. [PMID: 32730358 DOI: 10.1371/journal.pone.0236618] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 31.5] [Reference Citation Analysis]
27 Beitzke D, Salgado R, Francone M, Kreitner KF, Natale L, Bremerich J, Gutberlet M, Mousseaux E, Nikolaou K, Peebles C, Velthuis B, Vliegenthart R, Loewe C, Emrich T;  Executive Committee of the European Society of Cardiovascular Radiology (ESCR):; Luigi N, Matthias G, Rozemarijn V, Konstantin N, Marco F, Christian L, Brigitta V, Rodrigo S, Charles P, Ellie M. Cardiac imaging procedures and the COVID-19 pandemic: recommendations of the European Society of Cardiovascular Radiology (ESCR). Int J Cardiovasc Imaging. 2020;36:1801-1810. [PMID: 32451877 DOI: 10.1007/s10554-020-01892-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
28 Tsai SJ, Atai NA, Cacciottolo M, Nice J, Salehi A, Guo C, Sedgwick A, Kanagavelu S, Gould SJ. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity. J Biol Chem 2021;297:101266. [PMID: 34600888 DOI: 10.1016/j.jbc.2021.101266] [Reference Citation Analysis]
29 Adu-Amankwaah J, Mprah R, Adekunle AO, Ndzie Noah ML, Adzika GK, Machuki JO, Sun H. The cardiovascular aspect of COVID-19. Ann Med 2021;53:227-36. [PMID: 33345626 DOI: 10.1080/07853890.2020.1861644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
30 Khalirakhmanov AF, Idrisova KF, Gaifullina RF, Zinchenko SV, Litvinov RI, Sharafeev AZ, Kiyasov AP, Rizvanov AA. Pathogenesis, Diagnosis, and Treatment of Hemostatic Disorders in COVID-19 Patients. Acta Naturae 2021;13:79-84. [PMID: 34377558 DOI: 10.32607/actanaturae.11182] [Reference Citation Analysis]
31 Bhatt AS, Jering KS, Vaduganathan M, Claggett BL, Cunningham JW, Rosenthal N, Signorovitch J, Thune JJ, Vardeny O, Solomon SD. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail 2021;9:65-73. [PMID: 33384064 DOI: 10.1016/j.jchf.2020.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
32 Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb Res 2020;196:143-51. [PMID: 32871306 DOI: 10.1016/j.thromres.2020.08.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
33 Chung MK, Karnik S, Saef J, Bergmann C, Barnard J, Lederman MM, Tilton J, Cheng F, Harding CV, Young JB, Mehta N, Cameron SJ, McCrae KR, Schmaier AH, Smith JD, Kalra A, Gebreselassie SK, Thomas G, Hawkins ES, Svensson LG. SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. EBioMedicine 2020;58:102907. [PMID: 32771682 DOI: 10.1016/j.ebiom.2020.102907] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 25.5] [Reference Citation Analysis]
34 Mousseaux E, Fayol A, Danchin N, Soulat G, Charpentier E, Livrozet M, Carves JB, Tea V, Salem FB, Chamandi C, Hulot JS, Puymirat E. Association between coronary artery calcifications and 6-month mortality in hospitalized patients with COVID-19. Diagn Interv Imaging 2021:S2211-5684(21)00169-8. [PMID: 34312110 DOI: 10.1016/j.diii.2021.06.007] [Reference Citation Analysis]
35 Chatzis DG, Magounaki KT, Pantazopoulos IN, Johnson EO, Tsioufis KP. COVID-19 pandemic and cardiovascular disease: where do we stand? Minerva Cardioangiol 2020;68:347-58. [PMID: 32472990 DOI: 10.23736/S0026-4725.20.05298-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
36 Pimentel M, Magalhães APA, Novak CV, May BM, Rosa LGBD, Zimerman LI. Cardiac Arrhythmias in Patients with COVID-19. Arq Bras Cardiol 2021;117:1010-5. [PMID: 34550170 DOI: 10.36660/abc.20200963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Dewland TA, Whitman IR, Win S, Sanchez JM, Olgin JE, Pletcher MJ, Santhosh L, Kumar U, Joyce S, Yang V, Hwang J, Ogomori K, Peyser N, Horner C, Wen D, Butcher X, Marcus GM. Prospective arrhythmia surveillance after a COVID-19 diagnosis. Open Heart 2022;9:e001758. [DOI: 10.1136/openhrt-2021-001758] [Reference Citation Analysis]
38 Alsagaff MY, Oktaviono YH, Dharmadjati BB, Lefi A, Al-Farabi MJ, Gandi P, Marsudi BA, Azmi Y. Electrocardiography on admission is associated with poor outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis. J Arrhythm 2021;37:877-85. [PMID: 34386111 DOI: 10.1002/joa3.12573] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Cadegiani FA. Repurposing existing drugs for COVID-19: an endocrinology perspective. BMC Endocr Disord 2020;20:149. [PMID: 32993622 DOI: 10.1186/s12902-020-00626-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
40 Sato K, Sinclair JE, Sadeghirad H, Fraser JF, Short KR, Kulasinghe A. Cardiovascular disease in SARS-CoV-2 infection. Clin Transl Immunology 2021;10:e1343. [PMID: 34512975 DOI: 10.1002/cti2.1343] [Reference Citation Analysis]
41 Bhandari M, Pradhan A, Vishwakarma P, Sethi R. Coronavirus and cardiovascular manifestations- getting to the heart of the matter. World J Cardiol 2021; 13(10): 556-565 [PMID: 34754400 DOI: 10.4330/wjc.v13.i10.556] [Reference Citation Analysis]
42 Ali A, Noman M, Guo Y, Liu X, Zhang R, Zhou J, Zheng Y, Zhang XE, Qi Y, Chen X, Men D. Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality. Sci Rep 2021;11:5975. [PMID: 33727641 DOI: 10.1038/s41598-021-85426-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Contini C, Enrica Gallenga C, Neri G, Maritati M, Conti P. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application. Med Hypotheses 2020;144:109876. [PMID: 32562915 DOI: 10.1016/j.mehy.2020.109876] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
44 Bompard F, Monnier H, Saab I, Tordjman M, Abdoul H, Fournier L, Sanchez O, Lorut C, Chassagnon G, Revel MP. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020;56. [PMID: 32398297 DOI: 10.1183/13993003.01365-2020] [Cited by in Crossref: 144] [Cited by in F6Publishing: 137] [Article Influence: 72.0] [Reference Citation Analysis]
45 Shambu SK, B SPS, Gona OJ, Desai N, B M, Madhan R, V R. Implementation and Evaluation of Virtual Anticoagulation Clinic Care to Provide Incessant Care During COVID-19 Times in an Indian Tertiary Care Teaching Hospital. Front Cardiovasc Med 2021;8:648265. [PMID: 33855052 DOI: 10.3389/fcvm.2021.648265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Wang Y, Zheng Y, Tong Q, Wang L, Lv G, Xi Z, Liu W. Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019. Front Cardiovasc Med 2020;7:147. [PMID: 33195443 DOI: 10.3389/fcvm.2020.00147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Fathi M, Vakili K, Sayehmiri F, Mohamadkhani A, Hajiesmaeili M, Rezaei-Tavirani M, Eilami O. The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study. PLoS One 2021;16:e0246190. [PMID: 33592019 DOI: 10.1371/journal.pone.0246190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
48 Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost 2020;120:949-56. [PMID: 32349133 DOI: 10.1055/s-0040-1710317] [Cited by in Crossref: 105] [Cited by in F6Publishing: 91] [Article Influence: 52.5] [Reference Citation Analysis]
49 Elias P, Poterucha TJ, Jain SS, Sayer G, Raikhelkar J, Fried J, Clerkin K, Griffin J, DeFilippis EM, Gupta A, Lawlor M, Madhavan M, Rosenblum H, Roth ZB, Natarajan K, Hripcsak G, Perotte A, Wan EY, Saluja A, Dizon J, Ehlert F, Morrow JP, Yarmohammadi H, Kumaraiah D, Redfors B, Gavin N, Kirtane A, Rabbani L, Burkhoff D, Moses J, Schwartz A, Leon M, Uriel N. The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19. Mayo Clin Proc 2020;95:2099-109. [PMID: 33012341 DOI: 10.1016/j.mayocp.2020.07.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
50 Sandkovsky U, Colley P, Sam T, Modrykamien AM, Berhe M. The dynamic treatment of SARS-CoV-2 disease. Proc (Bayl Univ Med Cent) 2020;33:572-9. [PMID: 33100531 DOI: 10.1080/08998280.2020.1780086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Shields AD, Byrne JJ, Munisteri M, Wood M. Survival from Maternal Cardiac Arrest Complicating Coronavirus Disease 2019. Case Rep Obstet Gynecol 2021;2021:3762198. [PMID: 34336319 DOI: 10.1155/2021/3762198] [Reference Citation Analysis]
52 Azul Freitas A, Baptista R, Gonçalves V, Ferreira C, Milner J, Lourenço C, Costa S, Franco F, Monteiro S, Gonçalves F, Gonçalves L. Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data. Rev Port Cardiol (Engl Ed) 2021;40:465-71. [PMID: 34274091 DOI: 10.1016/j.repce.2021.07.014] [Reference Citation Analysis]
53 Patel VD, Patel KH, Lakhani DA, Desai R, Mehta D, Mody P, Pruthi S. Acute pericarditis in a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a case report and review of the literature on SARS-CoV-2 cardiological manifestations. AME Case Rep 2021;5:6. [PMID: 33634246 DOI: 10.21037/acr-20-90] [Reference Citation Analysis]
54 Uranga A, Villanueva A, Lafuente I, González N, Legarreta MJ, Aguirre U, Pablo España P, Quintana JM, García-Gutiérrez S; el grupo de trabajo COVID-19-Osakidetza. [Risk factors for clinical deterioration in patients admitted for COVID-19: a case-control study]. Rev Clin Esp 2021. [PMID: 34054133 DOI: 10.1016/j.rce.2021.04.007] [Reference Citation Analysis]
55 Mei X, Ji Y, Qian Z, Ling Y, Zhu H, Zhao X, Shen F, Xu Q, Zhang Z, Cheng X, Liu Y, Guo H, Zou Y, Wang J, Zhang Y, Xu L, Lu H. Risk factors for myocardial injury at admission of 325 patients with coronavirus disease 2019 in Shanghai, China. Australas J Ageing 2021. [PMID: 34668629 DOI: 10.1111/ajag.13003] [Reference Citation Analysis]
56 Akintayo AA, Addo B, Soleye SO, Patel D, Ahmad A, Tongia S. Diagnostic dilemma: COVID-19 related cardiomyopathy or peripartum cardiomyopathy? J Cardiol Cases 2021;24:206-9. [PMID: 34178185 DOI: 10.1016/j.jccase.2021.05.012] [Reference Citation Analysis]
57 Desai AD, Boursiquot BC, Melki L, Wan EY. Management of Arrhythmias Associated with COVID-19. Curr Cardiol Rep 2020;23:2. [PMID: 33231782 DOI: 10.1007/s11886-020-01434-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
58 Baldassarre LA, Yang EH, Cheng RK, DeCara JM, Dent S, Liu JE, Rudski LG, Strom JB, Thavendiranathan P, Barac A, Zaha VG, Bucciarelli-Ducci C, Ellahham S, Deswal A, Lenneman C, Villarraga HR, Blaes AH, Ismail-Khan R, Ky B, Leja MJ, Scherrer-Crosbie M. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst 2021;113:513-22. [PMID: 33179744 DOI: 10.1093/jnci/djaa177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
59 Felsenstein S, Reiff AO. A hitchhiker's guide through the COVID-19 galaxy. Clin Immunol 2021;232:108849. [PMID: 34563684 DOI: 10.1016/j.clim.2021.108849] [Reference Citation Analysis]
60 Purroy F, Arqué G. Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study. PLoS One 2021;16:e0252351. [PMID: 34106984 DOI: 10.1371/journal.pone.0252351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Srinivasan A, Pansuriya T, Wilson B, Sarva ST, Jayaram T, Alim S, Kesavan R, Raza S. Systemic Inflammation-Related Bradycardia in COVID-19. Case Rep Cardiol 2021;2021:9986955. [PMID: 34567809 DOI: 10.1155/2021/9986955] [Reference Citation Analysis]
62 Sharma YP, Agstam S, Yadav A, Gupta A, Gupta A. Cardiovascular manifestations of COVID-19: An evidence-based narrative review. Indian J Med Res 2021;153:7-16. [PMID: 33818464 DOI: 10.4103/ijmr.IJMR_2450_20] [Reference Citation Analysis]
63 Grosse C, Grosse A, Salzer HJF, Dünser MW, Motz R, Langer R. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc Pathol 2020;49:107263. [PMID: 32784110 DOI: 10.1016/j.carpath.2020.107263] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
64 Khan MS, Shahid I, Anker SD, Solomon SD, Vardeny O, Michos ED, Fonarow GC, Butler J. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med 2020;18:403. [PMID: 33334360 DOI: 10.1186/s12916-020-01816-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
65 Colombo C, Garatti L, Ferrante G, Casadei F, Montalto C, Crimi G, Cogliati C, Ammirati E, Savonitto S, Morici N. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people. J Geriatr Cardiol 2021;18:534-48. [PMID: 34404990 DOI: 10.11909/j.issn.1671-5411.2021.07.001] [Reference Citation Analysis]
66 Ileri C, Dogan Z, Ozben B, Karaoglu C, Gunay N, Tigen K, Basat S, Uyan C. Evaluation of the relation between cardiac biomarkers and thorax computed tomography findings in COVID-19 patients. Biomark Med 2021;15:285-93. [PMID: 33501850 DOI: 10.2217/bmm-2020-0388] [Reference Citation Analysis]
67 Yu JS, Chen RD, Zeng LC, Yang HK, Li H. Myoglobin Offers Higher Accuracy Than Other Cardiac-Specific Biomarkers for the Prognosis of COVID-19. Front Cardiovasc Med 2021;8:686328. [PMID: 34458331 DOI: 10.3389/fcvm.2021.686328] [Reference Citation Analysis]
68 Zhao S, Lin Y, Zhou C, Wang L, Chen X, Clifford SP, Akca O, Huang J, Chen X. Short-Term Outcomes of Patients With COVID-19 Undergoing Invasive Mechanical Ventilation: A Retrospective Observational Study From Wuhan, China. Front Med (Lausanne) 2020;7:571542. [PMID: 33117833 DOI: 10.3389/fmed.2020.571542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Vedovati MC, Giustozzi M, Conti S, Becattini C. Shock and Diffuse ST-elevation in a Patient with Coronavirus Disease-2019 Disease. J Cardiovasc Echogr 2020;30:223-6. [PMID: 33828946 DOI: 10.4103/jcecho.jcecho_71_20] [Reference Citation Analysis]
70 Schiavone M, Gobbi C, Biondi-Zoccai G, D'Ascenzo F, Palazzuoli A, Gasperetti A, Mitacchione G, Viecca M, Galli M, Fedele F, Mancone M, Forleo GB. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med 2020;9:E1683. [PMID: 32498230 DOI: 10.3390/jcm9061683] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
71 Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol. 2020;215:108448. [PMID: 32353634 DOI: 10.1016/j.clim.2020.108448] [Cited by in Crossref: 254] [Cited by in F6Publishing: 222] [Article Influence: 127.0] [Reference Citation Analysis]
72 Kirkbride RR, Rawal B, Mirsadraee S, Galperin-aizenberg M, Wechalekar K, Ridge CA, Litmanovich DE. Imaging of Cardiac Infections: A Comprehensive Review and Investigation Flowchart for Diagnostic Workup. Journal of Thoracic Imaging 2021;36:W70-88. [DOI: 10.1097/rti.0000000000000552] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Zhang R, Chen X, Zuo W, Ji Z, Qu Y, Su Y, Yang M, Zuo P, Ma G, Li Y. Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium. Bioengineered 2022;13:2486-97. [PMID: 35037831 DOI: 10.1080/21655979.2021.2014621] [Reference Citation Analysis]
74 Carretta DM, Silva AM, D'Agostino D, Topi S, Lovero R, Charitos IA, Wegierska AE, Montagnani M, Santacroce L. Cardiac Involvement in COVID-19 Patients: A Contemporary Review. Infect Dis Rep 2021;13:494-517. [PMID: 34206074 DOI: 10.3390/idr13020048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Gross A, Albrecht T. One year of COVID-19 pandemic: what we Radiologists have learned about imaging. Rofo 2021. [PMID: 34649291 DOI: 10.1055/a-1522-3155] [Reference Citation Analysis]
76 Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A, Contri E, Ronchi V, Beretta G, Reali F, Parogni P, Facchin F, Rizzi U, Bussi D, Ruggeri S, Oltrona Visconti L, Savastano S; Lombardia CARe researchers. COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests. Eur Heart J 2020;41:3045-54. [PMID: 32562486 DOI: 10.1093/eurheartj/ehaa508] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 43.5] [Reference Citation Analysis]
77 Sonsoz MR, Alp ME, Guven G, Guler A, Unsel M, Altuntas Aydin O. Increasing modified CHA2DS2-VASc risk score is associated with acute cardiac injury in hospitalised COVID-19 patients. Acta Cardiol 2021;:1-7. [PMID: 34275416 DOI: 10.1080/00015385.2021.1952000] [Reference Citation Analysis]
78 Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020;5:831-840. [PMID: 32219363 DOI: 10.1001/jamacardio.2020.1286] [Cited by in Crossref: 767] [Cited by in F6Publishing: 667] [Article Influence: 383.5] [Reference Citation Analysis]
79 Shibeeb S, Ahmad MN. Thrombotic and Hypercoagulability Complications of COVID-19: An Update. J Blood Med 2021;12:785-93. [PMID: 34512059 DOI: 10.2147/JBM.S316014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Mahan K, Kabrhel C, Goldsmith AJ. Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli. Am J Emerg Med 2020;38:2245.e3-5. [PMID: 32513452 DOI: 10.1016/j.ajem.2020.05.054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
81 Echarte-Morales J, Minguito-Carazo C, Del Castillo-García S, Borrego-Rodríguez J, Rodríguez-Santamarta M, Sánchez-Muñoz E, Bergel-García R, González-Maniega C, Prieto-González S, Menéndez-Suarez P, Tundidor-Sanz E, Benito-González T, Fernández-Vázquez F. Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19. J Electrocardiol 2021;64:30-5. [PMID: 33307378 DOI: 10.1016/j.jelectrocard.2020.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 [DOI: 10.1101/2020.05.01.20087114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
83 Yang L, Han Y, Jaffré F, Nilsson-Payant BE, Bram Y, Wang P, Zhu J, Zhang T, Redmond D, Houghton S, Uhl S, Borczuk A, Huang Y, Richardson C, Chandar V, Acklin JA, Lim JK, Chen Z, Xiang J, Ho DD, tenOever BR, Schwartz RE, Evans T, Chen S. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts. Circ Res 2021;129:33-46. [PMID: 33853355 DOI: 10.1161/CIRCRESAHA.121.319060] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
84 Wolfe J, Safdar B, Madsen TE, Sethuraman KN, Becker B, Greenberg MR, McGregor AJ. Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2. Clin Ther 2021;43:557-571.e1. [PMID: 33583576 DOI: 10.1016/j.clinthera.2021.01.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
85 Alger HM, Rutan C, Williams JH 4th, Walchok JG, Bolles M, Hall JL, Bradley SM, Elkind MSV, Rodriguez F, Wang TY, Morrow DA, Das SR, de Lemos JA. American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines. Circ Cardiovasc Qual Outcomes 2020;13:e006967. [PMID: 32546000 DOI: 10.1161/CIRCOUTCOMES.120.006967] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
86 Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth 2020;125:912-25. [PMID: 32988604 DOI: 10.1016/j.bja.2020.08.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
87 Calvo-Fernández A, Izquierdo A, Subirana I, Farré N, Vila J, Durán X, García-Guimaraes M, Valdivielso S, Cabero P, Soler C, García-Ribas C, Rodríguez C, Llagostera M, Mojón D, Vicente M, Solé-González E, Sánchez-Carpintero A, Tevar C, Marrugat J, Vaquerizo B. [Markers of myocardial injury in the prediction of short-term COVID-19 prognosis]. Rev Esp Cardiol 2021;74:576-83. [PMID: 33262553 DOI: 10.1016/j.recesp.2020.09.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Wang N, Zhang M, Su H, Huang Z, Lin Y, Zhang M. Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic. J Int Med Res 2020;48:300060520966151. [PMID: 33108941 DOI: 10.1177/0300060520966151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
89 Tarun T, Kumar S, Johnson J, Chockalingam A. A case report on transient cardiomyopathy with cytokine storm in SARS-CoV-2. Eur Heart J Case Rep 2021;5:ytaa519. [PMID: 33594344 DOI: 10.1093/ehjcr/ytaa519] [Reference Citation Analysis]
90 Balsam LB, Hoffman WD. Commentary: The molecular pandemonium of coronavirus disease 2019. J Thorac Cardiovasc Surg 2021;161:e227-8. [PMID: 32624308 DOI: 10.1016/j.jtcvs.2020.06.003] [Reference Citation Analysis]
91 Muhanna D, Arnipalli SR, Kumar SB, Ziouzenkova O. Osmotic Adaptation by Na+-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19. Biomedicines 2020;8:E460. [PMID: 33142989 DOI: 10.3390/biomedicines8110460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
92 Trpkov C, MacMullan P, Feuchter P, Kachra R, Heydari B, Merchant N, Bristow MS, White JA. Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis. CJC Open 2021;3:210-3. [PMID: 33073222 DOI: 10.1016/j.cjco.2020.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Sriram K, Loomba R, Insel PA. Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges. Proc Natl Acad Sci U S A 2020;117:29274-82. [PMID: 33203679 DOI: 10.1073/pnas.2009875117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
94 Alvarez-Garcia J, Lee S, Gupta A, Cagliostro M, Joshi AA, Rivas-Lasarte M, Contreras J, Mitter SS, LaRocca G, Tlachi P, Brunjes D, Glicksberg BS, Levin MA, Nadkarni G, Fayad Z, Fuster V, Mancini D, Lala A. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19. J Am Coll Cardiol 2020;76:2334-48. [PMID: 33129663 DOI: 10.1016/j.jacc.2020.09.549] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 23.0] [Reference Citation Analysis]
95 Ofori-Asenso R, Ogundipe O, Agyeman AA, Chin KL, Mazidi M, Ademi Z, De Bruin ML, Liew D. Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis. Ecancermedicalscience 2020;14:1047. [PMID: 32565900 DOI: 10.3332/ecancer.2020.1047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
96 Ganatra S, Dani SS, Shah S, Asnani A, Neilan TG, Lenihan D, Ky B, Barac A, Hayek SS, Leja M, Herrmann J, Thavendiranathan P, Fradley M, Bang V, Shreyder K, Parikh R, Patel R, Singh A, Brar S, Guha A, Gupta D, Mascari P, Patten RD, Venesy DM, Nohria A, Resnic FS. Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic. Trends Cardiovasc Med 2020;30:315-25. [PMID: 32474135 DOI: 10.1016/j.tcm.2020.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
97 Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, Maureira P, Mraiche F, Gentile C, Hansbro PM, McClements L, Hasan A. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact 2021;351:109738. [PMID: 34740598 DOI: 10.1016/j.cbi.2021.109738] [Reference Citation Analysis]
98 Manolis AS, Manolis AA, Manolis TA, Apostolopoulos EJ, Papatheou D, Melita H. COVID-19 infection and cardiac arrhythmias. Trends Cardiovasc Med 2020;30:451-60. [PMID: 32814095 DOI: 10.1016/j.tcm.2020.08.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
99 Coneybeare D, Das D, Lema P, Chang B, Ng L. COVUS: An Algorithm to Maximize the Use of Point-of-Care Ultrasound in the Emergency Management of COVID-19. J Emerg Med 2021;61:61-6. [PMID: 33785247 DOI: 10.1016/j.jemermed.2021.02.008] [Reference Citation Analysis]
100 Yuan N, Wu S, Rader F, Siegel RJ. Determining Which Hospitalized Coronavirus Disease 2019 Patients Require Urgent Echocardiography. J Am Soc Echocardiogr 2021;34:831-8. [PMID: 33812952 DOI: 10.1016/j.echo.2021.03.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Addison D, Campbell CM, Guha A, Ghosh AK, Dent SF, Jneid H. Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond. J Am Heart Assoc 2020;9:e017787. [PMID: 32713239 DOI: 10.1161/JAHA.120.017787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
102 Sonsoz MR, Oncul A, Cevik E, Orta H, Yilmaz M, Ayduk Govdeli E, Nalbant A, Demirtakan ZG, Tonyali M, Durmus D, Anakli I, Polat O, Catma Y, Senkal N, Medetalibeyoglu A, Kose M, Emet S, Tukek T. Wide QRS Complex and Lateral ST-T Segment Abnormality Are Associated With Worse Clinical Outcomes in COVID-19 Patients. Am J Med Sci 2021;361:591-7. [PMID: 33581838 DOI: 10.1016/j.amjms.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Junapudi SS, Junapudi S, Ega K, Chidipi B. Major cardiac concerns in therapy and vaccinations for COVID-19. Metabol Open 2021;11:100102. [PMID: 34222851 DOI: 10.1016/j.metop.2021.100102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Cappuccio FP, Siani A. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint. Nutr Metab Cardiovasc Dis 2020;30:1227-35. [PMID: 32595085 DOI: 10.1016/j.numecd.2020.05.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
105 Kundra P, Vinayagam S. COVID-19 cardiopulmonary resuscitation: Guidelines and modifications. J Anaesthesiol Clin Pharmacol 2020;36:S39-44. [PMID: 33100644 DOI: 10.4103/joacp.JOACP_257_20] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Wenzel P, Kopp S, Göbel S, Jansen T, Geyer M, Hahn F, Kreitner KF, Escher F, Schultheiss HP, Münzel T. Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab. Cardiovasc Res 2020;116:1661-3. [PMID: 32562489 DOI: 10.1093/cvr/cvaa160] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 21.0] [Reference Citation Analysis]
107 Mitacchione G, Schiavone M, Gasperetti A, Forleo GB. Ventricular tachycardia storm management in a COVID-19 patient: a case report. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33089046 DOI: 10.1093/ehjcr/ytaa217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
108 Saxena A, Khare D, Agrawal S, Singh A, Dubey AK. Recent advances in materials science: a reinforced approach toward challenges against COVID-19. Emergent Mater 2021;:1-17. [PMID: 33644691 DOI: 10.1007/s42247-021-00179-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
109 Zhou J, Liu C, Sun Y, Huang W, Ye K. Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study. Brain Behav Immun 2021;91:383-92. [PMID: 33148439 DOI: 10.1016/j.bbi.2020.10.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
110 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res 2021:cvab343. [PMID: 34864876 DOI: 10.1093/cvr/cvab343] [Reference Citation Analysis]
111 Correale P, Caracciolo M, Bilotta F, Conte M, Cuzzola M, Falcone C, Mangano C, Falzea AC, Iuliano E, Morabito A, Foti G, Armentano A, Caraglia M, De Lorenzo A, Sitkovsky M, Macheda S. Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia. PLoS One 2020;15:e0239692. [PMID: 33031409 DOI: 10.1371/journal.pone.0239692] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
112 Stavroulakis GA, Koutroulis G, Kallirrhoe K. Complications in Patients With COVID-19. JAMA Cardiol 2021;6:359-60. [PMID: 33206141 DOI: 10.1001/jamacardio.2020.5791] [Reference Citation Analysis]
113 Hodson DZ, Reinhardt SW, Moore CL. Young Man With Shortness of Breath. Ann Emerg Med 2021;77:500-58. [PMID: 33902827 DOI: 10.1016/j.annemergmed.2020.10.026] [Reference Citation Analysis]
114 Martínez-Rubio A, Ascoeta S, Taibi F, Soldevila JG. Coronavirus Disease 2019 and Cardiac Arrhythmias. Eur Cardiol 2020;15:e66. [PMID: 33294034 DOI: 10.15420/ecr.2020.23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Del Castillo-García S, Minguito-Carazo C, Echarte JC, Rodríguez-Santamarta M, González TB, Terroba Seara S, Martìnez González L, Fernández-Vázquez F. A case report of arterial and venous thromboembolism in a patient with severe COVID-19 pneumonia. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33437918 DOI: 10.1093/ehjcr/ytaa350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
116 Dou Q, Wei X, Zhou K, Yang S, Jia P. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020;31:893-904. [PMID: 33172748 DOI: 10.1016/j.tem.2020.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
117 Nabeh OA, Helaly MM, Menshawey R, Menshawey E, Nasser MMM, Diaa El-Deen AM. Contemporary approach to understand and manage COVID-19-related arrhythmia. Egypt Heart J 2021;73:76. [PMID: 34459992 DOI: 10.1186/s43044-021-00201-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 [DOI: 10.1101/2020.07.11.20147793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Di Micco P, Di Micco G, Russo V, Poggiano MR, Salzano C, Bosevski M, Imparato M, Fontanella L, Fontanella A. Blood Targets of Adjuvant Drugs Against COVID19. J Blood Med 2020;11:237-41. [PMID: 32694923 DOI: 10.2147/JBM.S256121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
120 Kashour T, Halwani R, Arabi YM, Sohail MR, O'Horo JC, Badley AD, Tleyjeh IM. Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility. Immunopharmacol Immunotoxicol 2021;43:37-50. [PMID: 33406943 DOI: 10.1080/08923973.2020.1863984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
121 Lombardi CM, Carubelli V, Iorio A, Inciardi RM, Bellasi A, Canale C, Camporotondo R, Catagnano F, Dalla Vecchia LA, Giovinazzo S, Maccagni G, Mapelli M, Margonato D, Monzo L, Nuzzi V, Oriecuia C, Peveri G, Pozzi A, Provenzale G, Sarullo F, Tomasoni D, Ameri P, Gnecchi M, Leonardi S, Merlo M, Agostoni P, Carugo S, Danzi GB, Guazzi M, La Rovere MT, Mortara A, Piepoli M, Porto I, Sinagra G, Volterrani M, Specchia C, Metra M, Senni M. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.JAMA Cardiol. 2020;5:1274-1280. [PMID: 32845276 DOI: 10.1001/jamacardio.2020.3538] [Cited by in Crossref: 43] [Cited by in F6Publishing: 59] [Article Influence: 21.5] [Reference Citation Analysis]
122 Niazi I, Khan M. Arrhythmias in the Age of Coronavirus Disease 2019. J Innov Card Rhythm Manag 2021;12:4345-8. [PMID: 33520348 DOI: 10.19102/icrm.2021.120107] [Reference Citation Analysis]
123 Lutchmansingh DD, Knauert MP, Antin-Ozerkis DE, Chupp G, Cohn L, Dela Cruz CS, Ferrante LE, Herzog EL, Koff J, Rochester CL, Ryu C, Singh I, Tickoo M, Winks V, Gulati M, Possick JD. A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY: Learning From the Past, Looking to the Future. Chest 2021;159:949-58. [PMID: 33159907 DOI: 10.1016/j.chest.2020.10.067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
124 Mei Q, Wang F, Yang Y, Hu G, Guo S, Zhang Q, Bryant A, Zhang L, Kurts C, Wei L, Yuan X, Li J. Health Issues and Immunological Assessment Related to Wuhan's COVID-19 Survivors: A Multicenter Follow-Up Study. Front Med (Lausanne) 2021;8:617689. [PMID: 34026775 DOI: 10.3389/fmed.2021.617689] [Reference Citation Analysis]
125 Abdeen Y, Kaako A, Alnabulsi M, Okeh A, Meng W, Miller R. The prognostic effect of brain natriuretic peptide levels on outcomes of hospitalized patients with COVID-19. Avicenna J Med 2021;11:20-6. [PMID: 33520785 DOI: 10.4103/ajm.ajm_169_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
126 Sezer R, Esendagli D, Erol C, Hekimoglu K. New challenges for management of COVID-19 patients: Analysis of MDCT based "Automated pneumonia analysis program". Eur J Radiol Open 2021;8:100370. [PMID: 34307790 DOI: 10.1016/j.ejro.2021.100370] [Reference Citation Analysis]
127 Cagnazzo F, Arquizan C, Derraz I, Dargazanli C, Lefevre PH, Riquelme C, Gaillard N, Mourand I, Gascou G, Bonafe A, Costalat V. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature. J Neurol 2021;268:2656-65. [PMID: 33125542 DOI: 10.1007/s00415-020-10285-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
128 Kanthasamy V, Schilling RJ. Electrophysiology in the Era of Coronavirus Disease 2019. Arrhythm Electrophysiol Rev 2020;9:167-70. [PMID: 33240513 DOI: 10.15420/aer.2020.32] [Reference Citation Analysis]
129 Sarzani R, Giulietti F, Di Pentima C, Giordano P, Spannella F. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Am J Physiol Lung Cell Mol Physiol 2020;319:L325-36. [PMID: 32639866 DOI: 10.1152/ajplung.00189.2020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
130 Peiró ÓM, Carrasquer A, Sánchez-Gimenez R, Lal-Trehan N, Del-Moral-Ronda V, Bonet G, Fort-Gallifa I, Picó-Plana E, Bastón-Paz N, Gutiérrez C, Bardaji A. Biomarkers and short-term prognosis in COVID-19. Biomarkers 2021;26:119-26. [PMID: 33426934 DOI: 10.1080/1354750X.2021.1874052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
131 Chen Y, Ke Y, Liu X, Wang Z, Jia R, Liu W, Yang C, Jia L, Wang Y, Han L, Xia X, Zhang S, Wang C. Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China. J Med Virol 2021;93:2782-9. [PMID: 33085103 DOI: 10.1002/jmv.26617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
132 Laya BF, Cledera THC, Lim TRU, Baluyut JMP, Medina JMP, Pasia NV. Cross-sectional Imaging Manifestations of Extrapulmonary Involvement in COVID-19 Disease. J Comput Assist Tomogr 2021;45:253-62. [PMID: 33186179 DOI: 10.1097/RCT.0000000000001120] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Chang SH, Chen D, Paone D, Geraci TC, Scheinerman J, Bizekis C, Zervos M, Cerfolio RJ. Thoracic surgery outcomes for patients with Coronavirus Disease 2019. J Thorac Cardiovasc Surg 2021:S0022-5223(21)00168-9. [PMID: 33642100 DOI: 10.1016/j.jtcvs.2021.01.069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
134 Narvel H, Sayed A, Narvel N, Yakkali S, Katchi T. Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019? J Clin Med Res 2021;13:195-203. [PMID: 34007357 DOI: 10.14740/jocmr4254] [Reference Citation Analysis]
135 Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, Okell T, Sheerin F, Xie C, Mahmod M, Mózes FE, Lewandowski AJ, Ohuma EO, Holdsworth D, Lamlum H, Woodman MJ, Krasopoulos C, Mills R, McConnell FAK, Wang C, Arthofer C, Lange FJ, Andersson J, Jenkinson M, Antoniades C, Channon KM, Shanmuganathan M, Ferreira VM, Piechnik SK, Klenerman P, Brightling C, Talbot NP, Petousi N, Rahman NM, Ho LP, Saunders K, Geddes JR, Harrison PJ, Pattinson K, Rowland MJ, Angus BJ, Gleeson F, Pavlides M, Koychev I, Miller KL, Mackay C, Jezzard P, Smith SM, Neubauer S. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021;31:100683. [PMID: 33490928 DOI: 10.1016/j.eclinm.2020.100683] [Cited by in Crossref: 57] [Cited by in F6Publishing: 69] [Article Influence: 57.0] [Reference Citation Analysis]
136 Li C, Wang DW, Zhao C. Cardiovascular Involvement in Patients with 2019 Novel Coronavirus Disease. J Transl Int Med 2021;9:152-60. [PMID: 34900625 DOI: 10.2478/jtim-2021-0016] [Reference Citation Analysis]
137 Skoll D, Miller JC, Saxon LA. COVID-19 testing and infection surveillance: Is a combined digital contact-tracing and mass-testing solution feasible in the United States? Cardiovasc Digit Health J 2020;1:149-59. [PMID: 33043314 DOI: 10.1016/j.cvdhj.2020.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
138 Sanchez BG, Gasalla JM, Sánchez-Chapado M, Bort A, Diaz-Laviada I. Increase in Ischemia-Modified Albumin and Pregnancy-Associated Plasma Protein-A in COVID-19 Patients. J Clin Med 2021;10:5474. [PMID: 34884175 DOI: 10.3390/jcm10235474] [Reference Citation Analysis]
139 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Reference Citation Analysis]
140 Çınar T, Hayıroğlu Mİ, Çiçek V, Kılıç Ş, Asal S, Doğan S, Şeker M, Selçuk M, Uzun M, Orhan AL. Prognostic significance of cardiac troponin level in Covid-19 patients without known cardiovascular risk factors. Am J Emerg Med 2021;45:595-7. [PMID: 33349488 DOI: 10.1016/j.ajem.2020.12.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
141 Potere N, Valeriani E, Candeloro M, Tana M, Porreca E, Abbate A, Spoto S, Rutjes AWS, Di Nisio M. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care 2020;24:389. [PMID: 32616077 DOI: 10.1186/s13054-020-03022-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 28.0] [Reference Citation Analysis]
142 Augustine DX, Keteepe-Arachi T, Malhotra A. Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation. Eur Cardiol 2021;16:e03. [PMID: 33708264 DOI: 10.15420/ecr.2020.36] [Reference Citation Analysis]
143 Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? J Clin Med. 2020;9. [PMID: 32403217 DOI: 10.3390/jcm9051417] [Cited by in Crossref: 185] [Cited by in F6Publishing: 191] [Article Influence: 92.5] [Reference Citation Analysis]
144 Feng F, Chen J, Zhao J, Li Y, Li M, Sun C. Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection. Viruses 2021;13:2243. [PMID: 34835049 DOI: 10.3390/v13112243] [Reference Citation Analysis]
145 Çakmak Karaaslan Ö, Özilhan MO, Maden O, Tüfekçioğlu O. Prevalence of cardiac involvement in home-based recovered coronavirus disease 2019 (COVID-19) patients: a retrospective observational study. Ir J Med Sci 2021. [PMID: 34714493 DOI: 10.1007/s11845-021-02824-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Crook RL, Williams H, Green M, Brown S, Morris R, Fletcher H, Walters S, Walsh C, Price A, King S, McAloon CJ. Prospective multicentre cohort study of transthoracic echocardiography provision in the South West of the UK during the first wave of SARS-CoV-2 pandemic. Open Heart 2021;8:e001409. [PMID: 33504630 DOI: 10.1136/openhrt-2020-001409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Monteiro AC, Suri R, Emeruwa IO, Stretch RJ, Cortes-Lopez RY, Sherman A, Lindsay CC, Fulcher JA, Goodman-Meza D, Sapru A, Buhr RG, Chang S, Wang T, Qadir N. Obesity and Smoking as Risk Factors for Invasive Mechanical Ventilation in COVID-19: a Retrospective, Observational Cohort Study. medRxiv 2020:2020. [PMID: 32817959 DOI: 10.1101/2020.08.12.20173849] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
148 Shakaib B, Zohra T, Ikram A, Shakaib MB, Ali A, Bashir A, Salman M, Khan MA, Ansari J. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? Virol J 2021;18:120. [PMID: 34098986 DOI: 10.1186/s12985-021-01578-0] [Reference Citation Analysis]
149 Tao Z, Xu J, Chen W, Yang Z, Xu X, Liu L, Chen R, Xie J, Liu M, Wu J, Wang H, Liu J. Anemia is associated with severe illness in COVID-19: A retrospective cohort study. J Med Virol 2021;93:1478-88. [PMID: 32813298 DOI: 10.1002/jmv.26444] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
150 Singh H, Kakkar AK, Chauhan P. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges. Expert Rev Anti Infect Ther 2020;18:997-1003. [PMID: 32552044 DOI: 10.1080/14787210.2020.1782190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
151 Murugan C, Ramamoorthy S, Kuppuswamy G, Murugan RK, Sivalingam Y, Sundaramurthy A. COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks. Int J Biol Macromol 2021:S0141-8130(21)02301-1. [PMID: 34710479 DOI: 10.1016/j.ijbiomac.2021.10.144] [Reference Citation Analysis]
152 Cárdenas G, Torres-García D, Cervantes-Torres J, Rosales-Mendoza S, Fleury A, Fragoso G, Laclette JP, Sciutto E. Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection. Arch Med Res 2021;52:143-50. [PMID: 33160751 DOI: 10.1016/j.arcmed.2020.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Can Ö, Bilek G, Sahan S. Risk factors for infection and mortality among hemodialysis patients during COVID-19 pandemic. Int Urol Nephrol 2021. [PMID: 34227016 DOI: 10.1007/s11255-021-02926-3] [Reference Citation Analysis]
154 Sabatino J, Ferrero P, Chessa M, Bianco F, Ciliberti P, Secinaro A, Oreto L, Avesani M, Bucciarelli V, Calcaterra G, Calabrò MP, Russo MG, Bassareo PP, Guccione P, Indolfi C, Di Salvo G. COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey. J Clin Med 2020;9:E1774. [PMID: 32521643 DOI: 10.3390/jcm9061774] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
155 Al-Hanawi MK, Ahmad K, Haque R, Keramat SA. Willingness to receive COVID-19 vaccination among adults with chronic diseases in the Kingdom of Saudi Arabia. J Infect Public Health 2021;14:1489-96. [PMID: 34417135 DOI: 10.1016/j.jiph.2021.08.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Samuel RM, Majd H, Richter MN, Ghazizadeh Z, Zekavat SM, Navickas A, Ramirez JT, Asgharian H, Simoneau CR, Bonser LR, Koh KD, Garcia-Knight M, Tassetto M, Sunshine S, Farahvashi S, Kalantari A, Liu W, Andino R, Zhao H, Natarajan P, Erle DJ, Ott M, Goodarzi H, Fattahi F. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. Cell Stem Cell 2020;27:876-889.e12. [PMID: 33232663 DOI: 10.1016/j.stem.2020.11.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 48] [Article Influence: 19.0] [Reference Citation Analysis]
157 Kotecha T, Knight DS, Razvi Y, Kumar K, Vimalesvaran K, Thornton G, Patel R, Chacko L, Brown JT, Coyle C, Leith D, Shetye A, Ariff B, Bell R, Captur G, Coleman M, Goldring J, Gopalan D, Heightman M, Hillman T, Howard L, Jacobs M, Jeetley PS, Kanagaratnam P, Kon OM, Lamb LE, Manisty CH, Mathurdas P, Mayet J, Negus R, Patel N, Pierce I, Russell G, Wolff A, Xue H, Kellman P, Moon JC, Treibel TA, Cole GD, Fontana M. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 2021;42:1866-78. [PMID: 33596594 DOI: 10.1093/eurheartj/ehab075] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 37.0] [Reference Citation Analysis]
158 Rea IM, Alexander HD. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing. Ageing Res Rev 2021;73:101494. [PMID: 34688926 DOI: 10.1016/j.arr.2021.101494] [Reference Citation Analysis]
159 Lala A, Johnson KW, Russak AJ, Paranjpe I, Zhao S, Solani S, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Januzzi J, Mancini DM, Fuster V. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection. medRxiv 2020:2020. [PMID: 32511658 DOI: 10.1101/2020.04.20.20072702] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
160 Fernando ME, Drovandi A, Golledge J. Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality. Syst Rev 2021;10:243. [PMID: 34488897 DOI: 10.1186/s13643-021-01802-6] [Reference Citation Analysis]
161 Brojakowska A, Eskandari A, Bisserier M, Bander J, Garikipati VNS, Hadri L, Goukassian DA, Fish KM. Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients. PLoS One 2021;16:e0253660. [PMID: 34228746 DOI: 10.1371/journal.pone.0253660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Patel K, Savani S, DeSimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease. Clin Med Insights Cardiol 2020;14:1179546820977196. [PMID: 33312009 DOI: 10.1177/1179546820977196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
163 Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res 2020;116:1688-99. [PMID: 32293003 DOI: 10.1093/cvr/cvaa097] [Cited by in Crossref: 169] [Cited by in F6Publishing: 148] [Article Influence: 84.5] [Reference Citation Analysis]
164 Zuin M, Rigatelli G, Bilato C, Zuliani G, Roncon L. Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis. Acta Cardiol 2021;:1-7. [PMID: 34080948 DOI: 10.1080/00015385.2021.1890925] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
165 Khan SS, Krefman AE, Mccabe ME, Petito LC, Yang X, Kershaw KN, Pool LR, Allen NB. Association between county-level risk groups and COVID-19 outcomes in the United States: a socioecological study. BMC Public Health 2022;22. [DOI: 10.1186/s12889-021-12469-y] [Reference Citation Analysis]
166 Tedeschi D, Rizzi A, Biscaglia S, Tumscitz C. Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19. Catheter Cardiovasc Interv 2021;97:272-7. [PMID: 32767631 DOI: 10.1002/ccd.29179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
167 Hu J, Li C, Wang S, Li T, Zhang H. Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data. Hum Genomics 2021;15:10. [PMID: 33536081 DOI: 10.1186/s40246-021-00306-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
168 Triggle CR, Bansal D, Ding H, Islam MM, Farag EABA, Hadi HA, Sultan AA. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Front Immunol 2021;12:631139. [PMID: 33717166 DOI: 10.3389/fimmu.2021.631139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
169 Tomazou M, Bourdakou MM, Minadakis G, Zachariou M, Oulas A, Karatzas E, Loizidou E, Kakouri A, Christodoulou C, Savva K, Zanti M, Onisiforou A, Afxenti S, Richter J, Christodoulou CG, Kyprianou T, Kolios G, Dietis N, Spyrou GM. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19. Brief Bioinform 2021:bbab114. [PMID: 34009288 DOI: 10.1093/bib/bbab114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Shi C, Wang L, Ye J, Gu Z, Wang S, Xia J, Xie Y, Li Q, Xu R, Lin N. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis 2021;21:663. [PMID: 34238232 DOI: 10.1186/s12879-021-06369-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
171 Negreira-Caamaño M, Río JM, Águila-Gordo D, Mateo-Gómez C, Soto-Pérez M, Piqueras-Flores J. [Cardiovascular events after COVID-19 hospitalization: long-term follow-up]. Rev Esp Cardiol 2021. [PMID: 34334882 DOI: 10.1016/j.recesp.2021.07.009] [Reference Citation Analysis]
172 Norris T, Razieh C, Zaccardi F, Yates T, Islam N, Gillies CL, Chudasama YV, Rowlands AV, Davies MJ, McCann GP, Banerjee A, Lam CSP, Docherty AB, Openshaw PJ, Baillie JK, Semple MG, Lawson CA, Khunti K; ISARIC4C investigators. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19. Heart 2021:heartjnl-2021-320047. [PMID: 34911741 DOI: 10.1136/heartjnl-2021-320047] [Reference Citation Analysis]
173 Shah P, Doshi R, Chenna A, Owens R, Cobb A, Ivey H, Newton S, Mccarley K. Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients.Am J Cardiol. 2020;135:150-153. [PMID: 32861733 DOI: 10.1016/j.amjcard.2020.08.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
174 Haseeb S, Gul EE, Çinier G, Bazoukis G, Alvarez-Garcia J, Garcia-Zamora S, Lee S, Yeung C, Liu T, Tse G, Baranchuk A; International Society of Electrocardiology Young Community (ISE-YC). Value of electrocardiography in coronavirus disease 2019 (COVID-19). J Electrocardiol 2020;62:39-45. [PMID: 32805546 DOI: 10.1016/j.jelectrocard.2020.08.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
175 Moulson N, Baggish A. Subclinical COVID-19 Cardiac Imaging Findings: Resurgence of the Athletic "Grey-Zone". JACC Cardiovasc Imaging 2021;14:556-8. [PMID: 33454267 DOI: 10.1016/j.jcmg.2020.12.005] [Reference Citation Analysis]
176 Maev IV, Shpektor AV, Vasilyeva EY, Manchurov VN, Andreev DN. [Novel coronavirus infection COVID-19: extrapulmonary manifestations]. Ter Arkh 2020;92:4-11. [PMID: 33346454 DOI: 10.26442/00403660.2020.08.000767] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: Epidemiology Report 9 (Reporting week to 23:59 AEDT 29 March 2020). Commun Dis Intell (2018) 2020;44. [PMID: 32264802 DOI: 10.33321/cdi.2020.44.29] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
178 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
179 Reddy ST, Garg T, Shah C, Nascimento FA, Imran R, Kan P, Bowry R, Gonzales N, Barreto A, Kumar A, Volpi J, Misra V, Chiu D, Gadhia R, Savitz SI. Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series. Case Rep Neurol 2020;12:199-209. [PMID: 32647526 DOI: 10.1159/000508958] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 21.5] [Reference Citation Analysis]
180 Zeng L, Wang S, Cai J, Sun S, Wang S, Li J, Sun L. Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis. Epidemiol Infect 2020;148:e266. [PMID: 33092664 DOI: 10.1017/S0950268820002587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
181 Ma L, Song K, Huang Y. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications. J Cardiothorac Vasc Anesth 2021;35:1860-5. [PMID: 32451271 DOI: 10.1053/j.jvca.2020.04.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
182 Radke RM, Frenzel T, Baumgartner H, Diller GP. Adult congenital heart disease and the COVID-19 pandemic. Heart 2020;106:1302-9. [PMID: 32522822 DOI: 10.1136/heartjnl-2020-317258] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
183 Amin A, Eftekhar SP, Ziaie N, Roudbari S, Salehi P, Jalali F, Jafaripour I, Ghaffari S, Mohseni Salehi M, Ebadi R. Clinically suspected myocarditis in COVID-19 patients: Case series and review of the literature. Clin Case Rep 2021;9:e05236. [PMID: 34963812 DOI: 10.1002/ccr3.5236] [Reference Citation Analysis]
184 Gupta YS, Finkelstein M, Manna S, Toussie D, Bernheim A, Little BP, Concepcion J, Maron SZ, Jacobi A, Chung M, Kukar N, Voutsinas N, Cedillo MA, Fernandes A, Eber C, Fayad ZA, Hota P. Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes. Clin Imaging 2021;77:1-8. [PMID: 33601125 DOI: 10.1016/j.clinimag.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
185 Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron LM, Pagliaro P, Pasqua T, Penna C, Rocca C, Samaja M, Angelone T. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. Geroscience 2020;42:1021-49. [PMID: 32430627 DOI: 10.1007/s11357-020-00198-w] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 25.0] [Reference Citation Analysis]
186 Rabbani AB, Parikh RV, Rafique AM. Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life? JAMA Netw Open 2020;3:e2013556. [PMID: 32579190 DOI: 10.1001/jamanetworkopen.2020.13556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
187 Jin ZM, Shi JC, Zheng M, Chen QL, Zhou YY, Cheng F, Cai J, Jiang XG. Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19. World J Clin Cases 2022; 10(1): 128-135 [DOI: 10.12998/wjcc.v10.i1.128] [Reference Citation Analysis]
188 Li Y, Xu Y, Shi P, Zhu Y, Hu W, Chen C. Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21380. [PMID: 32769869 DOI: 10.1097/MD.0000000000021380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
189 Kaur U, Acharya K, Mondal R, Singh A, Saso L, Chakrabarti S, Chakrabarti SS. Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2. Eur J Pharmacol 2020;887:173545. [PMID: 32926917 DOI: 10.1016/j.ejphar.2020.173545] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
190 Liu M, Jiang H, Li Y, Li C, Tan Z, Jin F, Zhang T, Nan Y. Independent Risk Factors for the Dynamic Development of COVID-19: A Retrospective Study. Int J Gen Med 2021;14:4349-67. [PMID: 34408476 DOI: 10.2147/IJGM.S325112] [Reference Citation Analysis]
191 Vrettou AR, Parissis J, Ikonomidis I. The Dual Role of Echocardiography in the Diagnosis of Acute Cardiac Complications and Treatment Monitoring for Coronavirus Disease 2019 (COVID-19). Front Cardiovasc Med. 2020;7:129. [PMID: 32984405 DOI: 10.3389/fcvm.2020.00129] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
192 McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2:e437-e445. [PMID: 32835247 DOI: 10.1016/s2665-9913(20)30121-1] [Cited by in Crossref: 299] [Cited by in F6Publishing: 189] [Article Influence: 149.5] [Reference Citation Analysis]
193 Garau G, Joachim S, Duliere GL, Melissopoulou M, Boccar S, Fraipont V, Dugauquier C, Troisfontaines P, Hougrand O, Delvenne P, Hoffer E. Sudden cardiogenic shock mimicking fulminant myocarditis in a surviving teenager affected by severe acute respiratory syndrome coronavirus 2 infection. ESC Heart Fail 2021;8:766-73. [PMID: 33190387 DOI: 10.1002/ehf2.13049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Arnold RH, Tideman PA, Devlin GP, Carroll GE, Elder A, Lowe H, Macdonald PS, Bannon PG, Juergens C, McGuire M, Mariani JA, Coffey S, Faddy S, Brown A, Inglis S, Wang WYS. Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement. Heart Lung Circ 2020;29:e88-93. [PMID: 32487432 DOI: 10.1016/j.hlc.2020.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
195 Yang TY, Li YC, Wang SC, Dai QQ, Jiang XS, Zuo S, Jia L, Zheng JB, Wang HL. Clinical characteristics of patients with COVID-19 presenting with gastrointestinal symptoms as initial symptoms: Retrospective case series. World J Clin Cases 2020; 8(14): 2950-2958 [PMID: 32775377 DOI: 10.12998/wjcc.v8.i14.2950] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
196 Ridgway JP, Farley B, Benoit JL, Frohne C, Hazra A, Pettit N, Pho M, Pursell K, Saltzman J, Schmitt J, Uvin AZ, Pitrak D, McNulty M. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois. AIDS Patient Care STDS 2020;34:331-5. [PMID: 32469614 DOI: 10.1089/apc.2020.0103] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
197 Iturbe-Hernandez T, García de Guadiana Romualdo L, Gil Ortega I, Martínez Francés A, Meca Birlanga O, Cerezo-Manchado JJ. Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocol. Drugs Context 2020;9:2020-8-3. [PMID: 33014097 DOI: 10.7573/dic.2020-8-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
198 Garg N, McClafferty B, Ramgobin D, Golamari R, Jain R, Jain R. Cardiology and COVID-19: do we have sufficient information? Future Cardiol 2021;17:705-11. [PMID: 33124920 DOI: 10.2217/fca-2020-0126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Kunal S, Sharma SM, Sharma SK, Gautam D, Bhatia H, Mahla H, Sharma S, Bhandari S. Cardiovascular complications and its impact on outcomes in COVID-19. Indian Heart J 2020;72:593-8. [PMID: 33357651 DOI: 10.1016/j.ihj.2020.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
200 Costa IBSDS, Rochitte CE, Campos CM, Barberato SH, Oliveira GMM, Lopes MACQ, Nomura CH, Abizaid AA, Cerri G, Kalil Filho R, Hajjar LA. Cardiovascular Imaging and Interventional Procedures in Patients with Novel Coronavirus Infection. Arq Bras Cardiol 2020;115:111-26. [PMID: 32813825 DOI: 10.36660/abc.20200370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
201 Yenerçağ M, Arslan U, Şeker OO, Dereli S, Kaya A, Doğduş M, Öztürk ÇE, Akpınar ÇK, Şen A. Evaluation of P-wave dispersion in patients with newly diagnosed coronavirus disease 2019. J Cardiovasc Med (Hagerstown) 2021;22:197-203. [PMID: 33186236 DOI: 10.2459/JCM.0000000000001135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
202 Feldman C, Anderson R. Brief review: Cardiac complications and platelet activation in COVID-19 infection. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235425 DOI: 10.7196/AJTCCM.2020.v26i3.107] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
203 Perez-Bermejo JA, Kang S, Rockwood SJ, Simoneau CR, Joy DA, Silva AC, Ramadoss GN, Flanigan WR, Fozouni P, Li H, Chen PY, Nakamura K, Whitman JD, Hanson PJ, McManus BM, Ott M, Conklin BR, McDevitt TC. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19. Sci Transl Med 2021;13:eabf7872. [PMID: 33723017 DOI: 10.1126/scitranslmed.abf7872] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
204 Fleming N, Sacks LJ, Pham CT, Neoh SL, Ekinci EI. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting. Diabet Med 2021;38:e14509. [PMID: 33377213 DOI: 10.1111/dme.14509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
205 Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Ul Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz CS, Parise H, Lansky A. Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial. Contemp Clin Trials 2021;110:106547. [PMID: 34461322 DOI: 10.1016/j.cct.2021.106547] [Reference Citation Analysis]
206 O'Shea PM, Lee GR, Griffin TP, Tormey V, Hayat A, Costelloe SJ, Griffin DG, Srinivasan S, O'Kane M, Burke CM, Faul J, Thompson CJ, Curley G, Tormey WP. COVID-19 in adults: test menu for hospital blood science laboratories. Ir J Med Sci 2020;189:1147-52. [PMID: 32424603 DOI: 10.1007/s11845-020-02252-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
207 Varma N, Marrouche NF, Aguinaga L, Albert CM, Arbelo E, Choi JI, Chung MK, Conte G, Dagher L, Epstein LM, Ghanbari H, Han JK, Heidbuchel H, Huang H, Lakkireddy DR, Ngarmukos T, Russo AM, Saad EB, Saenz Morales LC, Sandau KE, Sridhar ARM, Stecker EC, Varosy PD. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic. Europace 2021;23:313. [PMID: 32526011 DOI: 10.1093/europace/euaa187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
208 Wang YJ, Jin QQ, Zheng C, Lin JX, Lin YF, Xu Q, Li J, Lin JF. One-Year Recording of Cardiac Arrhythmias in a Non-Infected Population with Cardiac Implantable Devices During the COVID-19 Pandemic. Int J Gen Med 2021;14:7337-48. [PMID: 34737628 DOI: 10.2147/IJGM.S333093] [Reference Citation Analysis]
209 Rencilin CF, Rosy JC, Mohan M, Coico R, Sundar K. Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19. Infect Genet Evol 2021;89:104712. [PMID: 33422682 DOI: 10.1016/j.meegid.2021.104712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
210 Russo V, Bottino R, Carbone A, Rago A, Papa AA, Golino P, Nigro G. COVID-19 and Heart: From Clinical Features to Pharmacological Implications. J Clin Med 2020;9:E1944. [PMID: 32580344 DOI: 10.3390/jcm9061944] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
211 Göbölös L, Rácz I, Hogan M, Remsey-Semmelweis E, Atallah B, AlMahmeed W, AlSindi F, Suri RM, Bhatnagar G, Tuzcu EM. The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection. J Vasc Surg 2021;73:1889-97. [PMID: 33348007 DOI: 10.1016/j.jvs.2020.12.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
212 Kang IS, Kong KA. Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea. PLoS One 2021;16:e0253640. [PMID: 34157043 DOI: 10.1371/journal.pone.0253640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Correale M, Croella F, Leopizzi A, Mazzeo P, Tricarico L, Mallardi A, Fortunato M, Magnesa M, Ceci V, Puteo A, Iacoviello M, Di Biase M, Brunetti ND. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic. Cardiovasc Drugs Ther 2021. [PMID: 34328581 DOI: 10.1007/s10557-021-07217-8] [Reference Citation Analysis]
214 Biscetti F, Rando MM, Nardella E, Cecchini AL, Bruno P, Landolfi R, Flex A. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury. Int J Mol Sci 2020;21:E8141. [PMID: 33143371 DOI: 10.3390/ijms21218141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
215 Halpin-Veszeleiova K, Hatfield SM. Therapeutic Targeting of Hypoxia-A2-Adenosinergic Pathway in COVID-19 Patients. Physiology (Bethesda) 2022;37:46-52. [PMID: 34486395 DOI: 10.1152/physiol.00010.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 San Román JA, Uribarri A, Amat-Santos IJ, Aparisi Á, Catalá P, González-Juanatey JR. The presence of heart disease worsens prognosis in patients with COVID-19. Rev Esp Cardiol (Engl Ed) 2020;73:773-5. [PMID: 32622732 DOI: 10.1016/j.rec.2020.05.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
217 Haslbauer JD, Tzankov A, Mertz KD, Schwab N, Nienhold R, Twerenbold R, Leibundgut G, Stalder AK, Matter M, Glatz K. Characterisation of cardiac pathology in 23 autopsies of lethal COVID-19. J Pathol Clin Res 2021;7:326-37. [PMID: 33837673 DOI: 10.1002/cjp2.212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
218 Milligan GP, Alam A, Guerrero-Miranda C. Recognizing Right Ventricular Dysfunction in Coronavirus Disease-2019-Related Respiratory Illness. J Card Fail 2020;26:476. [PMID: 32407800 DOI: 10.1016/j.cardfail.2020.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
219 Liu J, Virani SS, Alam M, Denktas AE, Hamzeh I, Khalid U. Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Rev Med Virol 2021;31:e2172. [PMID: 32959951 DOI: 10.1002/rmv.2172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Su M, Yuan J, Peng J, Wu M, Yang Y, Peng YG. Clinical prediction model for mortality of adult diabetes inpatients with COVID-19 in Wuhan, China: A retrospective pilot study. J Clin Anesth 2020;66:109927. [PMID: 32570072 DOI: 10.1016/j.jclinane.2020.109927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Marchiano S, Hsiang TY, Khanna A, Higashi T, Whitmore LS, Bargehr J, Davaapil H, Chang J, Smith E, Ong LP, Colzani M, Reinecke H, Yang X, Pabon L, Sinha S, Najafian B, Sniadecki NJ, Bertero A, Gale M Jr, Murry CE. SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function. Stem Cell Reports 2021;16:478-92. [PMID: 33657418 DOI: 10.1016/j.stemcr.2021.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
222 Natale F, Capasso R, Casalino A, Crescenzi C, Sangiuolo P, Golino P, Loffredo FS, Cimmino G. Peripheral Artery Disease and Abdominal Aortic Aneurysm: The Forgotten Diseases in COVID-19 Pandemic. Results from an Observational Study on Real-World Management. Medicina (Kaunas) 2021;57:672. [PMID: 34209552 DOI: 10.3390/medicina57070672] [Reference Citation Analysis]
223 Bevilacqua M, De Togni P, Cattazzo F, Dell'Atti D, Dalbeni A, Mazzaferri F, Tacconelli E, Farzaneh-Far A, Fava C, Minuz P, Romano S. Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19-Related Disease. Am J Cardiol 2021:S0002-9149(21)01110-3. [PMID: 34895871 DOI: 10.1016/j.amjcard.2021.10.046] [Reference Citation Analysis]
224 Regan W, O'Byrne L, Stewart K, Miller O, Pushparajah K, Theocharis P, Wong J, Rosenthal E. Electrocardiographic Changes in Children with Multisystem Inflammation Associated with COVID-19: Associated with Coronavirus Disease 2019. J Pediatr 2021;234:27-32.e2. [PMID: 33358846 DOI: 10.1016/j.jpeds.2020.12.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
225 Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci 2021;58:297-310. [PMID: 33347790 DOI: 10.1080/10408363.2020.1860895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
226 Schloer S, Brunotte L, Goretzko J, Mecate-Zambrano A, Korthals N, Gerke V, Ludwig S, Rescher U. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Emerg Microbes Infect 2020;9:2245-55. [PMID: 32975484 DOI: 10.1080/22221751.2020.1829082] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
227 Chowdhury UN, Faruqe MO, Mehedy M, Ahmad S, Islam MB, Shoombuatong W, Azad AKM, Moni MA. Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection. Comput Biol Med 2021;138:104891. [PMID: 34624759 DOI: 10.1016/j.compbiomed.2021.104891] [Reference Citation Analysis]
228 Chung CJ, Nazif TM, Wolbinski M, Hakemi E, Lebehn M, Brandwein R, Rezende CP, Doolittle J, Rabbani L, Uriel N, Schwartz A, Biviano A, Wan E, Hathaway L, Hahn R, Khalique O, Hamid N, Ng V, Patel A, Vahl T, Kirtane A, Bapat V, George I, Leon MB, Kodali SK. Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic: JACC Review Topic of the Week. J Am Coll Cardiol 2020;75:2974-83. [PMID: 32278716 DOI: 10.1016/j.jacc.2020.04.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
229 Law CC, Puranik R, Fan J, Fei J, Hambly BD, Bao S. Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19. Front Cardiovasc Med 2021;8:630767. [PMID: 34422917 DOI: 10.3389/fcvm.2021.630767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Funck-Brentano C, Nguyen LS, Salem JE. Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19. Lancet 2020;396:e2-3. [PMID: 32653079 DOI: 10.1016/S0140-6736(20)31528-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
231 Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, Ammirati E, Wang DW. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol 2020;147:74-87. [PMID: 32827510 DOI: 10.1016/j.yjmcc.2020.08.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
232 Kostova D, Richter P, Van Vliet G, Mahar M, Moolenaar RL. The Role of Noncommunicable Diseases in the Pursuit of Global Health Security. Health Secur 2021;19:288-301. [PMID: 33961498 DOI: 10.1089/hs.2020.0121] [Reference Citation Analysis]
233 Myers KD, Wilemon K, McGowan MP, Howard W, Staszak D, Rader DJ. COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD. Am J Prev Cardiol 2021;7:100197. [PMID: 34611637 DOI: 10.1016/j.ajpc.2021.100197] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
234 Calvo-Fernández A, Izquierdo A, Subirana I, Farré N, Vila J, Durán X, García-Guimaraes M, Valdivielso S, Cabero P, Soler C, García-Ribas C, Rodríguez C, Llagostera M, Mojón D, Vicente M, Solé-González E, Sánchez-Carpintero A, Tevar C, Marrugat J, Vaquerizo B. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis. Rev Esp Cardiol (Engl Ed) 2021;74:576-83. [PMID: 33153955 DOI: 10.1016/j.rec.2020.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
235 Kavsak PA, Hammarsten O, Worster A, Smith SW, Apple FS. Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results. Clin Chem 2021;67:107-13. [PMID: 33045044 DOI: 10.1093/clinchem/hvaa225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
236 Choi JH, Park JH. Things You Should Know in the Performing Echocardiographic Examination in Patients with COVID-19. J Cardiovasc Imaging 2021;29:20-30. [PMID: 33511797 DOI: 10.4250/jcvi.2020.0128] [Reference Citation Analysis]
237 Aciksari G, Cetinkal G, Kocak M, Cag Y, Atici A, Altunal LN, Barman HA, Aydın M, Kocas BB, Cam G, Guclu KG, Caliskan M. Evaluation of Modified ATRIA Risk Score in Predicting Mortality in Hospitalized Patients with COVID-19. Am J Med Sci 2021:S0002-9629(21)00214-7. [PMID: 34107275 DOI: 10.1016/j.amjms.2021.06.001] [Reference Citation Analysis]
238 Guo C, Li B, Ma H, Wang X, Cai P, Yu Q, Zhu L, Jin L, Jiang C, Fang J, Liu Q, Zong D, Zhang W, Lu Y, Li K, Gao X, Fu B, Liu L, Ma X, Weng J, Wei H, Jin T, Lin J, Qu K. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm. Nat Commun 2020;11:3924. [PMID: 32764665 DOI: 10.1038/s41467-020-17834-w] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 32.0] [Reference Citation Analysis]
239 Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci 2021;46:1-14. [PMID: 33487787 DOI: 10.30476/ijms.2020.87233.1730] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
240 Gordon JS, Drazner MH. Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review. Curr Heart Fail Rep 2021;18:163-8. [PMID: 33666855 DOI: 10.1007/s11897-021-00505-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, Kabra R, Natale A, Poe S, Saha SA, Russo AM. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol 2020;59:329-36. [PMID: 32494896 DOI: 10.1007/s10840-020-00789-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 20.5] [Reference Citation Analysis]
242 Sorrentino S, Cacia M, Leo I, Polimeni A, Sabatino J, Spaccarotella CAM, Mongiardo A, De Rosa S, Indolfi C. B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis. J Clin Med 2020;9:E2957. [PMID: 32932743 DOI: 10.3390/jcm9092957] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
243 Chen S, Yang L, Nilsson-Payant B, Han Y, Jaffré F, Zhu J, Wang P, Zhang T, Redmond D, Houghton S, Møller R, Hoagland D, Horiuchi S, Acklin J, Lim J, Bram Y, Richardson C, Chandar V, Borczuk A, Huang Y, Xiang J, Ho D, Schwartz R, tenOever B, Evans T. SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2. Res Sq 2020:rs. [PMID: 33236003 DOI: 10.21203/rs.3.rs-94634/v1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
244 Ma H, Cassedy A, O'Kennedy R. The role of antibody-based troponin detection in cardiovascular disease: A critical assessment. J Immunol Methods 2021;:113108. [PMID: 34329690 DOI: 10.1016/j.jim.2021.113108] [Reference Citation Analysis]
245 Matos JHF, Gomes EB, Formiga NPF, Nascimento MNR, Lima GS, Moreira TMM. Interventions related to cardiovascular complications in people hospitalized by covid-19: a scoping review. Rev Bras Enferm 2021;74:e20200568. [PMID: 33566953 DOI: 10.1590/0034-7167-2020-0568] [Reference Citation Analysis]
246 Sharma P, Pradhan A, Vohra S, Sethi R. COVID-19 and Cardiovascular Diseases: Challenges and Solutions. Cardiol Res 2021;12:149-55. [PMID: 34046108 DOI: 10.14740/cr1244] [Reference Citation Analysis]
247 Rezabakhsh A, Sadat-Ebrahimi SR, Ala A, Nabavi SM, Banach M, Ghaffari S. A close-up view of dynamic biomarkers in the setting of COVID-19: Striking focus on cardiovascular system. J Cell Mol Med 2021. [PMID: 34894069 DOI: 10.1111/jcmm.17122] [Reference Citation Analysis]
248 Saleh M, Vaezi AA, Aliannejad R, Sohrabpour AA, Kiaei SZF, Shadnoush M, Siavashi V, Aghaghazvini L, Khoundabi B, Abdoli S, Chahardouli B, Seyhoun I, Alijani N, Verdi J. Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial. Stem Cell Res Ther 2021;12:410. [PMID: 34271988 DOI: 10.1186/s13287-021-02483-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
249 Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol 2020;76:1244-58. [PMID: 32652195 DOI: 10.1016/j.jacc.2020.06.068] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 50.0] [Reference Citation Analysis]
250 Coto E, Avanzas P, Gómez J. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019. Eur Cardiol 2021;16:e07. [PMID: 33737961 DOI: 10.15420/ecr.2020.30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
251 Wei ZY, Qiao R, Chen J, Huang J, Wang WJ, Yu H, Xu J, Wu H, Wang C, Gu CH, Li HJ, Li M, Liu C, Yang J, Ding HM, Lu MJ, Yin WH, Wang Y, Li KW, Shi HF, Qian HY, Yang WX, Geng YJ. Pre-existing Health Conditions and Epicardial Adipose Tissue Volume: Potential Risk Factors for Myocardial Injury in COVID-19 Patients. Front Cardiovasc Med 2020;7:585220. [PMID: 33505992 DOI: 10.3389/fcvm.2020.585220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Alkotaji M, Al-Zidan RN. Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients? Curr Pharmacol Rep 2021;:1-5. [PMID: 33907665 DOI: 10.1007/s40495-021-00257-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Bitew G, Sharew M, Belsti Y. Factors associated with knowledge, attitude, and practice of COVID-19 among health care professional's working in South Wollo Zone Hospitals, Northeast Ethiopia. SAGE Open Med 2021;9:20503121211025147. [PMID: 34178343 DOI: 10.1177/20503121211025147] [Reference Citation Analysis]
254 Egolum UO, Parikh K, Lekavich C, Wosik J, Frazier-Mills C, Fudim M. Applications of the Multisensor HeartLogic Heart Failure Monitoring Algorithm During the COVID-19 Global Pandemic. JACC Case Rep 2020;2:2265-9. [PMID: 33073246 DOI: 10.1016/j.jaccas.2020.09.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
255 Bartolomucci A, Sapolsky RM. Psychosocial Risk Factors, Noncommunicable Diseases, and Animal Models for COVID-19. Biol Psychiatry 2021;89:e67-71. [PMID: 33487440 DOI: 10.1016/j.biopsych.2020.12.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
256 Puttegowda B, Shivashankarappa AB, Dutta S, Chikkamuniswamy R, Bhat P, Krishnan S, Nanjappa MC. Patterns of cardiovascular diseases in COVID-19 patients admitted to tertiary cardiac care centre. Indian Heart J 2021;73:682-6. [PMID: 34695446 DOI: 10.1016/j.ihj.2021.10.007] [Reference Citation Analysis]
257 Elfasi A, Echevarria FD, Rodriguez R, Roman Casul YA, Khanna AY, Mankowski RT, Simpkins AN. Impact of COVID-19 on Future Ischemic Stroke Incidence. eNeurologicalSci 2021;22:100325. [PMID: 33553699 DOI: 10.1016/j.ensci.2021.100325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Possari RY, Andrade-Gomes HJ, Mello VC, Galdeano EA, Aguiar-Filho LF, Bittencourt MS, Ponte EV, Bertoche LR, Caio LRS, Rodrigues JD, Alcantara FB, Freitas MAC, Sarinho JCGC, Cervigne NK, Rodrigues WM, Aprahamian I. Association of coronary calcification with prognosis of Covid-19 patients without known heart disease. Braz J Med Biol Res 2021;54:e11681. [PMID: 34878066 DOI: 10.1590/1414-431X2021e11681] [Reference Citation Analysis]
259 Wojtys EM. Unintentional Consequences. Sports Health 2021;13:13-4. [PMID: 33302808 DOI: 10.1177/1941738120974679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
260 Cihakova D, Streiff MB, Menez SP, Chen TK, Gilotra NA, Michos ED, Marr KA, Karaba AH, Robinson ML, Blair PW, Dioverti MV, Post WS, Cox AL, R Antar AA. High-value laboratory testing for hospitalized COVID-19 patients: a review. Future Virol 2021. [PMID: 34567235 DOI: 10.2217/fvl-2020-0316] [Reference Citation Analysis]
261 Baker SM, Leedy DJ, Klafter JA, Zhang Y, Secrest KM, Osborn TR, Cheng RK, Judson SD, Merel SE, Mikacenic C, Bhatraju PK, Liles WC. Clinical presentation, complications, and outcomes of hospitalized COVID-19 patients in an academic center with a centralized palliative care consult service. Health Sci Rep 2021;4:e423. [PMID: 34754946 DOI: 10.1002/hsr2.423] [Reference Citation Analysis]
262 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Reference Citation Analysis]
263 Chua PEY, Shah SU, Gui H, Koh J, Somani J, Pang J. Epidemiological and clinical characteristics of non-severe and severe pediatric and adult COVID-19 patients across different geographical regions in the early phase of pandemic: a systematic review and meta-analysis of observational studies. J Investig Med 2021:jim-2021-001858. [PMID: 34135068 DOI: 10.1136/jim-2021-001858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
264 Ferrari F, Martins VM, Fuchs FD, Stein R. Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review. Clinics (Sao Paulo) 2021;76:e2342. [PMID: 33852652 DOI: 10.6061/clinics/2021/e2342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Caillon A, Zhao K, Klein KO, Greenwood CMT, Lu Z, Paradis P, Schiffrin EL. High Systolic Blood Pressure at Hospital Admission Is an Important Risk Factor in Models Predicting Outcome of COVID-19 Patients. Am J Hypertens 2021;34:282-90. [PMID: 33386395 DOI: 10.1093/ajh/hpaa225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
266 Smyk W, Janik MK, Portincasa P, Milkiewicz P, Lammert F, Krawczyk M. COVID-19: Focus on the lungs but do not forget the gastrointestinal tract. Eur J Clin Invest. 2020;50:e13276. [PMID: 32406522 DOI: 10.1111/eci.13276] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
267 Ishigami J, Kou M, Ding N, Matsushita K. Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention. Curr Epidemiol Rep 2021;:1-8. [PMID: 33425654 DOI: 10.1007/s40471-020-00261-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
268 Duckheim M, Schreieck J. COVID-19 and Cardiac Arrhythmias. Hamostaseologie 2021;41:372-8. [PMID: 34695853 DOI: 10.1055/a-1581-6881] [Reference Citation Analysis]
269 Hatami F, Valizadeh N, Ansari Ramandi MM. Emerging mechanisms for the new coronavirus-related myocardial injury and ischemia: A review of the literature. Anatol J Cardiol 2020;24:7-12. [PMID: 32628143 DOI: 10.14744/AnatolJCardiol.2020.68166] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
270 Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, Scicchitano M, Macrì R, Nucera S, Bosco F, Scarano F, Zito MC, Ruga S, Tavernese A, Mollace V. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci 2020;21:E9309. [PMID: 33291346 DOI: 10.3390/ijms21239309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
271 Yu WL, Toh HS, Liao CT, Chang WT. Cardiovascular Complications of COVID-19 and Associated Concerns: A Review. Acta Cardiol Sin 2021;37:9-17. [PMID: 33488023 DOI: 10.6515/ACS.202101_37(1).20200913A] [Reference Citation Analysis]
272 Li X, Pan X, Li Y, An N, Xing Y, Yang F, Tian L, Sun J, Gao Y, Shang H, Xing Y. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care. 2020;24:468. [PMID: 32723362 DOI: 10.1186/s13054-020-03183-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
273 Dan S, Pant M, Upadhyay SK. The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic. Curr Pharmacol Rep 2020;:1-10. [PMID: 32953401 DOI: 10.1007/s40495-020-00239-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
274 Yang J, Liao X, Yin W, Wang B, Yue J, Bai L, Liu D, Zhu T, Huang Z, Kang Y. Elevated cardiac biomarkers may be effective prognostic predictors for patients with COVID-19: A multicenter, observational study. The American Journal of Emergency Medicine 2021;39:34-41. [DOI: 10.1016/j.ajem.2020.10.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
275 Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
276 Tomasoni D, Inciardi RM, Lombardi CM, Tedino C, Agostoni P, Ameri P, Barbieri L, Bellasi A, Camporotondo R, Canale C, Carubelli V, Carugo S, Catagnano F, Dalla Vecchia LA, Danzi GB, Di Pasquale M, Gaudenzi M, Giovinazzo S, Gnecchi M, Iorio A, La Rovere MT, Leonardi S, Maccagni G, Mapelli M, Margonato D, Merlo M, Monzo L, Mortara A, Nuzzi V, Piepoli M, Porto I, Pozzi A, Sarullo F, Sinagra G, Volterrani M, Zaccone G, Guazzi M, Senni M, Metra M. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.Eur J Heart Fail. 2020;22:2238-2247. [PMID: 33179839 DOI: 10.1002/ejhf.2052] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
277 Tomidokoro D, Hiroi Y. Cardiovascular implications of the COVID-19 pandemic. J Cardiol 2021:S0914-5087(21)00243-4. [PMID: 34563439 DOI: 10.1016/j.jjcc.2021.09.010] [Reference Citation Analysis]
278 Singh A, Akbar MS, McElroy D, McCurdy M, Young F, Thomas J, Nguyen C, Pfirman KS. The electrocardiographic manifestations and derangements of 2019 novel coronavirus disease (COVID-19). Indian Pacing Electrophysiol J 2021;21:156-61. [PMID: 33657456 DOI: 10.1016/j.ipej.2021.02.005] [Reference Citation Analysis]
279 Merlo E, Grutta G, Tiberio I, Martelli G. Right Heart Thrombus in an Adult COVID-19 Patient: A Case Report. J Crit Care Med (Targu Mures) 2020;6:237-42. [PMID: 33200095 DOI: 10.2478/jccm-2020-0039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
280 Gormeli Kurt N, Gunes C. How has Covid-19 pandemic affected crowded emergency services? Int J Clin Pract 2020;74:e13624. [PMID: 33448533 DOI: 10.1111/ijcp.13624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
281 Tudoran M, Tudoran C, Lazureanu VE, Marinescu AR, Pop GN, Pescariu AS, Enache A, Cut TG. Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously Diagnosed Cardiovascular Pathology. J Pers Med 2021;11:225. [PMID: 33809873 DOI: 10.3390/jpm11030225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Kulkarni PG, Sakharkar A, Banerjee T. Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients. Hypertens Res 2021. [PMID: 34848886 DOI: 10.1038/s41440-021-00800-4] [Reference Citation Analysis]
283 Kumar V. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us. Int Rev Immunol 2021;40:5-53. [PMID: 32744465 DOI: 10.1080/08830185.2020.1800688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
284 Megiorni F, Pontecorvi P, Gerini G, Anastasiadou E, Marchese C, Ceccarelli S. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19. Biomolecules 2022;12:21. [DOI: 10.3390/biom12010021] [Reference Citation Analysis]
285 Morici N, Sacco A, Forleo G, Brunelli D, De Luca G, Savonitto S. The other side of the coin: 'centralization' against 'optimization' in COVID-19 pandemic. ESC Heart Fail 2021;8:2354-6. [PMID: 33830668 DOI: 10.1002/ehf2.13289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
286 Windham S, Hirsch K, Peterson R, Douin D, Chauhan L, Heery L, Fling C, Vukovic N, Holguin F, Zimmer S, Erlandson K. The Predictive Potential of Elevated Serum Inflammatory Markers in Determining the Need for Intubation in CoVID-19 Patients. The Journal of Critical Care Medicine 2021;0. [DOI: 10.2478/jccm-2021-0035] [Reference Citation Analysis]
287 Fujita K, Kanai O, Nanba K, Esaka N, Hata H, Seta K, Odagaki T. Acute rhabdomyolysis in a young woman with moderate COVID-19. IDCases 2021;25:e01212. [PMID: 34221896 DOI: 10.1016/j.idcr.2021.e01212] [Reference Citation Analysis]
288 Tersalvi G, Veronese G, Winterton D. Emerging evidence of myocardial injury in COVID-19: A path through the smoke. Theranostics 2020;10:9888-9. [PMID: 32863965 DOI: 10.7150/thno.50788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
289 Pfeifer M, Hamer OW. [COVID-19 pneumonia]. Internist (Berl) 2020;61:793-803. [PMID: 32728817 DOI: 10.1007/s00108-020-00854-5] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
290 Lu J, Lin J, Yin L, Shi R, Li H, Ge Y, Luo J. Using remote consultation to enhance diagnostic accuracy of bedside transthoracic echocardiography during COVID-19 pandemic. Echocardiography 2021;38:1245-53. [PMID: 34056743 DOI: 10.1111/echo.15124] [Reference Citation Analysis]
291 Rodríguez-Santamarta M, Minguito-Carazo C, Echarte-Morales JC, Del Castillo-García S, Valdivia-Ruiz J, Fernández-Vázquez F. [Echocardiographic findings in critical patients with COVID-19]. Rev Esp Cardiol 2020;73:861-3. [PMID: 32836661 DOI: 10.1016/j.recesp.2020.06.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
292 Galvani AP, Parpia AS, Pandey A, Zimmer C, Kahn JG, Fitzpatrick MC. The imperative for universal healthcare to curtail the COVID-19 outbreak in the USA. EClinicalMedicine 2020;23:100380. [PMID: 32426707 DOI: 10.1016/j.eclinm.2020.100380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
293 Saba L, Gerosa C, Wintermark M, Hedin U, Fanni D, Suri JS, Balestrieri A, Faa G. Can COVID19 trigger the plaque vulnerability-a Kounis syndrome warning for "asymptomatic subjects". Cardiovasc Diagn Ther. 2020;10:1352-1355. [PMID: 33224760 DOI: 10.21037/cdt-20-561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
294 Shang Y, Liu T, Wei Y, Li J, Shao L, Liu M, Zhang Y, Zhao Z, Xu H, Peng Z, Zhou F, Wang X. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine 2020;24:100426. [PMID: 32766541 DOI: 10.1016/j.eclinm.2020.100426] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
295 Huang Z, Huang P, Du B, Kong L, Zhang W, Zhang Y, Dong J. Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:2-13. [PMID: 33229199 DOI: 10.1016/j.numecd.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
296 Williams V, Dash N, Suthar R, Mohandoss V, Jaiswal N, Kavitha T, Nallasamy K, Angurana SK. Clinicolaboratory Profile, Treatment, Intensive Care Needs, and Outcome of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: A Systematic Review and Meta-analysis. J Pediatr Intensive Care. [DOI: 10.1055/s-0040-1719173] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
297 Shmueli H, Shah M, Ebinger JE, Nguyen LC, Chernomordik F, Flint N, Botting P, Siegel RJ. Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19. Int J Cardiol Heart Vasc 2021;32:100719. [PMID: 33521240 DOI: 10.1016/j.ijcha.2021.100719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
298 Nemer DM, Wilner BR, Burkle A, Aguilera J, Adewumi J, Gillombardo C, Wazni O, Menon V, Pengel S, Foxx M, Petre M, Hamilton AC, Cantillon DJ. Clinical Characteristics and Outcomes of Non-ICU Hospitalization for COVID-19 in a Nonepicenter, Centrally Monitored Healthcare System. J Hosp Med 2021;16:7-14. [PMID: 33147132 DOI: 10.12788/jhm.3510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
299 Singh T, Kite TA, Joshi SS, Spath NB, Kershaw L, Baker A, Jordan H, Gulsin GS, Williams MC, van Beek EJR, Arnold JR, Semple SIK, Moss AJ, Newby DE, Dweck M, McCann GP. MRI and CT coronary angiography in survivors of COVID-19. Heart 2021:heartjnl-2021-319926. [PMID: 34615668 DOI: 10.1136/heartjnl-2021-319926] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Liaqat A, Ali-Khan RS, Asad M, Rafique Z. Evaluation of myocardial injury patterns and ST changes among critical and non-critical patients with coronavirus-19 disease. Sci Rep 2021;11:4828. [PMID: 33649391 DOI: 10.1038/s41598-021-84467-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
301 An YW, Song S, Li WX, Chen YX, Hu XP, Zhao J, Li ZW, Jiang GY, Wang C, Wang JC, Yuan B, Liu HQ. Liver function recovery of COVID-19 patients after discharge, a follow-up study. Int J Med Sci. 2021;18:176-186. [PMID: 33390786 DOI: 10.7150/ijms.50691] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
302 Denaxas S, Shah AD, Mateen BA, Kuan V, Quint JK, Fitzpatrick N, Torralbo A, Fatemifar G, Hemingway H. A semi-supervised approach for rapidly creating clinical biomarker phenotypes in the UK Biobank using different primary care EHR and clinical terminology systems. JAMIA Open 2020;3:545-56. [PMID: 33619467 DOI: 10.1093/jamiaopen/ooaa047] [Reference Citation Analysis]
303 Shao MJ, Shang LX, Luo JY, Shi J, Zhao Y, Li XM, Yang YN. Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: a meta-analysis. J Geriatr Cardiol 2020;17:224-8. [PMID: 32362922 DOI: 10.11909/j.issn.1671-5411.2020.04.009] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
304 Aung S, Vittinghoff E, Nah G, Lin A, Joyce S, Mann NC, Marcus GM. Emergency activations for chest pain and ventricular arrhythmias related to regional COVID-19 across the US. Sci Rep 2021;11:23959. [PMID: 34907226 DOI: 10.1038/s41598-021-03243-6] [Reference Citation Analysis]
305 Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy. Res Pract Thromb Haemost 2020;4:731-6. [PMID: 32685880 DOI: 10.1002/rth2.12372] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 16.5] [Reference Citation Analysis]
306 König S, Hohenstein S, Meier-Hellmann A, Kuhlen R, Hindricks G, Bollmann A; Helios Hospitals, Germany. In-hospital care in acute heart failure during the COVID-19 pandemic: insights from the German-wide Helios hospital network. Eur J Heart Fail 2020;22:2190-201. [PMID: 33135851 DOI: 10.1002/ejhf.2044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
307 Jiang N, Li Z, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients. Biomed Res Int 2021;2021:9101082. [PMID: 33542929 DOI: 10.1155/2021/9101082] [Reference Citation Analysis]
308 Almeida Junior GLG, Braga F, Jorge JK, Nobre GF, Kalichsztein M, Faria PMP, Bussade B, Penna GL, Alves VO, Pereira MA, Gorgulho PC, Faria MRDSE, Drumond LE, Carpinete FBS, Neno ACLB, Neno ACA. Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19. Arq Bras Cardiol 2020;115:660-6. [PMID: 33111866 DOI: 10.36660/abc.20200385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
309 Page EM, Ariëns RAS. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thromb Res 2021;200:1-8. [PMID: 33493983 DOI: 10.1016/j.thromres.2021.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
310 Cheah IK, Halliwell B. Could Ergothioneine Aid in the Treatment of Coronavirus Patients? Antioxidants (Basel) 2020;9:E595. [PMID: 32646061 DOI: 10.3390/antiox9070595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
311 Sharma K, Desai HD, Patoliya JV, Jadeja DM, Gadhiya D. Takotsubo Syndrome a Rare Entity in COVID-19: a Systemic Review-Focus on Biomarkers, Imaging, Treatment, and Outcome. SN Compr Clin Med 2021;:1-11. [PMID: 33458567 DOI: 10.1007/s42399-021-00743-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
312 Lee T, Cau A, Cheng MP, Levin A, Lee TC, Vinh DC, Lamontagne F, Singer J, Walley KR, Murthy S, Patrick D, Rewa OG, Winston BW, Marshall J, Boyd J, Tran K, Kalil AC, Mcculoh R, Fowler R, Luther JM, Russell JA; ARBs CORONA. Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors. CJC Open 2021;3:965-75. [PMID: 33842874 DOI: 10.1016/j.cjco.2021.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Miossec P. [Proinflammatory cytokines and cardio-vascular risk: From myocardial infarction tocytokine storm of COVID-19]. Bull Acad Natl Med 2021;205:43-8. [PMID: 33199926 DOI: 10.1016/j.banm.2020.10.012] [Reference Citation Analysis]
314 Al Hashmi AM, Ozdemir AO, Shuaib A, Al-Jehani H, Mansour OY, Alhazzani A, Aladhem F, Farhoudi M, John S, Saqqur M. Current Recommendations for the Management of Stroke Patients in the Middle East in the Era of COVID-19 Pandemic; Statement from the MENA SINO. J Stroke Cerebrovasc Dis 2020;29:105181. [PMID: 33066945 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
315 Srinivasan K, Pandey AK, Livingston A, Venkatesh S. Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? Mol Biomed 2021;2:38. [PMID: 34841263 DOI: 10.1186/s43556-021-00060-1] [Reference Citation Analysis]
316 Varma A, Dergaa I, Mohammed AR, Abubaker M, Al Naama A, Mohammed S, Rafique MA, Manu L, Vedasalam S, Parveze P, Hammouda O, Ammar A. Covid-19 and diabetes in primary care - How do hematological parameters present in this cohort? Expert Rev Endocrinol Metab 2021;16:147-53. [PMID: 33818239 DOI: 10.1080/17446651.2021.1909472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
317 Goldstein MR, Poland GA, Graeber CW. Response to: Cardiac drugs and outcome in COVID-19. QJM 2020;113:525-6. [PMID: 32289171 DOI: 10.1093/qjmed/hcaa128] [Reference Citation Analysis]
318 Xie Y, Wang L, Li M, Li H, Zhu S, Wang B, He L, Zhang D, Zhang Y, Yuan H, Wu C, Sun W, Zhang Y, Cui L, Cai Y, Wang J, Yang Y, Lv Q, Xie M, Li Y, Zhang L. Biventricular Longitudinal Strain Predict Mortality in COVID-19 Patients. Front Cardiovasc Med 2020;7:632434. [PMID: 33537350 DOI: 10.3389/fcvm.2020.632434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
319 Ranard LS, Fried JA, Abdalla M, Anstey DE, Givens RC, Kumaraiah D, Kodali SK, Takeda K, Karmpaliotis D, Rabbani LE, Sayer G, Kirtane AJ, Leon MB, Schwartz A, Uriel N, Masoumi A. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail 2020;13:e007220. [PMID: 32500721 DOI: 10.1161/CIRCHEARTFAILURE.120.007220] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
320 Chang YK, Hung CL, Timme S, Nosrat S, Chu CH. Exercise Behavior and Mood during the COVID-19 Pandemic in Taiwan: Lessons for the Future. Int J Environ Res Public Health 2020;17:E7092. [PMID: 32998207 DOI: 10.3390/ijerph17197092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
321 Kaur N, Oskotsky B, Butte AJ, Hu Z. Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patients. Genome Biol 2022;23:15. [PMID: 35012625 DOI: 10.1186/s13059-021-02589-4] [Reference Citation Analysis]
322 Conte C, Esposito A, De Lorenzo R, Di Filippo L, Palmisano A, Vignale D, Leone R, Nicoletti V, Ruggeri A, Gallone G, Secchi A, Bosi E, Tresoldi M, Castagna A, Landoni G, Zangrillo A, De Cobelli F, Ciceri F, Camici P, Rovere-Querini P. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis 2021;31:2156-64. [PMID: 34059384 DOI: 10.1016/j.numecd.2021.04.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
323 Tersalvi G, Winterton D, Cioffi GM, Ghidini S, Roberto M, Biasco L, Pedrazzini G, Dauw J, Ameri P, Vicenzi M. Telemedicine in Heart Failure During COVID-19: A Step Into the Future. Front Cardiovasc Med 2020;7:612818. [PMID: 33363223 DOI: 10.3389/fcvm.2020.612818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
324 Kim IC, Song JE, Lee HJ, Park JH, Hyun M, Lee JY, Kim HA, Kwon YS, Park JS, Youn JC, Hwang J, Lee CH, Cho YK, Park HS, Yoon HJ, Nam CW, Han S, Hur SH, Eisen HJ, Kim H. The Implication of Cardiac Injury Score on In-hospital Mortality of Coronavirus Disease 2019. J Korean Med Sci 2020;35:e349. [PMID: 33045772 DOI: 10.3346/jkms.2020.35.e349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
325 Castelletti S, Gati S. The Female Athlete's Heart: Overview and Management of Cardiovascular Diseases. Eur Cardiol 2021;16:e47. [PMID: 34950243 DOI: 10.15420/ecr.2021.29] [Reference Citation Analysis]
326 Tsivgoulis G, Palaiodimou L, Katsanos AH, Caso V, Köhrmann M, Molina C, Cordonnier C, Fischer U, Kelly P, Sharma VK, Chan AC, Zand R, Sarraj A, Schellinger PD, Voumvourakis KI, Grigoriadis N, Alexandrov AV, Tsiodras S. Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord 2020;13:1756286420932036. [PMID: 32565914 DOI: 10.1177/1756286420932036] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 27.5] [Reference Citation Analysis]
327 Stockenhuber A, Vrettos A, Androschuck V, George M, Robertson C, Bowers N, Clifford P, Firoozan S. A pilot study on right ventricular longitudinal strain as a predictor of outcome in COVID‐19 patients with evidence of cardiac involvement. Echocardiography 2021;38:222-9. [DOI: 10.1111/echo.14966] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
328 van den Heuvel FMA, Vos JL, Koop Y, van Dijk APJ, Duijnhouwer AL, de Mast Q, van de Veerdonk FL, Bosch F, Kok B, Netea MG, Hoogerwerf J, Hoefsloot W, Tjwa ETTL, de Korte CL, van Kimmenade RRJ, Nijveldt R. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19. Neth Heart J 2020;28:410-7. [PMID: 32643071 DOI: 10.1007/s12471-020-01458-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
329 Šikić J, Planinić Z, Matišić V, Friščić T, Molnar V, Jagačić D, Vujičić L, Tudorić N, Postružin Gršić L, Ljubičić Đ, Primorac D. COVID-19: The Impact on Cardiovascular System. Biomedicines 2021;9:1691. [PMID: 34829920 DOI: 10.3390/biomedicines9111691] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
330 Gerstein NS, Venkataramani R, Goumas AM, Chapman NN, Deriy L. COVID-19-Related Cardiovascular Disease and Practical Considerations for Perioperative Clinicians. Semin Cardiothorac Vasc Anesth 2020;24:293-303. [PMID: 32706293 DOI: 10.1177/1089253220943019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
331 Rex DAB, Arun Kumar ST, Modi PK, Keshava Prasad TS. Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target? OMICS 2021;25:408-16. [PMID: 34191617 DOI: 10.1089/omi.2021.0080] [Reference Citation Analysis]
332 Chatterjee NA, Cheng RK. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment. Heart 2020;106:1119-21. [PMID: 32451360 DOI: 10.1136/heartjnl-2020-317110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
333 Liu Q, Chen H, Zeng Q. Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia. J Infect 2020;81:e6-8. [PMID: 32663485 DOI: 10.1016/j.jinf.2020.07.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
334 Nie L, Dai K, Wu J, Zhou X, Hu J, Zhang C, Zhan Y, Song Y, Fan W, Hu Z, Yang H, Yang Q, Wu D, Li F, Li D, Nie R. Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study. Thorac Cancer 2021;12:57-65. [PMID: 33142039 DOI: 10.1111/1759-7714.13710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
335 Najera H, Ortega-Avila AG. Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020. Am J Prev Med 2021;60:471-7. [PMID: 33745520 DOI: 10.1016/j.amepre.2020.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
336 Li J, Sun L, Wang F, Liu B, Li H, Tang G, Chang Z, Liu A, Fu C, Lv Y, Gao J, Li J. Relation between Cardiac Injury and Elevated Levels of Inflammatory Biomarkers in Patients with Severe COVID-19. Cardiovascular Innovations and Applications 2021;5:165-72. [DOI: 10.15212/cvia.2019.1264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Amir R, Kichloo A, Aljadah M, Kanjwal K. Arrhythmias and COVID 19. American Journal of Therapeutics 2021;28:e687-9. [DOI: 10.1097/mjt.0000000000001288] [Reference Citation Analysis]
338 Park J, Lee SH, You SC, Kim J, Yang K. Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea. PLoS One 2021;16:e0248058. [PMID: 33705440 DOI: 10.1371/journal.pone.0248058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Kavianpour M, Saleh M, Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther 2020;11:404. [PMID: 32948252 DOI: 10.1186/s13287-020-01849-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
340 Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte-Salles T, Fernández-Bertolín S, Aragón M, DuVall SL, Lynch K, Falconer T, van Bochove K, Sung C, Matheny ME, Lambert CG, Nyberg F, Alshammari TM, Williams AE, Park RW, Weaver J, Sena AG, Schuemie MJ, Rijnbeek PR, Williams RD, Lane JCE, Prats-Uribe A, Zhang L, Areia C, Krumholz HM, Prieto-Alhambra D, Ryan PB, Hripcsak G, Suchard MA. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health 2021;3:e98-e114. [PMID: 33342753 DOI: 10.1016/S2589-7500(20)30289-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
341 González-Arnay E, Martín-Olivera R, Quintero-Quintero YC, Hernández-Guerra AI. Proposal for a harmonized protocol for COVID-19 screening and necropsy in forensic sciences facilities. J Forensic Leg Med 2020;76:102067. [PMID: 33032204 DOI: 10.1016/j.jflm.2020.102067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Ricke DO. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies. Front Immunol 2021;12:640093. [PMID: 33717193 DOI: 10.3389/fimmu.2021.640093] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
343 Alonso MN, Javier Jareño Esteban J, García-León N. [PULMONARY VASCULAR TONE DYSREGULATION AND MICROTHROMBOSIS IN COVID-19]. Arch Bronconeumol 2021. [PMID: 34054194 DOI: 10.1016/j.arbres.2021.05.007] [Reference Citation Analysis]
344 Sheng CC, Sahoo D, Dugar S, Prada RA, Wang TKM, Abou Hassan OK, Brennan D, Culver DA, Rajendram P, Duggal A, Lincoff AM, Nissen SE, Menon V, Cremer PC. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study). Clin Cardiol 2020;43:1055-63. [PMID: 32830894 DOI: 10.1002/clc.23451] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
345 Martins-Filho PR, Barreto-Filho JAS, Santos VS. Myocardial Injury Biomarkers and Cardiac Complications Associated with Mortality in Patients with COVID-19. Arq Bras Cardiol 2020;115:273-7. [PMID: 32876196 DOI: 10.36660/abc.20200372] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
346 Baral R, White M, Vassiliou VS. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients. Curr Atheroscler Rep 2020;22:61. [PMID: 32830286 DOI: 10.1007/s11883-020-00880-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 21.5] [Reference Citation Analysis]
347 Liu D, Wang Y, Wang J, Liu J, Yue Y, Liu W, Zhang F, Wang Z. Characteristics and Outcomes of a Sample of Patients With COVID-19 Identified Through Social Media in Wuhan, China: Observational Study. J Med Internet Res 2020;22:e20108. [PMID: 32716901 DOI: 10.2196/20108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
348 Hajouli S. A 29-Year-Old Man with COVID-19 Pneumonia, Heart Failure-Reduced Ejection Fraction, and Atrial Fibrillation with a Father and 2 Grandparents Who Were Positive for SARS-CoV-2 Infection. Am J Case Rep 2021;22:e933163. [PMID: 34294675 DOI: 10.12659/AJCR.933163] [Reference Citation Analysis]
349 Burger AL, Kaufmann CC, Jäger B, Pogran E, Ahmed A, Wojta J, Farhan S, Huber K. Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic : A review. Wien Klin Wochenschr 2021;133:1289-97. [PMID: 34671829 DOI: 10.1007/s00508-021-01956-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
350 Cho JH, Namazi A, Shelton R, Ramireddy A, Ehdaie A, Shehata M, Wang X, Marbán E, Chugh SS, Cingolani E. Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States. PLoS One 2020;15:e0244533. [PMID: 33370347 DOI: 10.1371/journal.pone.0244533] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
351 Caro-Codón J, Rey JR, Buño A, Iniesta AM, Rosillo SO, Castrejon-Castrejon S, Merino C, Marco I, Martinez LA, Garcia-Veas JM, Martin-Polo L, Rodriguez-Sotelo L, Martinez-Cossiani M, Gonzalez-Valle L, Herrero A, López-de-Sá E, Merino JL; CARD-COVID Investigators. Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection. Med Clin (Engl Ed) 2021;157:274-80. [PMID: 34568576 DOI: 10.1016/j.medcle.2021.02.008] [Reference Citation Analysis]
352 Baracchini C, Pieroni A. Acute stroke treatment during coronavirus disease 2019 pandemic. Curr Opin Neurol 2021;34:11-7. [PMID: 33196578 DOI: 10.1097/WCO.0000000000000886] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
353 Cárdenas Suri H, Jimomila Bening D. Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19. Expert Rev Respir Med 2020;14:1071-2. [PMID: 32746642 DOI: 10.1080/17476348.2020.1801427] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
354 de Falco R, Vargas M, Palma D, Savoia M, Miscioscia A, Pinchera B, Vano M, Servillo G, Gentile I, Fortunato G. B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer? J Clin Med 2021;10:2726. [PMID: 34205536 DOI: 10.3390/jcm10122726] [Reference Citation Analysis]
355 Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction 2021;116:1319-68. [PMID: 33007104 DOI: 10.1111/add.15276] [Cited by in Crossref: 35] [Cited by in F6Publishing: 80] [Article Influence: 17.5] [Reference Citation Analysis]
356 Linares L, Cofan F, Diekmann F, Herrera S, Marcos MA, Castel MA, Farrero M, Colmenero J, Ruiz P, Crespo G, Llopis J, Garcia-Vidal C, Soriano À, Moreno A, Bodro M; Hospital Clínic COVID-19 research group. A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients. PLoS One 2021;16:e0247251. [PMID: 33657157 DOI: 10.1371/journal.pone.0247251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
357 Chen L, Hu W, Guo X, Zhao P, Tang J, Gu Y, Huang N, Wang C, Cui A, Zhang D, Hu L, Feng Y, Hu S, Chen M, Duru F, Xiong C. Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19. Sci Rep 2021;11:4432. [PMID: 33627696 DOI: 10.1038/s41598-021-83822-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
358 Jacquet-Lagrèze M, Riad Z, Hugon-Vallet E, Ferraris A, Fellahi JL. Left ventricular dysfunction in COVID-19: A diagnostic issue. Anaesth Crit Care Pain Med 2020;39:393-4. [PMID: 32562808 DOI: 10.1016/j.accpm.2020.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
359 Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C. Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thromb Haemost 2020;120:1629-41. [PMID: 33124029 DOI: 10.1055/s-0040-1718735] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
360 Case BC, Yerasi C, Forrestal BJ, Shea C, Rappaport H, Medranda GA, Zhang C, Satler LF, Ben-Dor I, Hashim H, Rogers T, Waksman R. Comparison of Characteristics and Outcomes of Patients With Acute Myocardial Infarction With Versus Without Coronarvirus-19. Am J Cardiol 2021;144:8-12. [PMID: 33385357 DOI: 10.1016/j.amjcard.2020.12.059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
361 Kelham M, Choudry FA, Hamshere S, Beirne AM, Rathod KS, Baumbach A, Ahluwalia A, Mathur A, Jones DA. Therapeutic Implications of COVID-19 for the Interventional Cardiologist. J Cardiovasc Pharmacol Ther 2021;26:203-16. [PMID: 33331160 DOI: 10.1177/1074248420982736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
362 Alam S, Kamal TB, Sarker MMR, Zhou JR, Rahman SMA, Mohamed IN. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021. Front Pharmacol 2021;12:659577. [PMID: 34220503 DOI: 10.3389/fphar.2021.659577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
363 Liu Y, Wu S, Qin M, Jiang W, Liu X. Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data. J Am Heart Assoc 2020;9:e016812. [PMID: 32673529 DOI: 10.1161/JAHA.120.016812] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
364 Zwaenepoel B, Dhont S, Schaubroeck H, Gevaert S. The use of cardiac troponins and B-type natriuretic peptide in COVID-19. Acta Cardiol 2021;:1-6. [PMID: 34459705 DOI: 10.1080/00015385.2021.1970403] [Reference Citation Analysis]
365 Guimarães PO, de Souza FR, Lopes RD, Bittar C, Cardozo FA, Caramelli B, Calderaro D, Albuquerque CP, Drager LF, Feres F, Baracioli L, Feitosa Filho G, Barbosa RR, Ribeiro HB, Ribeiro E, Alves RJ, Soeiro A, Faillace B, Figueiredo E, Damiani LP, do Val RM, Huemer N, Nicolai LG, Hajjar LA, Abizaid A, Kalil Filho R. High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort study. Int J Cardiol Heart Vasc 2021;36:100853. [PMID: 34345648 DOI: 10.1016/j.ijcha.2021.100853] [Reference Citation Analysis]
366 Shelton KT, Wiener-kronish JP. Evolving Role of Anesthesiology Intensivists in Cardiothoracic Critical Care. Anesthesiology 2020;133:1120-6. [DOI: 10.1097/aln.0000000000003407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
367 Thakore A, Nguyen J, Pollack S, Muehlbauer S, Chi B, Knight D, Mehrotra B, Stern J, Cao JJ, Lucore C, Levine J. Electrocardiographic manifestations of COVID-19: Effect on cardiac activation and repolarization. EClinicalMedicine 2021;39:101057. [PMID: 34377967 DOI: 10.1016/j.eclinm.2021.101057] [Reference Citation Analysis]
368 Uranga A, Villanueva A, Lafuente I, González N, Legarreta MJ, Aguirre U, España PP, Quintana JM, García-Gutiérrez S; COVID-19-Osakidetza working group. Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study. Rev Clin Esp (Barc) 2021:S2254-8874(21)00149-1. [PMID: 34556435 DOI: 10.1016/j.rceng.2021.04.009] [Reference Citation Analysis]
369 Cheng FY, Joshi H, Tandon P, Freeman R, Reich DL, Mazumdar M, Kohli-Seth R, Levin M, Timsina P, Kia A. Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients. J Clin Med 2020;9:E1668. [PMID: 32492874 DOI: 10.3390/jcm9061668] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 22.5] [Reference Citation Analysis]
370 Xu F, Gao J, Munkhsaikhan U, Li N, Gu Q, Pierre JF, Starlard-Davenport A, Towbin JA, Cui Y, Purevjav E, Lu L. The Genetic Dissection of Ace2 Expression Variation in the Heart of Murine Genetic Reference Population. Front Cardiovasc Med 2020;7:582949. [PMID: 33330645 DOI: 10.3389/fcvm.2020.582949] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
371 Chukwunyere U, Sehirli AO, Abacioglu N. COVID-19-related arrhythmias and the possible effects of ranolazine. Med Hypotheses 2021;149:110545. [PMID: 33636586 DOI: 10.1016/j.mehy.2021.110545] [Reference Citation Analysis]
372 Viecca M, Radovanovic D, Forleo GB, Santus P. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol Res 2020;158:104950. [PMID: 32450344 DOI: 10.1016/j.phrs.2020.104950] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 24.5] [Reference Citation Analysis]
373 Liu W, Liu Z, Li YC. COVID-19-related myocarditis and cholinergic anti-inflammatory pathways. Hellenic J Cardiol 2021;62:265-9. [PMID: 33301863 DOI: 10.1016/j.hjc.2020.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
374 Yenerçağ M, Arslan U, Doğduş M, Günal Ö, Öztürk ÇE, Aksan G, Erdoğan G, Gül S, Yontar OC, Şen A. Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19. J Electrocardiol 2020;62:5-9. [PMID: 32731139 DOI: 10.1016/j.jelectrocard.2020.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
375 Pfeifer M, Ewig S, Voshaar T, Randerath WJ, Bauer T, Geiseler J, Dellweg D, Westhoff M, Windisch W, Schönhofer B, Kluge S, Lepper PM. Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19. Respiration 2020;99:521-42. [PMID: 32564028 DOI: 10.1159/000509104] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
376 Kosiborod M, Berwanger O, Koch GG, Martinez F, Mukhtar O, Verma S, Chopra V, Javaheri A, Ambery P, Gasparyan SB, Buenconsejo J, Sjöström CD, Langkilde AM, Oscarsson J, Esterline R. Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes Obes Metab 2021;23:886-96. [PMID: 33319454 DOI: 10.1111/dom.14296] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
377 Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, Papa A, Motta A, Maniscalco M, Di Minno MND. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines 2021;9:957. [PMID: 34440161 DOI: 10.3390/biomedicines9080957] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
378 Dehghani P, Davidson LJ, Grines CL, Nayak K, Saw J, Kaul P, Bagai A, Garberich R, Schmidt C, Ly HQ, Giri J, Meraj P, Shah B, Garcia S, Sharkey S, Wood DA, Welt FG, Mahmud E, Henry TD. North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications. Am Heart J 2020;227:11-8. [PMID: 32425198 DOI: 10.1016/j.ahj.2020.05.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
379 Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, Tan J, Xu Y, Song R, Song M, Wang L, Zhang W, Han B, Yang L, Wang X, Zhou G, Zhang T, Li B, Wang Y, Chen Z, Wang X. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med 2020;18:206. [PMID: 32434518 DOI: 10.1186/s12967-020-02374-0] [Cited by in Crossref: 240] [Cited by in F6Publishing: 224] [Article Influence: 120.0] [Reference Citation Analysis]
380 Drunat O, Roche J, Kohler S, Julien V, Pascal S, Lenoir H, Soto-Martin M, Lepetit A, Volpe-Gillot L, Leclercq V, Romdhani M, Koskas P, Lebert F. What the COVID-19 pandemic entails for the management of patients with behavioral and psychological symptoms of dementia: experience in France. Int Psychogeriatr 2020;32:1361-4. [PMID: 32930087 DOI: 10.1017/S1041610220003567] [Reference Citation Analysis]
381 Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV 3rd, Kwon DH, Singh T, Tilton JC, Tsai EJ, Tucker NR, Barnard J, Loscalzo J. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ Res 2021;128:1214-36. [PMID: 33856918 DOI: 10.1161/CIRCRESAHA.121.317997] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
382 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25-33. [PMID: 32835666 DOI: 10.1016/j.yjmcc.2020.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
383 Yadav R, Aroshidze B, Yadav V, Zahid U, Jayarangaiah A, Gandhi A, Gotlieb V. Observational Study of Thrombotic Events in a Random Cohort of Hospitalized COVID-19 Patients at a Community-Based Hospital of New York City During the Beginning of the 2020 Pandemic. Cureus 2021;13:e18601. [PMID: 34765362 DOI: 10.7759/cureus.18601] [Reference Citation Analysis]
384 Siripanthong B, Hanff TC, Levin MG, Vidula MK, Khanji MY, Nazarian S, Chahal CAA. Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure. Future Cardiol 2021;17:3-6. [PMID: 32608242 DOI: 10.2217/fca-2020-0088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
385 Mansueto G, Niola M, Napoli C. Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases? Pathol Res Pract 2020;216:153086. [PMID: 32825954 DOI: 10.1016/j.prp.2020.153086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
386 Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, Metra M. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020;22:957-966. [PMID: 32412156 DOI: 10.1002/ejhf.1871] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 42.0] [Reference Citation Analysis]
387 Feldman C. Cardiac complications in community-acquired pneumonia and COVID-19. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235421 DOI: 10.7196/AJTCCM.2020.v26i2.077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
388 Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, Ceirano A, Espinosa F, Saavedra E, Sanguine V, Tassara A, Cid C, Catalano HN, Agarwal A, Foroutan F, Rada G. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One 2020;15:e0241955. [PMID: 33201896 DOI: 10.1371/journal.pone.0241955] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 35.5] [Reference Citation Analysis]
389 Patil M, Singh S, Henderson J, Krishnamurthy P. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link? J Cell Physiol 2021;236:3366-82. [PMID: 33078408 DOI: 10.1002/jcp.30109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
390 Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;. [PMID: 32450107 DOI: 10.1016/s0140-6736(20)31180-6] [Cited by in Crossref: 267] [Cited by in F6Publishing: 259] [Article Influence: 133.5] [Reference Citation Analysis]
391 Ammirati E, Wang DW. SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients. Int J Cardiol 2020;311:122-3. [PMID: 32276774 DOI: 10.1016/j.ijcard.2020.03.086] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
392 Li Z, Shao W, Zhang J, Ma J, Huang S, Yu P, Zhu W, Liu X. Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:720129. [PMID: 34722658 DOI: 10.3389/fcvm.2021.720129] [Reference Citation Analysis]
393 Chow J, Alhussaini A, Calvillo-Argüelles O, Billia F, Luk A. Cardiovascular Collapse in COVID-19 Infection: The Role of Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). CJC Open 2020;2:273-7. [PMID: 32363334 DOI: 10.1016/j.cjco.2020.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
394 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 770] [Cited by in F6Publishing: 675] [Article Influence: 385.0] [Reference Citation Analysis]
395 Ghasemi M, Umeton RP, Keyhanian K, Mohit B, Rahimian N, Eshaghhosseiny N, Davoudi V. SARS-CoV-2 and Acute Cerebrovascular Events: An Overview. J Clin Med 2021;10:3349. [PMID: 34362133 DOI: 10.3390/jcm10153349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
396 Hoechter DJ, Becker-Pennrich A, Langrehr J, Bruegel M, Zwissler B, Schaefer S, Spannagl M, Hinske LC, Zoller M. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients. Thromb Res 2020;196:186-92. [PMID: 32891904 DOI: 10.1016/j.thromres.2020.08.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
397 Atemnkeng F, Alataby H, Demirjian J, Kenne FM, Nfonoyim J. A Novel Report on the Compassionate Use of Baricitinib in Treating a Pediatric Patient With Severe Symptoms of COVID-19 Infection. J Med Cases 2021;12:94-8. [PMID: 33984091 DOI: 10.14740/jmc3629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
398 Lafuse WP, Wozniak DJ, Rajaram MVS. Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair. Cells 2020;10:E51. [PMID: 33396359 DOI: 10.3390/cells10010051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
399 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
400 Espinosa OA, Zanetti ADS, Antunes EF, Longhi FG, Matos TA, Battaglini PF. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Rev Inst Med Trop Sao Paulo 2020;62:e43. [PMID: 32578683 DOI: 10.1590/S1678-9946202062043] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
401 Yasuhara J, Watanabe K, Takagi H, Sumitomo N, Kuno T. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis. Pediatr Pulmonol 2021;56:837-48. [PMID: 33428826 DOI: 10.1002/ppul.25245] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
402 Cameli M, Pastore MC, Soliman Aboumarie H, Mandoli GE, D'Ascenzi F, Cameli P, Bigio E, Franchi F, Mondillo S, Valente S. Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients. Echocardiography 2020;37:1278-86. [PMID: 32654210 DOI: 10.1111/echo.14779] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
403 Monteonofrio L, Florio MC, AlGhatrif M, Lakatta EG, Capogrossi MC. Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease. Vasc Biol 2021;3:R1-R14. [PMID: 33537555 DOI: 10.1530/VB-20-0014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
404 Salbach C, Mueller-Hennessen M, Biener M, Stoyanov K, Preusch M, Kihm L, Merle U, Schnitzler P, Katus HA, Giannitsis E. Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction. Biomarkers 2021;26:401-9. [PMID: 33998352 DOI: 10.1080/1354750X.2021.1921031] [Reference Citation Analysis]
405 Morris G, Bortolasci CC, Puri BK, Marx W, O'Neil A, Athan E, Walder K, Berk M, Olive L, Carvalho AF, Maes M. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine 2021;144:155593. [PMID: 34074585 DOI: 10.1016/j.cyto.2021.155593] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
406 Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, Mansour S, Zhao X, Ybarra LF, Abbate A, Vilca LM, Azzalini L. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can J Cardiol 2020;36:1068-80. [PMID: 32425328 DOI: 10.1016/j.cjca.2020.05.018] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 34.0] [Reference Citation Analysis]
407 Knight DS, Kotecha T, Razvi Y, Chacko L, Brown JT, Jeetley PS, Goldring J, Jacobs M, Lamb LE, Negus R, Wolff A, Moon JC, Xue H, Kellman P, Patel N, Fontana M. COVID-19: Myocardial Injury in Survivors. Circulation 2020;142:1120-2. [PMID: 32673505 DOI: 10.1161/CIRCULATIONAHA.120.049252] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 20.5] [Reference Citation Analysis]
408 Adabag S, Zimmerman P, Black A, Madjid M, Safavi-Naeini P, Cheng A. Implantable Cardioverter-Defibrillator Shocks During COVID-19 Outbreak. J Am Heart Assoc 2021;10:e019708. [PMID: 34044586 DOI: 10.1161/JAHA.120.019708] [Reference Citation Analysis]
409 Obukhov AG, Stevens BR, Prasad R, Li Calzi S, Boulton ME, Raizada MK, Oudit GY, Grant MB. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes. Diabetes. 2020;69:1875-1886. [PMID: 32669391 DOI: 10.2337/dbi20-0019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
410 Oussalah A, Gleye S, Clerc Urmes I, Laugel E, Callet J, Barbé F, Orlowski S, Malaplate C, Aimone-Gastin I, Caillierez BM, Merten M, Jeannesson E, Kormann R, Olivier JL, Rodriguez-Guéant RM, Namour F, Bevilacqua S, Losser MR, Levy B, Kimmoun A, Gibot S, Thilly N, Frimat L, Schvoerer E, Guéant JL. Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France. Clin Infect Dis 2020;71:2447-56. [PMID: 32623470 DOI: 10.1093/cid/ciaa677] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
411 Fan ZX, Yang J, Zhang J, He C, Wu H, Yang CJ, Zheng T, Ma C, Xiang ZJ, Zhai YH, Jiang J, Qiu SQ. Analysis of influencing factors related to elevated serum troponin I level for COVID-19 patients in Yichang, China.Cardiovasc Diagn Ther. 2020;10:678-686. [PMID: 32968624 DOI: 10.21037/cdt-20-510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
412 Mumoli N, Cei M, Mazzone A, Conte G. Cardiac injury as prognostic value in COVID-19: more remains to be clarified. Intern Emerg Med 2021;16:267-8. [PMID: 33113079 DOI: 10.1007/s11739-020-02540-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
413 Mi X, Li H, Tan R, Feng B, Tu Y. The TDs/aptamer cTnI biosensors based on HCR and Au/Ti3C2-MXene amplification for screening serious patient in COVID-19 pandemic. Biosens Bioelectron 2021;192:113482. [PMID: 34256261 DOI: 10.1016/j.bios.2021.113482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Nan J, Jin YB, Myo Y, Zhang G. Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies. J Geriatr Cardiol. 2020;17:221-223. [PMID: 32362921 DOI: 10.11909/j.issn.1671-5411.2020.04.010] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
415 Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. [PMID: 32754159 DOI: 10.3389/fimmu.2020.01648] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 56.0] [Reference Citation Analysis]
416 Asokan I, Rabadia SV, Yang EH. The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population. Curr Oncol Rep 2020;22:60. [PMID: 32462289 DOI: 10.1007/s11912-020-00945-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
417 Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One 2020;15:e0238215. [PMID: 32845926 DOI: 10.1371/journal.pone.0238215] [Cited by in Crossref: 123] [Cited by in F6Publishing: 115] [Article Influence: 61.5] [Reference Citation Analysis]
418 Lao N, Lim J, Bashir H, Mahalwar G, Adebolu O, Mangira C, Courson J, Hegde V. Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019. J Cardiol 2021:S0914-5087(21)00305-1. [PMID: 34848117 DOI: 10.1016/j.jjcc.2021.10.025] [Reference Citation Analysis]
419 Lazzeri C, Bonizzoli M, Batacchi S, Cianchi G, Franci A, Fulceri GE, Peris A. Cardiac Involvment in COVID-19-Related Acute Respiratory Distress Syndrome. Am J Cardiol 2020;132:147-9. [PMID: 32762961 DOI: 10.1016/j.amjcard.2020.07.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
420 Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: A review of underlying molecular mechanisms. Prog Cardiovasc Dis 2021;67:53-64. [PMID: 33621589 DOI: 10.1016/j.pcad.2021.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
421 Wallukat G, Hohberger B, Wenzel K, Fürst J, Schulze-Rothe S, Wallukat A, Hönicke AS, Müller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 2021;4:100100. [PMID: 33880442 DOI: 10.1016/j.jtauto.2021.100100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
422 Saleh A, Matsumori A, Abdelrazek S, Eltaweel S, Salous A, Neumann FJ, Antz M. Myocardial involvement in coronavirus disease 19. Herz 2020;45:719-25. [PMID: 33216154 DOI: 10.1007/s00059-020-05001-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
423 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
424 Nascimento CRD, Leão SC, Barbosa RHA, Tenório PP. Cardiovascular damage due to COVID-19: what do we need to know? Rev Assoc Med Bras (1992) 2021;67Suppl 1:121-6. [PMID: 34406302 DOI: 10.1590/1806-9282.67.Suppl1.20200706] [Reference Citation Analysis]
425 Poppas A, Chung EH, Kovacs R. COVID-19 and the Athlete: Gaining Ground But Not Yet at the Finish. J Am Coll Cardiol 2021;77:1368-71. [PMID: 33706880 DOI: 10.1016/j.jacc.2021.02.002] [Reference Citation Analysis]
426 Cetinkal G, Kocas BB, Ser OS, Kilci H, Keskin K, Ozcan SN, Verdi Y, Zeren MI, Demir T, Kilickesmez K. Assessment of the Modified CHA2DS2VASc Risk Score in Predicting Mortality in Patients Hospitalized With COVID-19. Am J Cardiol 2020;135:143-9. [PMID: 32861734 DOI: 10.1016/j.amjcard.2020.08.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
427 Kaseb AO, Mohamed YI, Malek AE, Raad II, Altameemi L, Li D, Kaseb OA, Kaseb SA, Selim A, Ma Q. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection. Pathogens 2021;10:379. [PMID: 33809851 DOI: 10.3390/pathogens10030379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
428 Rajagopal K, Keller SP, Akkanti B, Bime C, Loyalka P, Cheema FH, Zwischenberger JB, El Banayosy A, Pappalardo F, Slaughter MS, Slepian MJ. Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document. Circ Heart Fail 2020;13:e007175. [PMID: 32357074 DOI: 10.1161/CIRCHEARTFAILURE.120.007175] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
429 Maino A, Di Stasio E, Grimaldi MC, Cappannoli L, Rocco E, Vergallo R, Biscetti F, Baroni S, Urbani A, Landolfi R, Biasucci LM. Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin. Int J Cardiol 2021;338:278-85. [PMID: 34157355 DOI: 10.1016/j.ijcard.2021.06.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
430 Deng YP, Xie W, Liu T, Wang SY, Wang MR, Zan YX, Meng XB, Deng YQ, Xiong HR, Fu XD. Association of Hypertension with Severity and Mortality in Hospitalized Patients with COVID-19 in Wuhan, China: A Single-centered, Retrospective Study. Arq Bras Cardiol 2021:S0066-782X2021005010205. [PMID: 34287571 DOI: 10.36660/abc.20200733] [Reference Citation Analysis]
431 Agrawal S, Dróżdż M, Makuch S, Pietraszek A, Sobieszczańska M, Mazur G. The Assessment of Fear of COVID-19 among the Elderly Population: A Cross-Sectional Study. J Clin Med 2021;10:5537. [PMID: 34884241 DOI: 10.3390/jcm10235537] [Reference Citation Analysis]
432 Xu D, Zhou F, Sun W, Chen L, Lan L, Li H, Xiao F, Li Y, Kolachalama VB, Wang X, Xu H. Relationship Between serum SARS-CoV-2 nucleic acid(RNAemia) and Organ Damage in COVID-19 Patients: A Cohort Study. Clin Infect Dis. 2020;epub ahead of print. [PMID: 32720678 DOI: 10.1093/cid/ciaa1085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
433 Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H. Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus. J Infect 2020;81:205-12. [PMID: 32579986 DOI: 10.1016/j.jinf.2020.06.039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
434 [DOI: 10.1101/2020.04.12.20062869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
435 Dherange P, Lang J, Qian P, Oberfeld B, Sauer WH, Koplan B, Tedrow U. Arrhythmias and COVID-19: A Review. JACC Clin Electrophysiol 2020;6:1193-204. [PMID: 32972561 DOI: 10.1016/j.jacep.2020.08.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
436 Zhang Q, Zheng Z, Zhang Y. Association of Myocardial Enzyme Abnormality with Clinical Outcomes of Patients with COVID-19: A Retrospective Study. Dis Markers 2021;2021:3440714. [PMID: 34725560 DOI: 10.1155/2021/3440714] [Reference Citation Analysis]
437 Tanwar V, Adelstein JM, Wold LE. Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019. Cardiovasc Res 2021;117:85-95. [PMID: 33084879 DOI: 10.1093/cvr/cvaa293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
438 Citro R, Pontone G, Bellino M, Silverio A, Iuliano G, Baggiano A, Manka R, Iesu S, Vecchione C, Asch FM, Ghadri JR, Templin C. Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19. Trends Cardiovasc Med. 2021;31:8-16. [PMID: 33065315 DOI: 10.1016/j.tcm.2020.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
439 Janda L, Mihalčin M, Šťastná M. Is a healthy microbiome responsible for lower mortality in COVID-19? Biologia (Bratisl) 2020;:1-11. [PMID: 33078028 DOI: 10.2478/s11756-020-00614-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
440 Casucci G, Acanfora D, Incalzi RA. The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets. Drugs Aging 2020;37:779-85. [PMID: 33084001 DOI: 10.1007/s40266-020-00808-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
441 Carmona A, Marchandot B, Matsushita K, Morel O. Letter by Carmona et al Regarding Article, "Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: a National Population-Based Cohort Study". Arterioscler Thromb Vasc Biol 2021;41:e280-1. [PMID: 33881925 DOI: 10.1161/ATVBAHA.121.316224] [Reference Citation Analysis]
442 Mu S, Wei W, Jin C, Pu N, Yu K, Gu G, Luo Z, Tong C, Han Y. Risk factors for COVID-19 patients with cardiac injury: pulmonary ventilation dysfunction and oxygen inhalation insufficiency are not the direct causes. Aging (Albany NY) 2020;12:23464-77. [PMID: 33226958 DOI: 10.18632/aging.104148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
443 Pierri MD, Alfonsi J, Cefarelli M, Berretta P, Di Eusanio M. COVID 19- Perspective of an Italian Center. J Card Surg 2021;36:1696-702. [PMID: 33032377 DOI: 10.1111/jocs.15099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
444 Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med 2020;382:e102. [PMID: 32356626 DOI: 10.1056/NEJMoa2007621] [Reference Citation Analysis]
445 Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020;14:1043-51. [PMID: 32640416 DOI: 10.1016/j.dsx.2020.06.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
446 Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504-7. [PMID: 32317203 DOI: 10.1016/j.ajem.2020.04.048] [Cited by in Crossref: 275] [Cited by in F6Publishing: 221] [Article Influence: 137.5] [Reference Citation Analysis]
447 Dinc Asarcikli L. Comparison of clinical and echocardiographic features of first and second waves of COVID-19 pandemic. Int J Cardiovasc Imaging 2021;37:3191-2. [PMID: 34550510 DOI: 10.1007/s10554-021-02422-w] [Reference Citation Analysis]
448 Oehmke JF, Moss CB, Singh LN, Oehmke TB, Post LA. Dynamic Panel Surveillance of COVID-19 Transmission in the United States to Inform Health Policy: Observational Statistical Study. J Med Internet Res 2020;22:e21955. [PMID: 32924962 DOI: 10.2196/21955] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
449 Su YB, Kuo MJ, Lin TY, Chien CS, Yang YP, Chou SJ, Leu HB. Cardiovascular manifestation and treatment in COVID-19. J Chin Med Assoc 2020;83:704-9. [PMID: 32433342 DOI: 10.1097/JCMA.0000000000000352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
450 Zhao D, Zhang S, Igawa T, Frishman W. Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy? Cardiology in Review 2020;28:303-7. [DOI: 10.1097/crd.0000000000000340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
451 Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, Berger JS. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J 2021;42:2270-9. [PMID: 33448289 DOI: 10.1093/eurheartj/ehaa1103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
452 Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Dos Santos TM, Mazza L, Feldman A, D'Andréa Saba Arruda G, de Albuquerque DC, Camiletti AS, de Sousa AS, de Paula TC, Giusti KGD, Domiciano RAM, Noya-Rabelo MM, Hamilton AM, Loures VA, Dionísio RM, Furquim TAB, De Luca FA, Dos Santos Sousa ÍB, Bandeira BS, Zukowski CN, de Oliveira RGG, Ribeiro NB, de Moraes JL, Petriz JLF, Pimentel AM, Miranda JS, de Jesus Abufaiad BE, Gibson CM, Granger CB, Alexander JH, de Souza OF; BRACE CORONA Investigators. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA 2021;325:254-64. [PMID: 33464336 DOI: 10.1001/jama.2020.25864] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 70.0] [Reference Citation Analysis]
453 Gunadi, Hakim MS, Wibawa H, Marcellus, Trisnawati I, Supriyati E, Afiahayati, Khair RE, Iskandar K, Siswanto, Irene, Anggorowati N, Daniwijaya EW, Nugrahaningsih DAA, Puspadewi Y, Simanjaya S, Puspitarani DA, Hanifin HF, Setiawan AA, Tania I, Amalia CS, Artayasa IPA, Rachman H, Mulyawan H, Ananda NR, Arguni E, Nuryastuti T, Wibawa T. Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations. Sci Rep 2021;11:21352. [PMID: 34725366 DOI: 10.1038/s41598-021-00459-4] [Reference Citation Analysis]
454 Randhawa PK, Scanlon K, Rappaport J, Gupta MK. Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System. Front Physiol 2020;11:611275. [PMID: 33329064 DOI: 10.3389/fphys.2020.611275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
455 Katkat F, Kalyoncuoğlu M, Karahan S, Abanus H, Turhan Çağlar FN, Karabulut D, Varol S, Şahin İ, Erkalp K, Okuyan E. Does coexistence of fragmented QRS and cardiovascular disease have the ability to predict the mortality in hospitalized, critically ill patients with COVID-19? Anatol J Cardiol 2021;25:803-10. [PMID: 34734814 DOI: 10.5152/AnatolJCardiol.2021.13611] [Reference Citation Analysis]
456 Ahmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med 2021;25:77-84. [PMID: 33603306 DOI: 10.5005/jp-journals-10071-23706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
457 Pirola CJ, Sookoian S. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis. J Infect. 2020;81:276-281. [PMID: 32474043 DOI: 10.1016/j.jinf.2020.05.052] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 22.0] [Reference Citation Analysis]
458 Cao J, Zheng Y, Luo Z, Mei Z, Yao Y, Liu Z, Liang C, Yang H, Song Y, Yu K, Gao Y, Zhu C, Huang Z, Qian J, Ge J. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease. Theranostics 2020;10:9663-73. [PMID: 32863952 DOI: 10.7150/thno.47980] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
459 Pascoal LB, Rodrigues PB, Genaro LM, Gomes ABDSP, Toledo-Teixeira DA, Parise PL, Bispo-Dos-Santos K, Simeoni CL, Guimarães PV, Buscaratti LI, Elston JGA, Marques-Souza H, Martins-de-Souza D, Ayrizono MLS, Velloso LA, Proenca-Modena JL, Moraes-Vieira PMM, Mori MAS, Farias AS, Vinolo MAR, Leal RF. Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples. Gut Microbes 2021;13:1-9. [PMID: 33550892 DOI: 10.1080/19490976.2021.1874740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
460 Raad M, Dabbagh M, Gorgis S, Yan J, Chehab O, Dagher C, Jamoor K, Hussein IH, Cook B, Van Harn M, Singh G, McCord J, Parikh S. Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19.Am J Cardiol. 2020;133:154-161. [PMID: 32829913 DOI: 10.1016/j.amjcard.2020.07.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
461 Yang J, Yan Y, Zhong W. Application of omics technology to combat the COVID-19 pandemic. MedComm (2020) 2021;2:381-401. [PMID: 34766152 DOI: 10.1002/mco2.90] [Reference Citation Analysis]
462 Navarra G, Komaei I, Currò G, Angrisani L, Bellini R, Cerbone MR, Di Lorenzo N, De Luca M, Foletto M, Gentileschi P, Musella M, Nannipieri M, Piazza L, Olmi S, Pilone V, Raffaelli M, Sarro G, Vitiello A, Zappa MA, Foschi D. Bariatric surgery and the COVID-19 pandemic: SICOB recommendations on how to perform surgery during the outbreak and when to resume the activities in phase 2 of lockdown. Updates Surg 2020;72:259-68. [PMID: 32514743 DOI: 10.1007/s13304-020-00821-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
463 Khan S, Rasool ST, Ahmed SI. Role of Cardiac Biomarkers in COVID-19: What Recent Investigations Tell Us? Curr Probl Cardiol 2021;:100842. [PMID: 33994028 DOI: 10.1016/j.cpcardiol.2021.100842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
464 Ciaglia E, Lopardo V, Montella F, Sellitto C, Manzo V, De Bellis E, Iannaccone T, Franci G, Zannella C, Pagliano P, Di Pietro P, Carrizzo A, Vecchione C, Conti V, Filippelli A, Puca AA. BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19. J Gerontol A Biol Sci Med Sci 2021:glab208. [PMID: 34396395 DOI: 10.1093/gerona/glab208] [Reference Citation Analysis]
465 Raukar NP, Cooper LT. Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes. Sports Health 2021;13:145-8. [PMID: 33201768 DOI: 10.1177/1941738120974747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
466 Cappannoli L, Scacciavillani R, Iannaccone G, Anastasia G, DI Giusto F, Crea F. 2019 novel Coronavirus: current knowledge, cardiovascular implications and management. Minerva Cardiol Angiol 2021;69:377-88. [PMID: 32472991 DOI: 10.23736/S2724-5683.20.05311-6] [Reference Citation Analysis]
467 Kozlov IA, Tyurin IN. Cardiovascular complications of COVID-19. Vestn anesteziol reanimatol 2020;17:14-22. [DOI: 10.21292/2078-5658-2020-17-4-14-22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
468 Ramzy M, Montrief T, Gottlieb M, Brady WJ, Singh M, Long B. COVID-19 cardiac arrest management: A review for emergency clinicians. Am J Emerg Med 2020;38:2693-702. [PMID: 33041141 DOI: 10.1016/j.ajem.2020.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
469 Atri D, Siddiqi HK, Lang J, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist: A current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci. 2020;. [PMID: 32292848 DOI: 10.1016/j.jacbts.2020.04.002] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 53.5] [Reference Citation Analysis]
470 Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, Shafaati M, Abdoli A. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol 2021;101:108232. [PMID: 34673335 DOI: 10.1016/j.intimp.2021.108232] [Reference Citation Analysis]
471 Vitiello A, Ferrara F. Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients. Wien Klin Wochenschr 2021. [PMID: 33877436 DOI: 10.1007/s00508-021-01855-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
472 Dagher L, Wanna B, Mikdadi G, Young M, Sohns C, Marrouche NF. High-degree atrioventricular block in COVID-19 hospitalized patients. Europace 2021;23:451-5. [PMID: 33432349 DOI: 10.1093/europace/euaa333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
473 Amendola A, Garoffolo G, Songia P, Nardacci R, Ferrari S, Bernava G, Canzano P, Myasoedova V, Colavita F, Castilletti C, Sberna G, Capobianchi MR, Piacentini M, Agrifoglio M, Colombo GI, Poggio P, Pesce M. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression. Cardiovasc Res 2021;117:1557-66. [PMID: 33705542 DOI: 10.1093/cvr/cvab082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
474 Adhena G, Hidru HD. Knowledge, Attitude, and Practice of High-Risk Age Groups to Coronavirus Disease-19 Prevention and Control in Korem District, Tigray, Ethiopia: Cross-Sectional Study. Infect Drug Resist 2020;13:3801-9. [PMID: 33122925 DOI: 10.2147/IDR.S275168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
475 Stefanini GG, Chiarito M, Ferrante G, Cannata F, Azzolini E, Viggiani G, De Marco A, Briani M, Bocciolone M, Bragato R, Corrada E, Gasparini GL, Marconi M, Monti L, Pagnotta PA, Panico C, Pini D, Regazzoli D, My I, Kallikourdis M, Ciccarelli M, Badalamenti S, Aghemo A, Reimers B, Condorelli G; Humanitas COVID-19 Task Force. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart 2020;106:1512-8. [PMID: 32817312 DOI: 10.1136/heartjnl-2020-317322] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
476 Hu B, Deng Q, Zhou Q. Cardiac involvement of COVID-19: Looking forward to novel discoveries and clinically valuable evidence. Int J Cardiol 2020;314:95. [PMID: 32560765 DOI: 10.1016/j.ijcard.2020.05.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
477 Capone V, Cuomo V, Esposito R, Canonico ME, Ilardi F, Prastaro M, Esposito G, Santoro C. Epidemiology, prognosis, and clinical manifestation of cardiovascular disease in COVID-19. Expert Rev Cardiovasc Ther 2020;18:531-9. [PMID: 32672482 DOI: 10.1080/14779072.2020.1797491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
478 Castiello T, Georgiopoulos G, Finocchiaro G, Claudia M, Gianatti A, Delialis D, Aimo A, Prasad S. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail Rev 2021. [PMID: 33761041 DOI: 10.1007/s10741-021-10087-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
479 Sadler C, Alvarez Villela M, Van Hoesen K, Grover I, Lang M, Neuman T, Lindholm P. Diving after SARS-CoV-2 (COVID-19) infection: Fitness to dive assessment and medical guidance. Diving Hyperb Med 2020;50:278-87. [PMID: 32957131 DOI: 10.28920/dhm50.3.278-287] [Reference Citation Analysis]
480 Saeed S, Rajani R. The cardiovascular complications in COVID-19: Focus on acute cardiac injury. Pak J Med Sci 2021;37:908-12. [PMID: 34104187 DOI: 10.12669/pjms.37.3.4063] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
481 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
482 Sanghvi SK, Schwarzman LS, Nazir NT. Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis. Diagnostics (Basel) 2021;11:130. [PMID: 33467705 DOI: 10.3390/diagnostics11010130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
483 Wilson MG, Hull JH, Rogers J, Pollock N, Dodd M, Haines J, Harris S, Loosemore M, Malhotra A, Pieles G, Shah A, Taylor L, Vyas A, Haddad FS, Sharma S. Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. Br J Sports Med 2020;54:1157-61. [PMID: 32878870 DOI: 10.1136/bjsports-2020-102710] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 16.5] [Reference Citation Analysis]
484 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
485 Maab H, Mustafa F, Shabbir SJ. Cardiovascular impact of COVID-19: an array of presentations. Acta Biomed 2021;92:e2021021. [PMID: 33988162 DOI: 10.23750/abm.v92i2.10299] [Reference Citation Analysis]
486 Chen LQ, Burdowski J, Marfatia R, Weber J, Gliganic K, Diaz N, Ramjattan N, Zheng H, Mihalatos D, Wang L, Barasch E, Leung A, Gopal A, Craft J, Ren X, Stergiopoulos K, Jeremias A, Petrossian G, Robinson N, Levine J, Shlofmitz RA, Gulotta RJ, Muehlbauer SM, Lucore CL, Cao JJ. Reduced cardiac function is associated with cardiac injury and mortality risk in hospitalized COVID-19 Patients. Clin Cardiol 2020;43:1547-54. [PMID: 33280140 DOI: 10.1002/clc.23479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
487 Gona OJ, Madhan R, Shambu SK. Assessment of Clinical Pharmacists' Assistance for Patients With Established Cardiovascular Diseases During the COVID-19 Pandemic: Insights From Southern India. Front Cardiovasc Med 2020;7:599807. [PMID: 33426000 DOI: 10.3389/fcvm.2020.599807] [Reference Citation Analysis]
488 Nalugo M, Schulte LJ, Masood MF, Zayed MA. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med 2021;8:636843. [PMID: 33604359 DOI: 10.3389/fcvm.2021.636843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
489 Fu T, Mamaliga G, Pierce JD, Gilkeson R, Gupta A. COVID-19 infection complicated by acute ST-elevation myocardial infarction. Clin Imaging 2021;78:117-20. [PMID: 33774577 DOI: 10.1016/j.clinimag.2021.03.010] [Reference Citation Analysis]
490 Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, Yu J, Li W, Dong R, Yang Y, Tu L, Xu X. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis. Clin Cardiol 2020;43:1478-93. [PMID: 33026120 DOI: 10.1002/clc.23465] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
491 Wei ZY, Geng YJ, Huang J, Qian HY. Pathogenesis and management of myocardial injury in coronavirus disease 2019. Eur J Heart Fail 2020;22:1994-2006. [PMID: 32683753 DOI: 10.1002/ejhf.1967] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
492 Changal K, Veria S, Mack S, Paternite D, Sheikh SA, Patel M, Mir T, Sheikh M, Ramanathan PK. Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis. BMC Cardiovasc Disord 2021;21:626. [PMID: 34972516 DOI: 10.1186/s12872-021-02450-3] [Reference Citation Analysis]
493 Valchanov K, Krishnan U, Hoole SP, Davies WR, Pettit S, Jones N, Parmar J, Catarino P, Osman M, Berman M. COVID-19 patient with coronary thrombosis supported with ECMO and Impella 5.0 ventricular assist device: a case report. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33442588 DOI: 10.1093/ehjcr/ytaa342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
494 Abrams MP, Wan EY, Waase MP, Morrow JP, Dizon JM, Yarmohammadi H, Berman JP, Rubin GA, Kushnir A, Poterucha TJ, Elias PA, Rubin DA, Ehlert F, Biviano A, Uriel N, Garan H, Saluja D. Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort. J Cardiovasc Electrophysiol 2020;31:3086-96. [PMID: 33022765 DOI: 10.1111/jce.14772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
495 Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2021;35:215-29. [PMID: 33074525 DOI: 10.1007/s10557-020-07084-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
496 Ryu B, Kim YS, Jeon YJ. Seaweeds and Their Natural Products for Preventing Cardiovascular Associated Dysfunction. Mar Drugs 2021;19:507. [PMID: 34564168 DOI: 10.3390/md19090507] [Reference Citation Analysis]
497 Case BC, Yerasi C, Forrestal BJ, Shea C, Rappaport H, Medranda GA, Zhang C, Abramowitz J, Satler LF, Ben-Dor I, Hashim H, Rogers T, Waksman R. Clinical impact and predictors of troponin elevation in patients with COVID-19. Cardiovasc Revasc Med 2021:S1553-8389(21)00136-6. [PMID: 34053871 DOI: 10.1016/j.carrev.2021.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
498 Loghin C, Chauhan S, Lawless SM. Pseudo-Acute Myocardial Infarction in a Young COVID-19 Patient. JACC Case Rep 2020;2:1284-8. [PMID: 32342049 DOI: 10.1016/j.jaccas.2020.04.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
499 Milla-Godoy GC, Park R, Jiang W, Hartkopf MW, Treadwell T. Fulminant COVID-19-Associated Myocarditis in an Otherwise Healthy Female. Cureus 2021;13:e12736. [PMID: 33614338 DOI: 10.7759/cureus.12736] [Reference Citation Analysis]
500 Temgoua MN, Chanseaume S, Hilic E, Karamoko K, Tochie JN, Beyina G, Camus L, Chanseaume A, Alexandru M, Benfreha K, Diallo N, Eschalier R. Paroxysmal atrial fibrillation associated with a moderate form of COVID-19 in a middle-aged man with low cardiovascular risk factor: More still needs to be done in this topic. Clin Case Rep 2021. [PMID: 33821191 DOI: 10.1002/ccr3.3923] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
501 Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, Ye D, Liu J, Wan J. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother 2020;127:110230. [PMID: 32428835 DOI: 10.1016/j.biopha.2020.110230] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
502 Amere Subbarao S. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting. Inflammopharmacology 2021;29:343-66. [PMID: 33723711 DOI: 10.1007/s10787-021-00796-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
503 Bonnemain J, Ltaief Z, Liaudet L. The Right Ventricle in COVID-19. J Clin Med 2021;10:2535. [PMID: 34200990 DOI: 10.3390/jcm10122535] [Reference Citation Analysis]
504 Banach M, Penson PE, Fras Z, Vrablik M, Pella D, Reiner Ž, Nabavi SM, Sahebkar A, Kayikcioglu M, Daccord M; FH Europe and the International Lipid Expert Panel (ILEP). Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacol Res 2020;158:104891. [PMID: 32389859 DOI: 10.1016/j.phrs.2020.104891] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
505 Vinciguerra M, Romiti S, Fattouch K, De Bellis A, Greco E. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm. J Clin Med. 2020;9. [PMID: 32635302 DOI: 10.3390/jcm9072095] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
506 Kwan JM, Henry ML, Christophers B, Tamirisa K, Thamman R, Sadler D, Aggarwal NR, Cheng R, Parwani P, Dent S, Ismail-Khan R, Fradley MG, Brown SA. The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic. Curr Oncol Rep 2021;23:99. [PMID: 34259950 DOI: 10.1007/s11912-021-01081-3] [Reference Citation Analysis]
507 Palazzuoli A, Giustozzi M, Ruocco G, Tramonte F, Gronda E, Agnelli G. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021;11:395. [PMID: 33925334 DOI: 10.3390/life11050395] [Reference Citation Analysis]
508 Kobat H, Elkonaissi I, Dorak MT, Nabhani-Gebara S. Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology. Oncol Rev 2021;15:510. [PMID: 33747366 DOI: 10.4081/oncol.2021.510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Smith SW, Strobel AM, Saenger AK, Apple FS. Laboratory findings in a child with SARS-CoV-2 (COVID-19) multisystem inflammatory syndrome. Clin Chem Lab Med 2021;59:e259-61. [PMID: 33554562 DOI: 10.1515/cclm-2020-1699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 de Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M, Bertoluci MC; Brazilian Diabetes Society Study Group (SBD). Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr 2020;12:75. [PMID: 32874207 DOI: 10.1186/s13098-020-00586-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 22.5] [Reference Citation Analysis]
511 Wu Y, Hou B, Liu J, Chen Y, Zhong P. Risk Factors Associated With Long-Term Hospitalization in Patients With COVID-19: A Single-Centered, Retrospective Study. Front Med (Lausanne) 2020;7:315. [PMID: 32582749 DOI: 10.3389/fmed.2020.00315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
512 Jirak P, Larbig R, Shomanova Z, Fröb EJ, Dankl D, Torgersen C, Frank N, Mahringer M, Butkiene D, Haake H, Salzer HJF, Tschoellitsch T, Lichtenauer M, Egle A, Lamprecht B, Reinecke H, Hoppe UC, Pistulli R, Motloch LJ. Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre study. ESC Heart Fail 2021;8:37-46. [PMID: 33350605 DOI: 10.1002/ehf2.13136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
513 Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT. Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021;73:890-900. [PMID: 32415860 DOI: 10.1002/hep.31326] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 31.0] [Reference Citation Analysis]
514 Urmeneta Ulloa J, Martínez de Vega V, Salvador Montañés O, Álvarez Vázquez A, Sánchez-Enrique C, Hernández Jiménez S, Sancho García FD, López Ruiz L, Recio Rodríguez M, Pizarro G, Carnevali Ruiz D, Ángel Cabrera J. Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement. Int J Cardiol Heart Vasc 2021;36:100854. [PMID: 34368419 DOI: 10.1016/j.ijcha.2021.100854] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
515 Rodriguez F, Solomon N, de Lemos JA, Das SR, Morrow DA, Bradley SM, Elkind MSV, Williams JH, Holmes D, Matsouaka RA, Gupta D, Gluckman TJ, Abdalla M, Albert MA, Yancy CW, Wang TY. Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry. Circulation 2021;143:2332-42. [PMID: 33200953 DOI: 10.1161/CIRCULATIONAHA.120.052278] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
516 Xu H, Hou K, Xu R, Li Z, Fu H, Wen L, Xie L, Liu H, Selvanayagam JB, Zhang N, Yang Z, Yang M, Guo Y. Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19. J Am Heart Assoc 2020;9:e016807. [PMID: 32806998 DOI: 10.1161/JAHA.120.016807] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
517 Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta 2020;509:180-94. [PMID: 32511971 DOI: 10.1016/j.cca.2020.06.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
518 Shuroog J, Raffetto J, Soherwardi S, Hassan M, Eng S, Nayim F. A Unique Case of Acute Coronary Syndrome in a Patient With COVID-19 Infection. Cureus 2021;13:e15650. [PMID: 34306860 DOI: 10.7759/cureus.15650] [Reference Citation Analysis]
519 Fan Y, Wang X, Jun Zhang, Mo D, Xiao X. The Risk Factors for the Exacerbation of COVID-19 Disease: A Case-control Study. J Clin Nurs 2021;30:725-31. [PMID: 33331072 DOI: 10.1111/jocn.15601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
520 Koutsoukis A, Delmas C, Roubille F, Bonello L, Schurtz G, Manzo-Silberman S, Puymirat E, Elbaz M, Bouisset F, Meunier PA, Huet F, Paganelli F, Laine M, Lemesle G, Lamblin N, Henry P, Tea V, Gallet R, Teiger E, Huguet R, Fard D, Lim P. Acute Coronary Syndrome in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care. CJC Open 2021;3:311-7. [PMID: 33200121 DOI: 10.1016/j.cjco.2020.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
521 Aggarwal A, Singhal T, Bhatt M. Neurology and COVID-19: Acting now. Preparing for Future. Ann Indian Acad Neurol 2020;23:433-40. [PMID: 33223658 DOI: 10.4103/aian.AIAN_513_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
522 Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, Chen Y, Han Y. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132-1141. [PMID: 32354800 DOI: 10.1136/heartjnl-2020-317056] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 60.5] [Reference Citation Analysis]
523 Xu Q, Samanapally H, Nathala P, Salunkhe V, Furmanek S, Cahill MN, McGuffin T, Mohammad T, Marsili B, Petrey J, Carrico R, Ramirez J, Akca O, Clifford SP, Pahwa S, Roser L, Kong M, Huang J; Center of Excellence for Research in Infectious Diseases (CERID) Coronavirus Study Group on behalf of the COVID-19 CardioVascular Research Group (COVID-CVRG). Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00277-9. [PMID: 33867235 DOI: 10.1053/j.jvca.2021.03.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
524 Abrams ER, Rose G, Fields JM, Esener D. Point-of-Care Ultrasound in the Evaluation of COVID-19. J Emerg Med 2020;59:403-8. [PMID: 32712031 DOI: 10.1016/j.jemermed.2020.06.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
525 Bagate F, Masi P, d'Humières T, Al-Assaad L, Chakra LA, Razazi K, de Prost N, Carteaux G, Derumeaux G, Mekontso Dessap A. Advanced echocardiographic phenotyping of critically ill patients with coronavirus-19 sepsis: a prospective cohort study. J Intensive Care 2021;9:12. [PMID: 33472693 DOI: 10.1186/s40560-020-00516-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
526 Tardiolo G, Brianti P, Sapienza D, dell'Utri P, Dio VD, Rao G, Calabrò RS. Are We Paving the Way to Dig Out of the "Pandemic Hole"? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization. Med Sci (Basel) 2021;9:53. [PMID: 34449681 DOI: 10.3390/medsci9030053] [Reference Citation Analysis]
527 Qiang Z, Wang B, Garrett BC, Rainey RP, Superko HR. Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers. Curr Opin Cardiol 2021;36:367-73. [PMID: 33709980 DOI: 10.1097/HCO.0000000000000851] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
528 Toraih EA, Elshazli RM, Hussein MH, Elgaml A, Amin M, El-Mowafy M, El-Mesery M, Ellythy A, Duchesne J, Killackey MT, Ferdinand KC, Kandil E, Fawzy MS. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and decision tree analysis. J Med Virol 2020;92:2473-88. [PMID: 32530509 DOI: 10.1002/jmv.26166] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
529 Khandait H, Gandotra G, Sachdeva S, Kramer CA, Nye D, Golamari R, Jain R. COVID-19 and Hematology-What Do We Know So Far? SN Compr Clin Med 2020;:1-6. [PMID: 33134847 DOI: 10.1007/s42399-020-00607-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
530 Sagris D, Papanikolaou A, Kvernland A, Korompoki E, Frontera JA, Troxel AB, Gavriatopoulou M, Milionis H, Lip GYH, Michel P, Yaghi S, Ntaios G. COVID-19 and ischemic stroke. Eur J Neurol 2021. [PMID: 34224187 DOI: 10.1111/ene.15008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
531 Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, Salazar-Mather TP, Dumenco L, Savaria MC, Aung SN, Flanigan T, Michelow IC. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021;31:1-10. [PMID: 32845042 DOI: 10.1002/rmv.2146] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 20.0] [Reference Citation Analysis]
532 Song WM, Zhao JY, Zhang QY, Liu SQ, Zhu XH, An QQ, Xu TT, Li SJ, Liu JY, Tao NN, Liu Y, Li YF, Li HC. COVID-19 and Tuberculosis Coinfection: An Overview of Case Reports/Case Series and Meta-Analysis. Front Med (Lausanne) 2021;8:657006. [PMID: 34504847 DOI: 10.3389/fmed.2021.657006] [Reference Citation Analysis]
533 Yiangou L, Davis RP, Mummery CL. Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails. Stem Cell Reports. 2021;16:385-397. [PMID: 33306986 DOI: 10.1016/j.stemcr.2020.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
534 Turagam MK, Musikantow D, Goldman ME, Bassily-Marcus A, Chu E, Shivamurthy P, Lampert J, Kawamura I, Bokhari M, Whang W, Bier BA, Malick W, Hashemi H, Miller MA, Choudry S, Pumill C, Ruiz-Maya T, Hadley M, Giustino G, Koruth JS, Langan N, Sofi A, Dukkipati SR, Halperin JL, Fuster V, Kohli-Seth R, Reddy VY. Malignant Arrhythmias in Patients With COVID-19: Incidence, Mechanisms, and Outcomes. Circ Arrhythm Electrophysiol 2020;13:e008920. [PMID: 33026892 DOI: 10.1161/CIRCEP.120.008920] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
535 Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B, Hochman JS, Reynolds HR. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine 2020;24:100434. [PMID: 32766543 DOI: 10.1016/j.eclinm.2020.100434] [Cited by in Crossref: 180] [Cited by in F6Publishing: 172] [Article Influence: 90.0] [Reference Citation Analysis]
536 Giannini F, Toselli M, Palmisano A, Cereda A, Vignale D, Leone R, Nicoletti V, Gnasso C, Monello A, Manfrini M, Khokhar A, Sticchi A, Biagi A, Turchio P, Tacchetti C, Landoni G, Boccia E, Campo G, Scoccia A, Ponticelli F, Danzi GB, Loffi M, Muri M, Pontone G, Andreini D, Mancini EM, Casella G, Iannopollo G, Nannini T, Ippolito D, Bellani G, Franzesi CT, Patelli G, Besana F, Costa C, Vignali L, Benatti G, Sverzellati N, Scarnecchia E, Lombardo FP, Anastasio F, Iannaccone M, Vaudano PG, Pacielli A, Baffoni L, Gardi I, Cesini E, Sperandio M, Micossi C, De Carlini CC, Spreafico C, Maggiolini S, Bonaffini PA, Iacovoni A, Sironi S, Senni M, Fominskiy E, De Cobelli F, Maggioni AP, Rapezzi C, Ferrari R, Colombo A, Esposito A. Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients. J Cardiovasc Comput Tomogr 2021;15:421-30. [PMID: 33744175 DOI: 10.1016/j.jcct.2021.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
537 Silverio A, Di Maio M, Citro R, Esposito L, Iuliano G, Bellino M, Baldi C, De Luca G, Ciccarelli M, Vecchione C, Galasso G. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.BMC Cardiovasc Disord. 2021;21:23. [PMID: 33413093 DOI: 10.1186/s12872-020-01816-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
538 Schukraft S, Magnin JL, Cook S. Cardiovascular Manifestations of COVID-19: Insights into a Single-Center Experience. TH Open 2021;5:e329-34. [PMID: 34568743 DOI: 10.1055/s-0041-1731775] [Reference Citation Analysis]
539 de Cevins C, Luka M, Smith N, Meynier S, Magérus A, Carbone F, García-Paredes V, Barnabei L, Batignes M, Boullé A, Stolzenberg MC, Pérot BP, Charbit B, Fali T, Pirabakaran V, Sorin B, Riller Q, Abdessalem G, Beretta M, Grzelak L, Goncalves P, Di Santo JP, Mouquet H, Schwartz O, Zarhrate M, Parisot M, Bole-Feysot C, Masson C, Cagnard N, Corneau A, Brunaud C, Zhang SY, Casanova JL, Bader-Meunier B, Haroche J, Melki I, Lorrot M, Oualha M, Moulin F, Bonnet D, Belhadjer Z, Leruez M, Allali S, Gras-Leguen C, de Pontual L, Fischer A, Duffy D, Rieux-Laucat F, Toubiana J, Ménager MM; Pediatric-Biocovid Study Group. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis. Med (N Y) 2021;2:1072-1092.e7. [PMID: 34414385 DOI: 10.1016/j.medj.2021.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
540 Li N, Zhu L, Sun L, Shao G. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries. Stem Cell Res 2021;51:102168. [PMID: 33485182 DOI: 10.1016/j.scr.2021.102168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
541 Wetterslev M, Jacobsen PK, Hassager C, Jøns C, Risum N, Pehrson S, Bastiansen A, Andreasen AS, Tjelle Kristiansen K, Bestle MH, Mohr T, Møller-Sørensen H, Perner A. Cardiac arrhythmias in critically ill patients with coronavirus disease 2019: A retrospective population-based cohort study. Acta Anaesthesiol Scand 2021;65:770-7. [PMID: 33638870 DOI: 10.1111/aas.13806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
542 Satterfield BA, Dikilitas O, Kullo IJ. Leveraging the Electronic Health Record to Address the COVID-19 Pandemic. Mayo Clin Proc 2021;96:1592-608. [PMID: 34088418 DOI: 10.1016/j.mayocp.2021.04.008] [Reference Citation Analysis]
543 Siordia JA Jr. Epidemiology and clinical features of COVID-19: A review of current literature. J Clin Virol 2020;127:104357. [PMID: 32305884 DOI: 10.1016/j.jcv.2020.104357] [Cited by in Crossref: 146] [Cited by in F6Publishing: 106] [Article Influence: 73.0] [Reference Citation Analysis]
544 Prasitlumkum N, Chokesuwattanaskul R, Thongprayoon C, Bathini T, Vallabhajosyula S, Cheungpasitporn W. Incidence of Myocardial Injury in COVID-19-Infected Patients: A Systematic Review and Meta-Analysis. Diseases 2020;8:E40. [PMID: 33120956 DOI: 10.3390/diseases8040040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
545 Khismatullin RR, Ponomareva AA, Nagaswami C, Ivaeva RA, Montone KT, Weisel JW, Litvinov RI. Pathology of lung-specific thrombosis and inflammation in COVID-19. J Thromb Haemost 2021. [PMID: 34538029 DOI: 10.1111/jth.15532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
546 Vera-Pineda R, Francisco Carrizales-Sepulveda E, Camacho-Ortiz A, Nuzzolo-Shihadeh L, Cruz-Ramos F, Ordaz-Farias A, Benavides-Gonzalez MA, Carranza-Villegas G. Echocardiographic Characteristics of Subjects With COVID-19: A Case Series. Cardiol Res 2020;11:260-5. [PMID: 32595812 DOI: 10.14740/cr1084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
547 Varney JA, Dong VS, Tsao T, Sabir MS, Rivera AT, Ghula S, Moriles KE, Cherukuri ML, Fazal R, Azevedo CB, Mohamed RM, Jackson GR, Fleming SE, Rochez DE, Abbas KS, Shah JH, Minh LHN, Osman F, Rafla SM, Huy NT. COVID-19 and arrhythmia: An overview. Journal of Cardiology 2021. [DOI: 10.1016/j.jjcc.2021.11.019] [Reference Citation Analysis]
548 Baptista AF, Baltar A, Okano AH, Moreira A, Campos ACP, Fernandes AM, Brunoni AR, Badran BW, Tanaka C, de Andrade DC, da Silva Machado DG, Morya E, Trujillo E, Swami JK, Camprodon JA, Monte-Silva K, Sá KN, Nunes I, Goulardins JB, Bikson M, Sudbrack-Oliveira P, de Carvalho P, Duarte-Moreira RJ, Pagano RL, Shinjo SK, Zana Y. Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19. Front Neurol 2020;11:573718. [PMID: 33324324 DOI: 10.3389/fneur.2020.573718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
549 Li JW, Han TW, Woodward M, Anderson CS, Zhou H, Chen YD, Neal B. The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis. Prog Cardiovasc Dis. 2020;63:518-524. [PMID: 32305557 DOI: 10.1016/j.pcad.2020.04.008] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 43.5] [Reference Citation Analysis]
550 Wong Wai Cheong N, Meyyur Aravamudan V, Venkatachalam J, Kuthiah N. Gastrointestinal Symptoms in Association With Hypokalemia Can Be a Predictor of Inferior Outcomes in COVID-19. Cureus 2021;13:e14466. [PMID: 33996325 DOI: 10.7759/cureus.14466] [Reference Citation Analysis]
551 Sheehan MM, Saijo Y, Popovic ZB, Faulx MD. Echocardiography in suspected coronavirus infection: indications, limitations and impact on clinical management. Open Heart 2021;8:e001702. [PMID: 34376573 DOI: 10.1136/openhrt-2021-001702] [Reference Citation Analysis]
552 Ghazizadeh Z, Majd H, Richter M, Samuel R, Zekavat SM, Asgharian H, Farahvashi S, Kalantari A, Ramirez J, Zhao H, Natarajan P, Goodarzi H, Fattahi F. Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. bioRxiv 2020:2020. [PMID: 32511360 DOI: 10.1101/2020.05.12.091082] [Cited by in Crossref: 19] [Article Influence: 9.5] [Reference Citation Analysis]
553 Geng YJ, Wei ZY, Qian HY, Huang J, Lodato R, Castriotta RJ. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol. 2020;47:107228. [PMID: 32375085 DOI: 10.1016/j.carpath.2020.107228] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 23.5] [Reference Citation Analysis]
554 Alfarouk KO, Alhoufie STS, Hifny A, Schwartz L, Alqahtani AS, Ahmed SBM, Alqahtani AM, Alqahtani SS, Muddathir AK, Ali H, Bashir AHH, Ibrahim ME, Greco MR, Cardone RA, Harguindey S, Reshkin SJ. Of mitochondrion and COVID-19. J Enzyme Inhib Med Chem 2021;36:1258-67. [PMID: 34107824 DOI: 10.1080/14756366.2021.1937144] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
555 Buckley LF, Wohlford GF, Ting C, Alahmed A, Van Tassell BW, Abbate A, Devlin JW, Libby P. Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019. Crit Care Explor 2020;2:e0178. [PMID: 32832913 DOI: 10.1097/CCE.0000000000000178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
556 Kochav SM, Coromilas E, Nalbandian A, Ranard LS, Gupta A, Chung MK, Gopinathannair R, Biviano AB, Garan H, Wan EY. Cardiac Arrhythmias in COVID-19 Infection. Circ Arrhythm Electrophysiol 2020;13:e008719. [PMID: 32434385 DOI: 10.1161/CIRCEP.120.008719] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 23.5] [Reference Citation Analysis]
557 Bristow MR, Zisman LS, Altman NL, Gilbert EM, Lowes BD, Minobe WA, Slavov D, Schwisow JA, Rodriguez EM, Carroll IA, Keuer TA, Buttrick PM, Kao DP. Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium. JACC Basic Transl Sci 2020;5:871-83. [PMID: 32838074 DOI: 10.1016/j.jacbts.2020.06.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
558 Pérez-Bermejo JA, Kang S, Rockwood SJ, Simoneau CR, Joy DA, Ramadoss GN, Silva AC, Flanigan WR, Li H, Nakamura K, Whitman JD, Ott M, Conklin BR, McDevitt TC. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients. bioRxiv 2020:2020. [PMID: 32935097 DOI: 10.1101/2020.08.25.265561] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 19.5] [Reference Citation Analysis]
559 Younis NK, Zareef RO, Al Hassan SN, Bitar F, Eid AH, Arabi M. Hydroxychloroquine in COVID-19 Patients: Pros and Cons. Front Pharmacol 2020;11:597985. [PMID: 33364965 DOI: 10.3389/fphar.2020.597985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
560 Hosseinzadeh R, Goharrizi MASB, Bahardoust M, Alvanegh AG, Ataee MR, Bagheri M, Navidiyan ES, Zijoud SRH, Heiat M. Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)? Clin Hypertens 2021;27:3. [PMID: 33451360 DOI: 10.1186/s40885-021-00161-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
561 Tadic M, Saeed S, Grassi G, Taddei S, Mancia G, Cuspidi C. Hypertension and COVID-19: Ongoing Controversies. Front Cardiovasc Med 2021;8:639222. [PMID: 33681308 DOI: 10.3389/fcvm.2021.639222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
562 Bepouka BI, Mandina M, Makulo JR, Longokolo M, Odio O, Mayasi N, Pata T, Nsangana G, Tshikangu F, Mangala D, Maheshe D, Nkarnkwin S, Muamba J, Ndaie G, Ngwizani R, Yanga Y, Nkodila A, Keke H, Kokusa Y, Lepira F, Kashongwe I, Mbula M, Kayembe JM, Situakibanza H. Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo, from March to June 2020. Pan Afr Med J 2020;37:105. [PMID: 33425138 DOI: 10.11604/pamj.2020.37.105.25279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
563 Yoo J, Grewal P, Hotelling J, Papamanoli A, Cao K, Dhaliwal S, Jacob R, Mojahedi A, Bloom ME, Marcos LA, Skopicki HA, Kalogeropoulos AP. Admission NT-proBNP and outcomes in patients without history of heart failure hospitalized with COVID-19. ESC Heart Fail 2021. [PMID: 34346182 DOI: 10.1002/ehf2.13548] [Reference Citation Analysis]
564 Clifford SP, Ramirez J, Akca O, Ghafghazi S, Huang J. Perioperative Cardiac Research Considerations During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Cardiothorac Vasc Anesth 2021;35:1573-7. [PMID: 33618962 DOI: 10.1053/j.jvca.2021.01.052] [Reference Citation Analysis]
565 Sokolski M, Trenson S, Sokolska JM, D'Amario D, Meyer P, Poku NK, Biering-Sørensen T, Højbjerg Lassen MC, Skaarup KG, Barge-Caballero E, Pouleur AC, Stolfo D, Sinagra G, Ablasser K, Muster V, Rainer PP, Wallner M, Chiodini A, Heiniger PS, Mikulicic F, Schwaiger J, Winnik S, Cakmak HA, Gaudenzi M, Mapelli M, Mattavelli I, Paul M, Cabac-Pogorevici I, Bouleti C, Lilliu M, Minoia C, Dauw J, Costa J, Celik A, Mewton N, Montenegro CEL, Matsue Y, Loncar G, Marchel M, Bechlioulis A, Michalis L, Dörr M, Prihadi E, Schoenrath F, Messroghli DR, Mullens W, Lund LH, Rosano GMC, Ponikowski P, Ruschitzka F, Flammer AJ. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry. ESC Heart Fail 2021. [PMID: 34533287 DOI: 10.1002/ehf2.13549] [Reference Citation Analysis]
566 Islam M, Ozturk Y, Koc Y. Clinical outcomes of COVID-19 in hemodialysis patients in the city of Zonguldak, Turkey. Int Urol Nephrol 2021;53:1445-52. [PMID: 33449272 DOI: 10.1007/s11255-020-02781-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
567 Anzola GP, Bartolaminelli C, Gregorini GA, Coazzoli C, Gatti F, Mora A, Charalampakis D, Palmigiano A, De Simone M, Comini A, Dellaglio E, Cassetti S, Chiesa M, Spedini F, d'Ottavi P, Savio MC. Neither ACEIs nor ARBs are associated with respiratory distress or mortality in COVID-19 results of a prospective study on a hospital-based cohort. Intern Emerg Med 2020;15:1477-84. [PMID: 32965603 DOI: 10.1007/s11739-020-02500-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
568 Idhrees M, Padmanabhan C, Jagadeesan K, Velayudhan B. An Indian study: impact of COVID-19 on clinical decision-making and consensus in cardiac surgery practice across the country. Indian J Thorac Cardiovasc Surg 2020;:1-13. [PMID: 32837047 DOI: 10.1007/s12055-020-01022-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
569 Jain SS, Liu Q, Raikhelkar J, Fried J, Elias P, Poterucha TJ, DeFilippis EM, Rosenblum H, Wang EY, Redfors B, Clerkin K, Griffin JM, Wan EY, Abdalla M, Bello NA, Hahn RT, Shimbo D, Weiner SD, Kirtane AJ, Kodali SK, Burkhoff D, Rabbani LE, Schwartz A, Leon MB, Homma S, Di Tullio MR, Sayer G, Uriel N, Anstey DE. Indications for and Findings on Transthoracic Echocardiography in COVID-19. J Am Soc Echocardiogr 2020;33:1278-84. [PMID: 32782131 DOI: 10.1016/j.echo.2020.06.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
570 So A, Yang Z, Li L, Li W, Pan C, Vivekanantha P, Yun HW, Xie XY, Yun CH, Huang WM, Hung CL, Gao M, Zhang X, Zha Y, Shen J. Relationship between lung injury extent and phenotype manifested in non-contrast CT and cardiac injury during acute stage of COVID-19. Int J Cardiol Heart Vasc 2022;38:100938. [PMID: 34977329 DOI: 10.1016/j.ijcha.2021.100938] [Reference Citation Analysis]
571 Hafiane A. SARS-CoV-2 and the cardiovascular system. Clin Chim Acta 2020;510:311-6. [PMID: 32681935 DOI: 10.1016/j.cca.2020.07.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
572 Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
573 Singh AK, Gupta R, Misra A. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr 2020;14:283-7. [PMID: 32283499 DOI: 10.1016/j.dsx.2020.03.016] [Cited by in Crossref: 100] [Cited by in F6Publishing: 79] [Article Influence: 50.0] [Reference Citation Analysis]
574 Scudiero F, Silverio A, Di Maio M, Russo V, Citro R, Personeni D, Cafro A, D'Andrea A, Attena E, Pezzullo S, Canonico ME, Galasso G, Pitì A, Parodi G; Cov-IT Network. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res 2021;198:34-9. [PMID: 33271421 DOI: 10.1016/j.thromres.2020.11.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
575 Aikawa T, Takagi H, Ishikawa K, Kuno T. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: An insight from a meta-analysis. J Med Virol 2021;93:51-5. [PMID: 32484975 DOI: 10.1002/jmv.26108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
576 Newton-Cheh C, Zlotoff DA, Hung J, Rupasov A, Crowley JC, Funamoto M. Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock. N Engl J Med 2020;383:475-84. [PMID: 32668103 DOI: 10.1056/NEJMcpc2004975] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
577 Papageorgiou N, Sohrabi C, Prieto Merino D, Tyrlis A, Atieh AE, Saberwal B, Lim WY, Creta A, Khanji M, Rusinova R, Chooneea B, Khiani R, Wijesuriya N, Chow A, Butt H, Browne S, Joshi N, Kay J, Ahsan S, Providencia R. High sensitivity troponin and COVID-19 outcomes. Acta Cardiol 2021;:1-8. [PMID: 33685354 DOI: 10.1080/00015385.2021.1887586] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
578 Fan S, Xiao M, Han F, Xia P, Bai X, Chen H, Zhang H, Ding X, Zhao H, Zhao J, Sun X, Jiang W, Wang C, Cao W, Guo F, Tian R, Gao P, Wu W, Ma J, Wu D, Liu Z, Zhou X, Wang J, Guan T, Qin Y, Li T, Xu Y, Zhang D, Chen Y, Xie J, Li Y, Yan X, Zhu Y, Peng B, Cui L, Zhang S, Guan H. Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study. Front Neurol 2020;11:806. [PMID: 32754114 DOI: 10.3389/fneur.2020.00806] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
579 Chorin E, Dai M, Kogan E, Wadhwani L, Shulman E, Nadeau-Routhier C, Knotts R, Bar-Cohen R, Barbhaiya C, Aizer A, Holmes D, Bernstein S, Spinelli M, Park D, Chinitz L, Jankelson L. Electrocardiographic Risk Stratification in COVID-19 Patients. Front Cardiovasc Med 2021;8:636073. [PMID: 33604358 DOI: 10.3389/fcvm.2021.636073] [Reference Citation Analysis]
580 COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: Epidemiology Report 19 (Fortnightly reporting period ending 21 June 2020). Commun Dis Intell (2018) 2020;44. [PMID: 32600222 DOI: 10.33321/cdi.2020.44.54] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
581 Martin AK, Feinman JW, Bhatt HV, Subramani S, Malhotra AK, Townsley MM, Fritz AV, Sharma A, Patel SJ, Zhou EY, Owen RM, Ghofaily LA, Read SN, Teixeira MT, Arora L, Jayaraman AL, Weiner MM, Ramakrishna H. The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2021. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00931-9. [PMID: 34801393 DOI: 10.1053/j.jvca.2021.10.011] [Reference Citation Analysis]
582 Muhammad R, Ogunti R, Ahmed B, Munawar M, Donaldson S, Sumon M, Kibreab A, Thomas AN, Mehari A. Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection. J Racial Ethn Health Disparities 2021. [PMID: 33538998 DOI: 10.1007/s40615-020-00961-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
583 Biguetti C, Marrelli MT, Brotto M. Primum non nocere - Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)? Rev Saude Publica 2020;54:68. [PMID: 32638884 DOI: 10.11606/s1518-8787.2020054002631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
584 Zaveri S, Tagliaferri AR, Woldemariam S, Aron P, Palacios C, Melki G, Michael P. A Case of Multifactorial Viral Myocarditis. Cureus 2021;13:e18950. [PMID: 34812324 DOI: 10.7759/cureus.18950] [Reference Citation Analysis]
585 Ramadan MS, Bertolino L, Marrazzo T, Florio MT, Durante-Mangoni E; The Monaldi Hospital Cardiovascular Infection Study Group. Cardiac complications during the active phase of COVID-19: review of the current evidence. Intern Emerg Med 2021. [PMID: 34046852 DOI: 10.1007/s11739-021-02763-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
586 Ganjali S, Bianconi V, Penson PE, Pirro M, Banach M, Watts GF, Sahebkar A. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone. Metabolism 2020;113:154375. [PMID: 32976855 DOI: 10.1016/j.metabol.2020.154375] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
587 Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics (Sao Paulo) 2021;76:e2518. [PMID: 33787678 DOI: 10.6061/clinics/2021/e2518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
588 Yu JS, Pan NN, Chen RD, Zeng LC, Yang HK, Li H. Cardiac Biomarker Levels and Their Prognostic Values in COVID-19 Patients With or Without Concomitant Cardiac Disease. Front Cardiovasc Med 2020;7:599096. [PMID: 33553255 DOI: 10.3389/fcvm.2020.599096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
589 Kunutsor SK, Laukkanen JA. Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis. Thromb Res 2020;196:27-30. [PMID: 32823173 DOI: 10.1016/j.thromres.2020.08.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
590 Bahraini M, Dorgalaleh A. The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19. Semin Thromb Hemost 2021. [PMID: 34695858 DOI: 10.1055/s-0041-1736166] [Reference Citation Analysis]
591 Phelps M, Christensen DM, Gerds T, Fosbøl E, Torp-Pedersen C, Schou M, Køber L, Kragholm K, Andersson C, Biering-Sørensen T, Christensen HC, Andersen MP, Gislason G. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Eur Heart J Qual Care Clin Outcomes 2021;7:172-80. [PMID: 33107909 DOI: 10.1093/ehjqcco/qcaa081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
592 Samidurai A, Das A. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies. Int J Mol Sci. 2020;21. [PMID: 32947927 DOI: 10.3390/ijms21186790] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
593 Nakano H, Shiina K, Tomiyama H. Cardiovascular Outcomes in the Acute Phase of COVID-19. Int J Mol Sci 2021;22:4071. [PMID: 33920790 DOI: 10.3390/ijms22084071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
594 Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol 2021. [PMID: 34686843 DOI: 10.1038/s41569-021-00631-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
595 Varahachalam SP, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos JF, Kim NY, Kaushik A. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Int J Nanomedicine 2021;16:539-60. [PMID: 33519200 DOI: 10.2147/IJN.S283686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 13.0] [Reference Citation Analysis]
596 Mason KE, Maudsley G, McHale P, Pennington A, Day J, Barr B. Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic. Front Public Health 2021;9:584182. [PMID: 34422736 DOI: 10.3389/fpubh.2021.584182] [Reference Citation Analysis]
597 Zagidullin NS, Motloch LJ, Musin TI, Bagmanova ZA, Lakman IA, Tyurin AV, Gumerov RM, Enikeev D, Cai B, Gareeva DF, Davtyan PA, Gareev DA, Talipova HM, Badykov MR, Jirak P, Kopp K, Hoppe UC, Pistulli R, Pavlov VN. J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality? PLoS One 2021;16:e0257982. [PMID: 34648510 DOI: 10.1371/journal.pone.0257982] [Reference Citation Analysis]
598 Hess CB, Nasti TH, Dhere VR, Kleber TJ, Switchenko JM, Buchwald ZS, Stokes WA, Weinberg BD, Rouphael N, Steinberg JP, Godette KD, Murphy DJ, Ahmed R, Curran WJ Jr, Khan MK. Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia. Int J Radiat Oncol Biol Phys 2021;109:867-79. [PMID: 33340603 DOI: 10.1016/j.ijrobp.2020.12.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
599 Mishra AK, Sahu KK, George AA, Lal A. A review of cardiac manifestations and predictors of outcome in patients with COVID - 19. Heart Lung 2020;49:848-52. [PMID: 32593418 DOI: 10.1016/j.hrtlng.2020.04.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
600 Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, Tobin KA, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. [PMID: 32444366 DOI: 10.1136/bmj.m1966] [Cited by in Crossref: 903] [Cited by in F6Publishing: 829] [Article Influence: 451.5] [Reference Citation Analysis]
601 Parra-Lucares A, Toro L, Weitz-Muñoz S, Ramos C. Cardiomyopathy Associated with Anti-SARS-CoV-2 Vaccination: What Do We Know? Viruses 2021;13:2493. [PMID: 34960761 DOI: 10.3390/v13122493] [Reference Citation Analysis]
602 Pillai P, Joseph JP, Fadzillah NHM, Mahmod M. COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems. J Stroke Cerebrovasc Dis 2021;30:105427. [PMID: 33137615 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
603 Martos Pérez F, Luque Del Pino J, Jiménez García N, Mora Ruiz E, Asencio Méndez C, García Jiménez JM, Navarro Romero F, Núñez Rodríguez MV. Comorbidity and prognostic factors on admission in a COVID-19 cohort of a general hospital. Rev Clin Esp (Barc) 2021;221:529-35. [PMID: 34752264 DOI: 10.1016/j.rceng.2020.05.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
604 Bugert CL, Kwiat V, Valera IC, Bugert JJ, Parvatiyar MS. Cardiovascular Injury Due to SARS-CoV-2. Curr Clin Microbiol Rep 2021;:1-11. [PMID: 33717830 DOI: 10.1007/s40588-021-00160-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
605 Gao P, Wu W, Tian R, Yan X, Qian H, Guo F, Li T, Liu Z, Wang J, Zhou X, Qin Y, Zhao D, Bian X, Lin X, Zhang S. Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19). Ann Transl Med 2021;9:883. [PMID: 34164517 DOI: 10.21037/atm-21-2282] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
606 Myhre PL, Heck SL, Skranes JB, Prebensen C, Jonassen CM, Berge T, Mecinaj A, Melles W, Einvik G, Ingul CB, Tveit A, Berdal JE, Røsjø H, Lyngbakken MN, Omland T. Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity. Am Heart J 2021;242:61-70. [PMID: 34400140 DOI: 10.1016/j.ahj.2021.08.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
607 Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA; COVID-19 Global Rheumatology Alliance. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis 2020;79:734-6. [PMID: 32295786 DOI: 10.1136/annrheumdis-2020-217480] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
608 Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review. Qeios. [DOI: 10.32388/ujr2aw.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
609 Bansal A, Kumar A, Patel D, Puri R, Kalra A, Kapadia SR, Reed GW. Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19). Am J Cardiol 2021;141:140-6. [PMID: 33217345 DOI: 10.1016/j.amjcard.2020.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
610 Katsiki N, Banach M, Mikhailidis DP. Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic. Arch Med Sci 2020;16:485-9. [PMID: 32399093 DOI: 10.5114/aoms.2020.94503] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
611 Hantoushzadeh S, Nabavian SM, Soleimani Z, Soleimani A. COVID-19 Disease During Pregnancy and Peripartum Period: A Cardiovascular Review. Curr Probl Cardiol 2021;:100888. [PMID: 34127288 DOI: 10.1016/j.cpcardiol.2021.100888] [Reference Citation Analysis]
612 Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD). Issues for the management of people with diabetes and COVID-19 in ICU. Cardiovasc Diabetol 2020;19:114. [PMID: 32690029 DOI: 10.1186/s12933-020-01089-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
613 Kitakata H, Kohsaka S, Kuroda S, Nomura A, Kitai T, Yonetsu T, Torii S, Matsue Y, Matsumoto S. Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients. J Clin Med 2021;10:3086. [PMID: 34300252 DOI: 10.3390/jcm10143086] [Reference Citation Analysis]
614 Pettirosso E, Giles M, Cole S, Rees M. COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission. Aust N Z J Obstet Gynaecol. 2020;60:640-659. [PMID: 32779193 DOI: 10.1111/ajo.13204] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
615 Andersson C, Gerds T, Fosbøl E, Phelps M, Andersen J, Lamberts M, Holt A, Butt JH, Madelaire C, Gislason G, Torp-Pedersen C, Køber L, Schou M. Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study. Circ Heart Fail 2020;13:e007274. [PMID: 32482087 DOI: 10.1161/CIRCHEARTFAILURE.120.007274] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 16.5] [Reference Citation Analysis]
616 Kulkarni S, Jenner BL, Wilkinson I. COVID-19 and hypertension. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320927851. [PMID: 32431227 DOI: 10.1177/1470320320927851] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
617 Rochette L, Ghibu S. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection. Int J Mol Sci 2021;22:7979. [PMID: 34360751 DOI: 10.3390/ijms22157979] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
618 Wang Y, Shu H, Liu H, Li X, Zhou X, Zou X, Pan S, Xu J, Xu D, Zhao X, Yang X, Yu Y, Yuan Y, Qi H, Wang Q, Shang Y. The peak levels of highly sensitive troponin I predicts in-hospital mortality in COVID-19 patients with cardiac injury: a retrospective study. Eur Heart J Acute Cardiovasc Care 2021;10:6-15. [PMID: 33620438 DOI: 10.1093/ehjacc/zuaa019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
619 Jänig C, Gurney JM, Froklage R, Groth R, Wirth C, van de Krol H, Schmidbauer W, Güsgen C. Facing COVID-19: Early Recognition and Triage Tool for Medical Treatment Facilities With Limited Resources. Mil Med 2020:usaa296. [PMID: 33108437 DOI: 10.1093/milmed/usaa296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
620 Monreal E, Sainz de la Maza S, Fernández-Velasco JI, Natera-Villalba E, Rita CG, Rodríguez-Jorge F, Beltrán-Corbellini Á, Iturrieta-Zuazo I, Rodríguez de Santiago E, Espiño M, de Andrés A, Fortún J, Barbero E, Vázquez M, Fernández Lucas M, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19. J Clin Immunol 2021;41:315-23. [PMID: 33236261 DOI: 10.1007/s10875-020-00927-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
621 Lara-Ureña N, García-Domínguez M. Relevance of BET Family Proteins in SARS-CoV-2 Infection. Biomolecules 2021;11:1126. [PMID: 34439792 DOI: 10.3390/biom11081126] [Reference Citation Analysis]
622 Chilingaryan T, Tribunyan S, Poghosyan H, Sargsyan K, Hovhannisyan H, Karapetyan K, Niazyan L, Hayrapetyan H. The role of anticoagulation in preventing myocardial infarction and improving outcomes in COVID-19 patients. Herzschrittmacherther Elektrophysiol 2021;32:365-70. [PMID: 34269844 DOI: 10.1007/s00399-021-00786-z] [Reference Citation Analysis]
623 Dedè L, Regazzoni F, Vergara C, Zunino P, Guglielmo M, Scrofani R, Fusini L, Cogliati C, Pontone G, Quarteroni A. Modeling the cardiac response to hemodynamic changes associated with COVID-19: a computational study. Math Biosci Eng 2021;18:3364-83. [PMID: 34198390 DOI: 10.3934/mbe.2021168] [Reference Citation Analysis]
624 Ho JS, Sia CH, Chan MY, Lin W, Wong RC. Coronavirus-induced myocarditis: A meta-summary of cases. Heart Lung 2020;49:681-5. [PMID: 32861884 DOI: 10.1016/j.hrtlng.2020.08.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 17.0] [Reference Citation Analysis]
625 Bugger H, Gollmer J, Pregartner G, Wünsch G, Berghold A, Zirlik A, von Lewinski D. Complications and mortality of cardiovascular emergency admissions during COVID-19 associated restrictive measures. PLoS One 2020;15:e0239801. [PMID: 32970774 DOI: 10.1371/journal.pone.0239801] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
626 Cheng R, Leedy D. COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander? Heart 2020;106:1122-4. [PMID: 32354799 DOI: 10.1136/heartjnl-2020-317025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
627 Dawson D, Dominic P, Sheth A, Modi M. Prognostic value of Cardiac Biomarkers in COVID-19 Infection: A Meta-analysis. Res Sq 2020:rs. [PMID: 32702736 DOI: 10.21203/rs.3.rs-34729/v1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
628 Hsia BC, Greige N, Quiroz JA, Khokhar AS, Daily J, Di Biase L, Ferrick KJ, Fisher JD, Krumerman A. QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin. J Interv Card Electrophysiol 2020;59:337-45. [PMID: 32654098 DOI: 10.1007/s10840-020-00822-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
629 D'Andrea A, Radmilovic J, Carbone A, Forni A, Tagliamonte E, Riegler L, Liccardo B, Crescibene F, Sirignano C, Esposito G, Bossone E. Multimodality imaging in COVID-19 patients: A key role from diagnosis to prognosis. World J Radiol 2020; 12(11): 261-271 [PMID: 33362917 DOI: 10.4329/wjr.v12.i11.261] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
630 Song X, Tan L, Wang M, Ren C, Guo C, Yang B, Ren Y, Cao Z, Li Y, Pei J. Myricetin: A review of the most recent research. Biomed Pharmacother 2021;134:111017. [PMID: 33338751 DOI: 10.1016/j.biopha.2020.111017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
631 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
632 Dos Anjos F, Simões JLB, Assmann CE, Carvalho FB, Bagatini MD. Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2. J Immunol Res 2020;2020:8632048. [PMID: 33299899 DOI: 10.1155/2020/8632048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
633 Das D, Podder S. Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity. Comput Biol Med 2021;134:104459. [PMID: 34020127 DOI: 10.1016/j.compbiomed.2021.104459] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
634 Iroungou BA, Mangouka LG, Bivigou-Mboumba B, Moussavou-Boundzanga P, Obame-Nkoghe J, Nzigou Boucka F, Mouinga-Ondeme A, Aghokeng AF, Tchoua R, Pineau P, Nzenze JR. Demographic and Clinical Characteristics Associated With Severity, Clinical Outcomes, and Mortality of COVID-19 Infection in Gabon. JAMA Netw Open 2021;4:e2124190. [PMID: 34519768 DOI: 10.1001/jamanetworkopen.2021.24190] [Reference Citation Analysis]
635 Fratta Pasini AM, Stranieri C, Girelli D, Busti F, Cominacini L. Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? Antioxidants (Basel) 2021;10:1677. [PMID: 34829548 DOI: 10.3390/antiox10111677] [Reference Citation Analysis]
636 Cajamarca-Baron J, Guavita-Navarro D, Buitrago-Bohorquez J, Gallego-Cardona L, Navas A, Cubides H, Arredondo AM, Escobar A, Rojas-Villarraga A. SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression. Reumatol Clin (Engl Ed) 2021;17:408-19. [PMID: 34301385 DOI: 10.1016/j.reumae.2020.08.001] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
637 Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis. Int J Mol Sci 2021;22:1804. [PMID: 33670394 DOI: 10.3390/ijms22041804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
638 Peltzer B, Manocha KK, Ying X, Kirzner J, Ip JE, Thomas G, Liu CF, Markowitz SM, Lerman BB, Safford MM, Goyal P, Cheung JW. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19. J Cardiovasc Electrophysiol 2020;31:3077-85. [PMID: 33017083 DOI: 10.1111/jce.14770] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
639 Iwanski J, Kazmouz SG, Li S, Stansfield B, Salem TT, Perez-Miller S, Kazui T, Jena L, Uhrlaub JL, Lick S, Nikolich-Žugich J, Konhilas JP, Gregorio CC, Khanna M, Campos SK, Churko JM. Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells. Stem Cell Reports 2021;16:2459-72. [PMID: 34525378 DOI: 10.1016/j.stemcr.2021.08.018] [Reference Citation Analysis]
640 Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: Is there enough evidence? J Clin Hypertens (Greenwich) 2020;22:943-8. [PMID: 32472662 DOI: 10.1111/jch.13912] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
641 Jensch PJ, Stiermaier T, Eitel I. Takotsubo Syndrome-Is There a Need for CMR? Curr Heart Fail Rep 2021;18:200-10. [PMID: 34148183 DOI: 10.1007/s11897-021-00518-x] [Reference Citation Analysis]
642 De Michieli L, Ola O, Knott JD, Akula A, Mehta RA, Hodge DO, Dworak M, Yang EH, Gharacholou M, Singh G, Singh R, Gulati R, Jaffe AS, Sandoval Y. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19. Clin Chem 2021;67:1080-9. [PMID: 33860295 DOI: 10.1093/clinchem/hvab062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
643 Parker K, Hamilton P, Hanumapura P, Castelino L, Murphy M, Challiner R, Thachil J, Ebah L. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients. BMC Nephrol 2021;22:224. [PMID: 34134645 DOI: 10.1186/s12882-021-02436-5] [Reference Citation Analysis]
644 Singh J, Bhagaloo L, Sy E, Lavoie AJ, Dehghani P, Neary P. Novel effects of acute COVID-19 on cardiac mechanical function: Two case studies. Physiol Rep 2021;9:e14998. [PMID: 34448551 DOI: 10.14814/phy2.14998] [Reference Citation Analysis]
645 Ergün B, Ergan B, Sözmen MK, Küçük M, Yakar MN, Cömert B, Gökmen AN, Yaka E. New-onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID-19). J Arrhythm 2021. [PMID: 34518774 DOI: 10.1002/joa3.12619] [Reference Citation Analysis]
646 Zhu F, Li W, Lin Q, Xu M, Du J, Li H. Myoglobin and troponin as prognostic factors in patients with COVID-19 pneumonia. Med Clin (Engl Ed) 2021;157:164-71. [PMID: 34458579 DOI: 10.1016/j.medcle.2021.01.014] [Reference Citation Analysis]
647 Cordero A, Santos García-gallego C, Bertomeu-gonzález V, Fácila L, Rodríguez-mañero M, Escribano D, Castellano JM, Zuazola P, Núñez J, Badimón JJ, González-juanatey JR. Mortality associated with cardiovascular disease in patients with COVID-19. REC: CardioClinics 2021;56:30-8. [DOI: 10.1016/j.rccl.2020.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
648 Capecchi PL, Lazzerini PE. Targeting IL-6 in COVID-19. Response to: ‘Rational use of tocilizumab in COVID-19’ by Jain and Sharma. Ann Rheum Dis. [DOI: 10.1136/annrheumdis-2020-218627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
649 Wang Z, Zhang D, Wang S, Jin Y, Huan J, Wu Y, Xia C, Li Z, Qi X, Zhang D, Han X, Zhu X, Qu Y, Wang Q. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19. Med Sci Monit 2020;26:e926651. [PMID: 32969367 DOI: 10.12659/MSM.926651] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
650 McCarthy CG, Saha P, Golonka RM, Wenceslau CF, Joe B, Vijay-Kumar M. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs). Compr Physiol 2021;11:1575-89. [PMID: 33577121 DOI: 10.1002/cphy.c200020] [Reference Citation Analysis]
651 Donatelli F, Miceli A, Glauber M, Cirri S, Maiello C, Coscioni E, Napoli C. Adult cardiovascular surgery and the coronavirus disease 2019 (COVID-19) pandemic: the Italian experience. Interact Cardiovasc Thorac Surg 2020;31:755-62. [PMID: 33099647 DOI: 10.1093/icvts/ivaa186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
652 Fagyas M, Bánhegyi V, Úri K, Enyedi A, Lizanecz E, Mányiné IS, Mártha L, Fülöp GÁ, Radovits T, Pólos M, Merkely B, Kovács Á, Szilvássy Z, Ungvári Z, Édes I, Csanádi Z, Boczán J, Takács I, Szabó G, Balla J, Balla G, Seferovic P, Papp Z, Tóth A. Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients. Geroscience 2021;43:2289-304. [PMID: 34674152 DOI: 10.1007/s11357-021-00467-2] [Reference Citation Analysis]
653 Yarmohammadi H, Morrow JP, Dizon J, Biviano A, Ehlert F, Saluja D, Waase M, Elias P, Poterucha TJ, Berman J, Kushnir A, Abrams MP, Rubin GA, Jou S, Hennessey J, Uriel N, Wan EY, Garan H. Frequency of Atrial Arrhythmia in Hospitalized Patients With COVID-19. Am J Cardiol 2021;147:52-7. [PMID: 33617812 DOI: 10.1016/j.amjcard.2021.01.039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
654 Fu L, Fei J, Xu S, Xiang HX, Xiang Y, Hu B, Li MD, Liu FF, Li Y, Li XY, Zhao H, Xu DX. Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study. J Clin Transl Hepatol. 2020;8:246-254. [PMID: 33083246 DOI: 10.14218/jcth.2020.00043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
655 Grassi S, Campuzano O, Coll M, Cazzato F, Sarquella-Brugada G, Rossi R, Arena V, Brugada J, Brugada R, Oliva A. Update on the Diagnostic Pitfalls of Autopsy and Post-Mortem Genetic Testing in Cardiomyopathies. Int J Mol Sci 2021;22:4124. [PMID: 33923560 DOI: 10.3390/ijms22084124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
656 Yasri S, Wiwanitkit V. Troponin-T and B-Type Natriuretic Peptide in COVID-19. Arq Bras Cardiol 2021;116:854. [PMID: 33886740 DOI: 10.36660/abc.20201191] [Reference Citation Analysis]
657 Alghamdi S. Clinical characteristics and treatment outcomes of severe (ICU) COVID-19 patients in Saudi Arabia: A single centre study. Saudi Pharm J 2021. [PMID: 34366685 DOI: 10.1016/j.jsps.2021.08.008] [Reference Citation Analysis]
658 Bustin A, Sridi S, Gravinay P, Legghe B, Gosse P, Ouattara A, Rozé H, Coste P, Gerbaud E, Desclaux A, Boyer A, Prevel R, Gruson D, Bonnet F, Issa N, Montaudon M, Laurent F, Stuber M, Camou F, Cochet H. High-resolution Free-breathing late gadolinium enhancement Cardiovascular magnetic resonance to diagnose myocardial injuries following COVID-19 infection. Eur J Radiol 2021;144:109960. [PMID: 34600236 DOI: 10.1016/j.ejrad.2021.109960] [Reference Citation Analysis]
659 Yu B, Li C, Sun Y, Wang DW. Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.Cell Metab. 2021;33:65-77.e2. [PMID: 33248471 DOI: 10.1016/j.cmet.2020.11.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
660 Hayama H, Ide S, Moroi M, Kitami Y, Bekki N, Kubota S, Uemura Y, Hara H, Kutsuna S, Ohmagari N, Hiroi Y. Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019. Glob Health Med 2021;3:95-101. [PMID: 33937572 DOI: 10.35772/ghm.2021.01025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
661 Belarte-Tornero LC, Valdivielso-Moré S, Vicente Elcano M, Solé-González E, Ruíz-Bustillo S, Calvo-Fernández A, Subinara I, Cabero P, Soler C, Cubero-Gallego H, Vaquerizo B, Farré N. Prognostic Implications of Chronic Heart Failure and Utility of NT-proBNP Levels in Heart Failure Patients with SARS-CoV-2 Infection. J Clin Med 2021;10:323. [PMID: 33477268 DOI: 10.3390/jcm10020323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
662 Beyls C, Hermida A, Bohbot Y, Martin N, Viart C, Boisgard S, Daumin C, Huette P, Dupont H, Abou-Arab O, Mahjoub Y. Automated left atrial strain analysis for predicting atrial fibrillation in severe COVID-19 pneumonia: a prospective study. Ann Intensive Care 2021;11:168. [PMID: 34874509 DOI: 10.1186/s13613-021-00955-w] [Reference Citation Analysis]
663 Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight 2021;6:148980. [PMID: 34061779 DOI: 10.1172/jci.insight.148980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
664 Usman MS, Siddiqi TJ, Khan MS, Patel UK, Shahid I, Ahmed J, Kalra A, Michos ED. Is there a smoker’s paradox in COVID-19? BMJ EBM. [DOI: 10.1136/bmjebm-2020-111492] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
665 COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: Epidemiology Report 15 (Reporting week to 23:59 AEST 10 May 2020). Commun Dis Intell (2018) 2020;44. [PMID: 32438898 DOI: 10.33321/cdi.2020.44.43] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
666 Tan HL. How does COVID-19 kill at home and what should we do about it? Eur Heart J 2020;41:3055-7. [PMID: 32882708 DOI: 10.1093/eurheartj/ehaa599] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
667 Hotez PJ, Bottazzi ME, Corry DB. The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement. Microbes Infect 2020;22:165-7. [PMID: 32305501 DOI: 10.1016/j.micinf.2020.04.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 27.0] [Reference Citation Analysis]
668 Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20:529-536. [PMID: 32728222 DOI: 10.1038/s41577-020-0402-6] [Cited by in Crossref: 282] [Cited by in F6Publishing: 243] [Article Influence: 141.0] [Reference Citation Analysis]
669 Ragusa R, Basta G, Del Turco S, Caselli C. A possible role for ST2 as prognostic biomarker for COVID-19. Vascul Pharmacol 2021;138:106857. [PMID: 33746068 DOI: 10.1016/j.vph.2021.106857] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
670 Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol 2021. [PMID: 34531576 DOI: 10.1038/s41569-021-00611-7] [Reference Citation Analysis]
671 Lasbleiz A, Gaborit B, Soghomonian A, Bartoli A, Ancel P, Jacquier A, Dutour A. COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury. Front Endocrinol (Lausanne) 2021;12:726967. [PMID: 34484128 DOI: 10.3389/fendo.2021.726967] [Reference Citation Analysis]
672 Albani S, Vinhas H, Fuertes Ferre G, Basavarajaiah S, Khattak S, Tzanis G, Pizzato M, Toselli M, Khokhar AA, Musumeci G, Giannini F. Epidemiological findings on interventional cardiology procedures during the COVID-19 pandemic: A multi-center study. Indian Heart J 2021;73:647-9. [PMID: 34627586 DOI: 10.1016/j.ihj.2021.06.016] [Reference Citation Analysis]
673 Staub MB, Beaulieu RM, Graves J, Nelson GE. Changes in antimicrobial utilization during the coronavirus disease 2019 (COVID-19) pandemic after implementation of a multispecialty clinical guidance team. Infect Control Hosp Epidemiol 2021;42:810-6. [PMID: 33100250 DOI: 10.1017/ice.2020.1291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
674 Alam SR, Shah ASV, Ombati KO, Nganga E, Gitau S, Makhdomi K, Chung MH, Vinayak S. CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study). BMC Cardiovasc Disord 2021;21:234. [PMID: 33964872 DOI: 10.1186/s12872-021-02027-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
675 Karbalai Saleh S, Oraii A, Soleimani A, Hadadi A, Shajari Z, Montazeri M, Moradi H, Talebpour M, Sadat Naseri A, Balali P, Akhbari M, Ashraf H. The association between cardiac injury and outcomes in hospitalized patients with COVID-19.Intern Emerg Med. 2020;15:1415-1424. [PMID: 32772283 DOI: 10.1007/s11739-020-02466-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
676 Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, Schuepbach RA, Moch H, Varga Z. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine 2021;63:103182. [PMID: 33422990 DOI: 10.1016/j.ebiom.2020.103182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
677 Gao L, Jiang D, Wen XS, Cheng XC, Sun M, He B, You LN, Lei P, Tan XW, Qin S, Cai GQ, Zhang DY. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res. 2020;21:83. [PMID: 32293449 DOI: 10.1186/s12931-020-01352-w] [Cited by in Crossref: 112] [Cited by in F6Publishing: 108] [Article Influence: 56.0] [Reference Citation Analysis]
678 Malviya A, Yadav R. COVID -19 pandemic and paediatric population with special reference to congenital heart disease. Indian Heart J 2020;72:141-4. [PMID: 32768011 DOI: 10.1016/j.ihj.2020.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
679 Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 2020;57:236-43. [PMID: 32802325 DOI: 10.1016/j.amsu.2020.07.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
680 Zinellu A, Paliogiannis P, Carru C, Mangoni AA. Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression. Clin Exp Med 2021. [PMID: 34799779 DOI: 10.1007/s10238-021-00777-x] [Reference Citation Analysis]
681 Fraile Gutiérrez V, Ayuela Azcárate JM, Pérez-Torres D, Zapata L, Rodríguez Yakushev A, Ochagavía A. [Ultrasound in the management of the critically ill patient with SARS-CoV-2 infection (COVID-19): narrative review]. Med Intensiva (Engl Ed) 2020;44:551-65. [PMID: 32527471 DOI: 10.1016/j.medin.2020.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
682 Lopez-Pais J, Otero DL, Ferreiro TG, Antonio CEC, Muiños PJA, Perez-Poza M, García ÓO, Ramos VJ, Fernández MS, Fernandez MB, Pena XCS, Roman AV, Romero MP, Lago AL, Escudero JÁ, Román AS, Gonzalez-Juanatey JR; CARDIOVID investigators. Fast track triage for COVID-19 based on a population study: The soda score. Prev Med Rep 2021;21:101298. [PMID: 33489725 DOI: 10.1016/j.pmedr.2020.101298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
683 Iqubal A, Iqubal MK, Hoda F, Najmi AK, Haque SE. COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention. Expert Rev Anti Infect Ther 2021;19:1083-92. [PMID: 33618607 DOI: 10.1080/14787210.2021.1893692] [Reference Citation Analysis]
684 Yehualashet AS, Belachew TF. ACEIs and ARBs and Their Correlation with COVID-19: A Review. Infect Drug Resist 2020;13:3217-24. [PMID: 32982336 DOI: 10.2147/IDR.S264882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
685 Flacco ME, Acuti Martellucci C, Bravi F, Parruti G, Cappadona R, Mascitelli A, Manfredini R, Mantovani LG, Manzoli L. Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis. Heart 2020;106:1519-24. [PMID: 32611676 DOI: 10.1136/heartjnl-2020-317336] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 22.5] [Reference Citation Analysis]
686 Clemente-Suárez VJ, Dalamitros AA, Beltran-Velasco AI, Mielgo-Ayuso J, Tornero-Aguilera JF. Social and Psychophysiological Consequences of the COVID-19 Pandemic: An Extensive Literature Review. Front Psychol 2020;11:580225. [PMID: 33391099 DOI: 10.3389/fpsyg.2020.580225] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
687 Philips CA, Mohan N, Ahamed R, Kumbar S, Rajesh S, George T, Mohanan M, Augustine P. One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease. World J Clin Cases 2020; 8(18): 3956-3970 [PMID: 33024752 DOI: 10.12998/wjcc.v8.i18.3956] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
688 Kremer S, Lersy F, Anheim M, Merdji H, Schenck M, Oesterlé H, Bolognini F, Messie J, Khalil A, Gaudemer A, Carré S, Alleg M, Lecocq C, Schmitt E, Anxionnat R, Zhu F, Jager L, Nesser P, Mba YT, Hmeydia G, Benzakoun J, Oppenheim C, Ferré JC, Maamar A, Carsin-Nicol B, Comby PO, Ricolfi F, Thouant P, Boutet C, Fabre X, Forestier G, de Beaurepaire I, Bornet G, Desal H, Boulouis G, Berge J, Kazémi A, Pyatigorskaya N, Lecler A, Saleme S, Edjlali-Goujon M, Kerleroux B, Constans JM, Zorn PE, Mathieu M, Baloglu S, Ardellier FD, Willaume T, Brisset JC, Caillard S, Collange O, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, Meyer N, Helms J, Cotton F. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology 2020;95:e1868-82. [PMID: 32680942 DOI: 10.1212/WNL.0000000000010112] [Cited by in Crossref: 80] [Cited by in F6Publishing: 38] [Article Influence: 40.0] [Reference Citation Analysis]
689 Yang Y, Xiao Z, Ye K, He X, Sun B, Qin Z, Yu J, Yao J, Wu Q, Bao Z, Zhao W. SARS-CoV-2: characteristics and current advances in research. Virol J 2020;17:117. [PMID: 32727485 DOI: 10.1186/s12985-020-01369-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
690 Psotka MA, Abraham WT, Fiuzat M, Filippatos G, Lindenfeld J, Ahmad T, Bhatt AS, Carson PE, Cleland JGF, Felker GM, Januzzi JL Jr, Kitzman DW, Leifer ES, Lewis EF, McMurray JJV, Mentz RJ, Solomon SD, Stockbridge N, Teerlink JR, Vaduganathan M, Vardeny O, Whellan DJ, Wittes J, Anker SD, O'Connor CM. Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol 2020;76:2368-78. [PMID: 33183511 DOI: 10.1016/j.jacc.2020.09.544] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
691 Eskandari A, Brojakowska A, Bisserier M, Bander J, Garikipati VNS, Hadri L, Goukassian D, Fish K. Retrospective analysis of demographic factors in COVID-19 patients entering the Mount Sinai Health System. PLoS One 2021;16:e0254707. [PMID: 34270621 DOI: 10.1371/journal.pone.0254707] [Reference Citation Analysis]
692 Qin W, Chen S, Zhang Y, Dong F, Zhang Z, Hu B, Zhu Z, Li F, Wang X, Wang Y, Zhen K, Wang J, Wan Y, Li H, Elalamy I, Li C, Zhai Z, Wang C. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J 2021;58:2003677. [PMID: 33574077 DOI: 10.1183/13993003.03677-2020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
693 Burbelo PD, Riedo FX, Morishima C, Rawlings S, Smith D, Das S, Strich JR, Chertow DS, Davey RT Jr, Cohen JI. Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients. medRxiv 2020:2020. [PMID: 32511445 DOI: 10.1101/2020.04.20.20071423] [Cited by in Crossref: 48] [Cited by in F6Publishing: 11] [Article Influence: 24.0] [Reference Citation Analysis]
694 Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Fotiou D, Migkou M, Tzanninis IG, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Emerging treatment strategies for COVID-19 infection. Clin Exp Med 2021;21:167-79. [PMID: 33128197 DOI: 10.1007/s10238-020-00671-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
695 Cohen IV, Makunts T, Moumedjian T, Issa MA, Abagyan R. Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports. Sci Rep 2020;10:19199. [PMID: 33154498 DOI: 10.1038/s41598-020-76258-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
696 Rathore SS, Rojas GA, Sondhi M, Pothuru S, Pydi R, Kancherla N, Singh R, Ahmed NK, Shah J, Tousif S, Baloch UT, Wen Q. Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series. Int J Clin Pract 2021;:e14470. [PMID: 34235815 DOI: 10.1111/ijcp.14470] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
697 Abohamr SI, Aldossari MA, Amer HA, Saadeddin HM, Abulhamid SW, Bhat FA, Elsheikh E. The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study. J Saudi Heart Assoc 2021;33:128-34. [PMID: 34183909 DOI: 10.37616/2212-5043.1253] [Reference Citation Analysis]
698 Caro-Codón J, Rey JR, Buño A, Iniesta AM, Rosillo SO, Castrejon-Castrejon S, Merino C, Marco I, Martinez LA, Garcia-Veas JM, Martin-Polo L, Rodriguez-Sotelo L, Martinez-Cossiani M, Gonzalez-Valle L, Herrero A, López-de-Sá E, Merino JL; CARD-COVID Investigators. Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection. Med Clin (Barc) 2021:S0025-7753(21)00092-0. [PMID: 33846001 DOI: 10.1016/j.medcli.2021.02.001] [Reference Citation Analysis]
699 Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 2020;509:280-7. [PMID: 32531256 DOI: 10.1016/j.cca.2020.06.017] [Cited by in Crossref: 174] [Cited by in F6Publishing: 155] [Article Influence: 87.0] [Reference Citation Analysis]
700 Diaz T, Trachtenberg BH, Abraham SJK, KosagiSharaf R, Durant-Archibold AA. Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19. Front Cardiovasc Med 2020;7:562708. [PMID: 33330639 DOI: 10.3389/fcvm.2020.562708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
701 Llàcer P, Manzano L, Fernández C, Moreno MC, Núñez J. Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis. Eur J Intern Med 2021;88:136-8. [PMID: 33676804 DOI: 10.1016/j.ejim.2021.02.013] [Reference Citation Analysis]
702 Zhu H, Lai J, Liu B, Wen Z, Xiong Y, Li H, Zhou Y, Fu Q, Yu G, Yan X, Yang X, Zhang J, Wang C, Zeng H. Automatic pulmonary auscultation grading diagnosis of Coronavirus Disease 2019 in China with artificial intelligence algorithms: A cohort study. Comput Methods Programs Biomed 2022;213:106500. [PMID: 34768234 DOI: 10.1016/j.cmpb.2021.106500] [Reference Citation Analysis]
703 Ferrara F, Vitiello A. The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1589-93. [PMID: 34151392 DOI: 10.1007/s00210-021-02108-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
704 Assaf AM, Haddadin RN, Akour AA. COVID-19: Between Past and Present. Viral Immunol 2021;34:145-57. [PMID: 33017280 DOI: 10.1089/vim.2020.0102] [Reference Citation Analysis]
705 Giri M, Puri A, Wang T, Guo S. Clinical features, comorbidities, complications and treatment options in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Nurs Open 2021;8:1077-88. [PMID: 34482663 DOI: 10.1002/nop2.718] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
706 Mejia OAV, Borgomoni GB, Silveira LMV, Guerreiro GP, Falcão Filho ATG, Goncharov M, Dallan LRP, Oliveira MAP, de Sousa AG, Nakazone MA, Tiveron MG, Campagnucci VP, de Barros E Silva PGM, Dallan LAO, Lisboa LAF, Jatene FB; REPLICCAR Study Group. The arrival of COVID-19 in Brazil and the impact on coronary artery bypass surgery. J Card Surg 2021;36:3070-7. [PMID: 34091941 DOI: 10.1111/jocs.15712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
707 Sharma D, Rasmussen M, Han R, Whalin MK, Davis M, Kofke WA, Venkatraghvan L, Raychev R, Fraser JF. Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement From Society for Neuroscience in Anesthesiology & Critical Care (SNACC): Endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional Surgery (SNIS), Neurocritical Care Society (NCS), European Society of Minimally Invasive Neurological Therapy (ESMINT) and American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) Cerebrovascular Section. J Neurosurg Anesthesiol 2020;32:193-201. [PMID: 32282614 DOI: 10.1097/ANA.0000000000000688] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 24.0] [Reference Citation Analysis]
708 Yao Y, Wang H, Liu Z. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases. Clin Exp Allergy 2020;50:1313-24. [PMID: 32975865 DOI: 10.1111/cea.13746] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
709 Mottola FF, Verde N, Ricciolino R, Di Mauro MD, Migliaccio MG, Carfora V, Spiniello G, Coppola N, Vanvitelli Covid-Group. Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor? Life (Basel) 2020;10:E165. [PMID: 32867137 DOI: 10.3390/life10090165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
710 Cenko E, Badimon L, Bugiardini R, Claeys MJ, De Luca G, de Wit C, Derumeaux G, Dorobantu M, Duncker DJ, Eringa EC, Gorog DA, Hassager C, Heinzel FR, Huber K, Manfrini O, Milicic D, Oikonomou E, Padro T, Trifunovic-Zamaklar D, Vasiljevic-Pokrajcic Z, Vavlukis M, Vilahur G, Tousoulis D. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res 2021:cvab298. [PMID: 34528075 DOI: 10.1093/cvr/cvab298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
711 Zaccone G, Tomasoni D, Italia L, Lombardi CM, Metra M. Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation. Curr Heart Fail Rep 2021;18:99-106. [PMID: 33890193 DOI: 10.1007/s11897-021-00509-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
712 Miftode RS, Petriș AO, Onofrei Aursulesei V, Cianga C, Costache II, Mitu O, Miftode IL, Șerban IL. The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19. Diagnostics (Basel) 2021;11:175. [PMID: 33530550 DOI: 10.3390/diagnostics11020175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
713 Rehman S, Ravinayagam V, Nahvi I, Aldossary H, Al-Shammari M, Amiri MSA, Kishore U, Al-Suhaimi EA. Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women. Front Immunol 2021;12:680845. [PMID: 34484179 DOI: 10.3389/fimmu.2021.680845] [Reference Citation Analysis]
714 Calcaterra G, Bassareo PP, Barillà F, Sergi D, Chiocchi M, Romeo F, Mehta JL. The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High. Curr Cardiol Rev 2021;17:74-7. [PMID: 32735524 DOI: 10.2174/1573403X16666200731162614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
715 Tadic M, Cuspidi C, Mancia G, Dell'Oro R, Grassi G. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? Pharmacol Res 2020;158:104906. [PMID: 32461198 DOI: 10.1016/j.phrs.2020.104906] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
716 Su W, Qiu Z, Zhou L, Hou J, Wang Y, Huang F, Zhang Y, Jia Y, Zhou J, Liu D, Xia Z, Xia ZY, Lei S. Sex differences in clinical characteristics and risk factors for mortality among severe patients with COVID-19: a retrospective study. Aging (Albany NY) 2020;12:18833-43. [PMID: 33051404 DOI: 10.18632/aging.103793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
717 Ceylan H. A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling. Gene Rep 2021;24:101246. [PMID: 34131597 DOI: 10.1016/j.genrep.2021.101246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
718 Zarkesh K, Entezar-Almahdi E, Ghasemiyeh P, Akbarian M, Bahmani M, Roudaki S, Fazlinejad R, Mohammadi-Samani S, Firouzabadi N, Hosseini M, Farjadian F. Drug-based therapeutic strategies for COVID-19-infected patients and their challenges. Future Microbiol 2021;16:1415-51. [PMID: 34812049 DOI: 10.2217/fmb-2021-0116] [Reference Citation Analysis]
719 Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K, Boudreau E, Howe KL, Fish JE. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis? Arterioscler Thromb Vasc Biol 2020;40:1818-29. [PMID: 32510978 DOI: 10.1161/ATVBAHA.120.314558] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 16.5] [Reference Citation Analysis]
720 Akhtar S, Benter IF, Danjuma MI, Doi SAR, Hasan SS, Habib AM. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J Drug Target 2020;28:683-99. [PMID: 32700580 DOI: 10.1080/1061186X.2020.1797754] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
721 Lairez O, Blanchard V, Balardy L, Vardon-Bounes F, Cazalbou S, Ruiz S, Collot S, Houard V, Rolland Y, Conil JM, Minville V. Cardiac Imaging Phenotype in Patients with Coronavirus Disease 2019 - COCARDE study: prospective observational study. JMIR Res Protoc 2021. [PMID: 34751159 DOI: 10.2196/24931] [Reference Citation Analysis]
722 Sud M, Qui F, Shah R, Lee DS, Nallamothu BK, Natarajan MK, Wijeysundera HC, Ko DT. Rate of COVID-19 infection in patients with ST-segment elevation myocardial infarction. CJC Open 2021. [PMID: 34056569 DOI: 10.1016/j.cjco.2021.05.012] [Reference Citation Analysis]
723 Messina F, Giombini E, Montaldo C, Sharma AA, Zoccoli A, Sekaly RP, Locatelli F, Zumla A, Maeurer M, Capobianchi MR, Lauria FN, Ippolito G. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome. Cell Death Dis 2021;12:788. [PMID: 34385425 DOI: 10.1038/s41419-021-03881-8] [Reference Citation Analysis]
724 Babapoor-Farrokhran S, Rasekhi RT, Gill D, Babapoor S, Amanullah A. Arrhythmia in COVID-19. SN Compr Clin Med 2020;:1-6. [PMID: 32838188 DOI: 10.1007/s42399-020-00454-2] [Cited by in Crossref: 28] [